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Endocytic organelles maintain their characteristic, essential internal pH using the 
V-type ATPase H+-pump. Accumulation of H+ generates a voltage across the membrane; 
an additional ion, known as a counterion, must move to dissipate charge buildup. 
Chloride (Cl-) has been hypothesized to be an important counterion in the endosomal 
pathway, but its role is still debated. This thesis seeks to explore the role of counterions 
and the proteins that facilitate their movements in the acidification of clathrin-coated 
vesicles (CCVs), a subset of early endosomes, and lysosomes. We confirmed previous 
work showing that isolated bovine brain CCVs acidify in the presence of external Cl-, 
independent of the monovalent cations present. While unsuccessful at identifying the 
protein responsible for the observed anion transport, we used a new approach to confirm 
that most brain CCVs are synaptic vesicles. Secondly, because acidification in isolated 
lysosomes is Cl--dependent and the lysosomal protein ClC-7, a Cl-/H+ antiporter, moves 
Cl- into the organelles, this protein has been suggested to mediate such counterion 
movement. However, live cell ClC-7 knockout (KO) mouse lysosomes have the same pH 
as WT. We generated mice with a liver-specific deletion of ClC-7 to test these results in 
isolated lysosomes and live cells in parallel. While isolated ClC-7 KO lysosomes showed 
a drastic decrease in Cl--facilitated acidification, lysosomal pH was similar in WT and 
KO hepatocytes, even during metabolic and base challenges. Lastly, we present two 
patients with an identical pathogenic de novo variant in CLCN7, who display 
hypopigmentation, a delay in motor skills, abnormal liver/spleen/kidneys, and failure to 
thrive, but no osteopetrosis. Patient fibroblasts contain large vacuoles scattered 
throughout the cytoplasm that do not consistently stain for lysosomal markers, and 
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possess a vast increase in the lysosomal-like compartments that stain for Lamp1, a 
lysosomal protein. Lysosomal pH in cultured patient fibroblasts are more acidic than the 
neonatal controls and heterologous expression of the mutant ClC-7 in Xenopus oocytes 
revealed substantial increases in transport activity. These results suggest a novel gain-of-
function for this Cl-/H+ antiporter, one of the first reported instances of lysosomal 
hyperacidification, and shows that ClC-7 plays a role in lysosomal pH. Overall, this work 
contributes to the field of organelle acidification and brings us closer to understanding 
how organelles use counterions to assist in and regulate pH. 
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Chapter 1: Introduction 
 
pH in the endocytic pathway 
From prokaryotes to multicellular organisms, function and behavior is dictated by, 
and has evolved from, interactions with the pH of external and internal environments. For 
example, the human body carefully regulates the pH of its various systems to ensure 
proper function, ranging from the slightly basic pH of blood, where even small deviations 
can result in detrimental symptoms, to the extremely acidic pH of the stomach. On a 
cellular level, processes such as the generation of ATP in the mitochondria, the 
glycosylation and transport of proteins from the trans-Golgi network, and macromolecule 
degradation in lysosomes depend on precise pHs for proper function. Various diseases 
arise when pH is improperly regulated, with symptoms ranging from tolerable to life 
threatening.  
Careful regulation and maintenance of luminal pH is crucial for the function of 
the organelles that comprise the endocytic pathway, a transport network used to recycle 
or degrade various solutes and macromolecules within a cell (Figure 1). These 
membrane-delimited organelles consist of early endosomes, recycling endosomes, late 
endosomes, and lysosomes. The pathway begins with the fusion of endocytic vesicles to 
early endosomes, providing them with cargo and internal solutes. Early endosomes sort 
the internalized material, lipids, and membrane proteins, where they are sent to be 
degraded or recycled back to the plasma membrane, the trans-Golgi network (TGN), or 
recycling endosomes. After a short period of cargo accumulation and recycling, early 
endosomes undergo a maturation process and eventually transition to late endosomes. 
2 
 
Late endosomes fuse with lysosomes to become endolysosomes and these hybrid 
organelles ultimately mature into lysosomes, acidic compartments containing hydrolytic 








Figure 1: The endosome/lysosome system. 
Endocytic vesicles, typically originating from the plasma membrane and the trans-Golgi 
network (TGN) deliver their cargo to early endosomes (EEs). After a short period where EEs 
accumulate cargo and sort some away for recycling, the EEs mature into late endsosomes 
(LEs). Lysosomes fuse with LEs to form endolysosomes, which ultimately mature into 
lysosomes. pH progressively decreases along the endosomal pathway. EEs typically maintain 
a pH near 6.5, LE have a pH between 5.0-5.5, and lysosomes typically have a pH around 4.0-
5.0.  
Figure from Huotari and Helenius (2011). Full citation: (2). 
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The endosomal organelles progressively become more acidic, a process essential 
to their function. The pathway starts with early endosomes near pH 6.5 and end with 
lysosomes whose pH ranges from 4.0-5.0. In early and late endosomes, the decrease in 
pH to specific values induces conformation changes that trigger the release of ligands 
from their respective transmembrane receptor proteins. Once released, cargo remains in 
the organelle lumen and the receptors are recycled back to the plasma membrane or TGN. 
In the lysosome, the extremely acidic pH is vital to optimally activate internal hydrolyses 
and to provide the protons necessary to drive the transport of catabolites back into the 
cytoplasm.  
In this thesis, I explore mechanisms related to how pH is established/maintained 
in two endocytic compartments: clathrin-coated vesicles, a subset of early endosomes, 
and lysosomes. Although these organelles have drastically different internal pH values 
and function, both appear to utilize Cl- transporting membrane proteins to assist with 
maintaining internal acidification. 
 
The V-ATPase generates a pH gradient in endocytic organelles 
The acidic pH of endocytic organelles is generated and maintained by the 
vacuolar H+-ATPase (V-ATPase), a membrane protein that utilizes the metabolic energy 
from ATP hydrolysis to unidirectionally pump protons into the lumen. It is a multisubunit 
complex composed of a membrane-embedded V0 subcomplex (consisting of eight 
subunits, A-H) that contains a central stock attached to the soluble, cytoplasmic V1 
subcomplex (made up of five subunits, a,c,c’’,d, and e) (4). Hydrolysis of ATP drives the 
rotation of the V1 domain around the central stock, forcing protons to move through the 
V0 domain and into the lumen. Unlike the structurally-related F0F1 ATPases that both 
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synthesize and hydrolyze ATP, the V-ATPases only unidirectionally rotate to hydrolyze 
ATP. Assuming the efficiency of the V-ATPase is 2 protons pumped for every ATP 
hydrolyzed, Grabe et al. calculated that an ideal rotary pump could theoretically create up 
to a 4 pH unit gradient between the organelle lumen and the cytosol (5), a wide range that 
encompasses all of the pHs found within the endocytic pathway. 
The V-ATPase is responsible for acidifying various intracellular organelles, 
including clathrin-coated vesicles, endosomes, lysosomes, secretory vesicles, and the 
Golgi apparatus, yet each compartment maintains its own unique internal pH (4). 
Although the mechanisms that control internal organellar pH are unclear, one possible 
method is to regulate the H+ pump. Several potential mechanisms of V-ATPase activity 
have been observed, but none have been shown to directly regulate organelle pH. These 
mechanisms occur on both functional and transcriptional levels and include the reversible 
inactivation of the pump, utilization of different isoforms that control cellular localization 
and/or modify ATP hydrolysis-proton transport coupling efficiency, and interaction with 
regulating partners (4, 6).  
One form of V-ATPase regulation occurs at the functional level, where the 
soluble V1 subcomplex reversibly dissociates from the membrane-embedded V0 complex, 
resulting in the loss of both its ATP hydrolysis and H+ translocation capabilities. This 
process was first observed in the yeast S. cerevisiae upon glucose starvation and in the 
tobacco hornworm Manduca sexta (M. sexta) in response to molting or starvation (7, 8). 
Addition of glucose/nutrients reversed this process, inducing the reassembly of V1 with 
V0 and restoring H
+ pumping without the need for synthesis of new protein (7). Renal 
cells also display some V-ATPase dissociation in response to glucose starvation, although 
5 
 
the physiological significance of this has yet to be determined (9). The dissociation 
process is regulated and aided by various protein and protein complexes, including the 
RAVE complex, microtubules, and the glycolytic enzyme aldolase (6). Thus, V-ATPase 
activity acts as a metabolic sensor regulated by nutrient availability, although whether 
this specifically influences pH in different organelles is unknown. Additional instances of 
V-ATPase functional regulation have been observed in various mammalian cells. For 
example, maturing dendritic cells activate the proton pump on late endosomes/lysosomes 
to acidify the organelle and process antigens (10).   
Another mechanism of V-ATPase regulation is control of cellular localization. 
This regulation has been most studied in yeast, where two different isoforms of subunit a, 
Vph1p and Stv1p, dictate whether the protein is targeted to the vacuole or the TGN, 
respectively (11-13). To compare the properties of the two isoforms, the Forgac lab 
overexpressed one of the isoforms in a yeast strain where the genes of both isoforms had 
been disrupted. By only expressing one isoform, Kawasaki-Nishi et al. measured the 
kinetic properties of the two complexes and measured coupling efficiency of ATP 
hydrolysis, the ability of the pump to couple ATP hydrolysis to the pumping of H+ (13). 
While having similar rates of hydrolysis, complexes containing the Vph1p were 4-5 times 
more efficient at coupling ATP hydrolysis to H+ pumping than the Stv1p-containing 
complexes, indicating that the latter complexes slip and hydrolyze ATP without pumping 
H+. While this change to the pump mechanism seems inefficient, the lower pH in the 
vacuole compared to the Golgi complex mirrors the V-ATPase distribution and may 
assist in pH regulation in the compartments. 
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In addition to cellular localization, isoforms of certain subunits have been 
observed to be tissue specific. The most studied subunit is a, which has 4 isoforms in 
mammalian cells. These isoforms are heavily expressed in specific tissues, including a3 
in osteoclasts, a4 in renal tissue, and a1 in synaptic vesicles of neuronal tissues (14). 
These isoforms appear to be important for targeting the V-ATPase to specific locations, 
such as the plasma membrane during bone resorption or synaptic vesicles in neurons, 
where their function is required in a tissue specific manner. Besides subunit a, at least 6 
of the 14 V-ATPase subunits have multiple isoforms (14). In these cases, typically one 
subunit tends to be ubiquitously expressed and trafficked, while another directly targets a 
specific compartment. For example, the d1 subunit is ubiquitously expressed but the d2 
subunit has limited tissue distribution, expressed primarily in bone osteoclasts and kidney 
(15, 16), and mice lacking the subunit have increased bone mass due to defective 
osteoclasts (17). While their individual effects have been observed, combinations of 
isoforms may be an additional type of regulation that is unexplored.   
Therefore, while many mechanisms regulate activity on both transcriptional and 
functional levels, none directly show that the V-ATPase affects pH levels. It is possible 
cells may employ various combinations of isoforms to tune the targeting and coupling 
efficiency of the pump’s activity to certain tissues/locations, but these approaches have 
yet to be identified. Therefore, other mechanisms must be investigated in order to 
determine how different organelles maintain their various internal pHs. 
 
The electrogenic V-ATPase requires counterions to allow organelle acidification 
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 The proton pumping action of the V-ATPase is electrogenic because it 
translocates charge across the lumen of the membrane, creating a voltage difference. This 
electrogenic property was established in isolated lysosomes by experiments performed by 
Ohkuma et al. and Harikumar & Reeves using the voltage-sensitive fluorescent dye diS-
C3(5) (18, 19). This positively charged dye accumulates in the membrane of 
compartments with negative transmembrane voltages, resulting in the quenching of 
fluorescence. In their experiments, the fluorescence signal of the dye increased upon the 
activation of the V-ATPase (by ATP addition), indicating that H+ pumping shifts the 
lysosomal lumen from negative internal voltages to more positive ones. The change in 
membrane potential clearly shows that the H+ pump is electrogenic. The accumulation of 
charge from the continuous pumping of the V-ATPase eventually builds to the point 
where net transport is inhibited because it is no longer favorable to pump an additional 
H+ across the membrane. Thus, to efficiently acidify an organelle an additional ion, 
known as a counterion, must simultaneously move to dissipate charge buildup and allow 
bulk acidification. The counterion could be a cytoplasmic anion entering the organelle, a 
luminal cation exiting the organelle, or a combination of both mechanisms. If counterion 
movement is a rate-limiting step in acidification, this too could be a mechanism of 
regulation of organelle pH. 
The ions most likely to behave as counterions are Na+, K+, Cl-, and Ca2+, due to 
their relative cellular abundance. The identity of the counterion(s) utilized by the 
organelles in the endosomal pathway has been studied in various systems, but is still not 
fully understood. Most of the initial studies investigating the importance and identity of 
counterions were performed on isolated organelles, an approach that allows for precise 
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control over the external ion composition. These experiments revealed that in isolated 
clathrin-coated vesicles (CCVs), endosomes, and lysosomes, the presence of anions in the 
bathing solution, specifically Cl-, facilitate acidification when measured with pH sensitive 
dyes (20-24). Subsequent studies over the years show that CCVs and endosomes rely on 
Cl- to act as the primary counterion in acidification, but the ions utilized by lysosomes are 
less clear (25-27). In the following sections I will expand upon the potential counterion 
mechanisms used by organelles in the endosomal pathway, focusing on early endosomes 
and lysosomes.  
 
Endosomal acidification  
Early endosomes serve as the sorting hub of the endocytic pathway. They receive 
macromolecules and other cargo from endocytic vesicles formed at the plasma membrane 
or TGN, which then either fuse with existing early endosomes or with each other to 
generate early endosomes. Upon receiving cargo, early endosomes direct internal solutes 
to various locations in the cell using the same vesicles. The internal pH of ~6-6.5 of the 
early endosome induces the detachment of certain substrates from their transmembrane 
receptors, allowing for the recycling of receptors back to the plasma membrane/TGN. 
Those cargos that are not recycled in either the early or late endosomes are moved to the 
lysosome for degradation. Early endosomes mature into late endosomes through a series 
of fission and fusion events involving the modification or exchange of multiple organelle-
specific lipids and membrane proteins. Because of their diverse inputs and continuous 
maturation, endosomes tend to have an extremely heterogeneous composition. 
Consequentially, studying their acidification properties using a biochemical approach is 
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challenging because it is difficult to separate them from other endosomal organelles to 
obtain a well-defined population. Despite these barriers, it is well established that 
endosomes utilize the V-ATPase to acidify (28). Additionally, Cl- has emerged as the 
primary counterion that facilitates acidification, but some significant questions remain in 
the process. In the following sections, I will detail some of the proteins thought to be 
important in endosomal acidification, primarily focusing on the endosomal members of 
the chloride channel (ClC) superfamily, and propose a method to biochemically 
investigate early endosomal acidification. 
 
Early study of endosomal acidification 
The discovery of endocytic organelles occurred throughout the 1950s-60s, 
assisted by the technological advancements in ultracentrifugation and electron and 
fluorescence microscopy. While lysosomes were discovered in 1955 (29), endosomes 
were not characterized until 1964 when Werner Straus observed that internalized proteins 
passed through intermediate structures (‘prelysosomal vacuoles’) prior to reaching 
lysosomes (30). He noted a progression of protein localization from the peripheral 
cytoplasm at early time points to the perinuclear area near lysosomes at later time points 
(later defined as early and late endosomes). Twenty years later, Tycko and Maxfield 
incubated cultured cells with a fluorescein-labeled α2-macroglobulin to measure the pH 
changes in endosomes following receptor-mediated endocytosis, the process by which 
cells uptake extracellular solutes (31). They observed that after 15-20 min, the fluorescent 
ligand was contained in an acidic compartment with a pH of 5.0 +/- 0.2, in contrast to a 
fluorescein-dextran, which reached lysosomes after approximately 30-35 min and had a 
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pH of 4.6 +/- 0.2. These results were shortly verified both in vivo by Van Renswoude et 
al., who observed the acidification of internalized substrate prior to reaching the 
lysosome, and in vitro by Galloway et al., who demonstrated that isolated endosomes 
acidify in an ATP-dependent manner (32, 33). Thus, endosomes were discovered as 
intermediate transport vesicles that are not quite as acidic as lysosomes.  
Subsequent studies of endosomal pH acidification properties employed more 
precise methods to examine the organelles in both isolated and live cell settings. 
Obtaining a well-defined population of isolated endosomes is challenging due to their 
constant, rapid maturation process. To evaluate the acidification properties in vitro, 
isolated endosomes are either harvested after a brief exposure to a pH sensitive dye that is 
rapidly internalized via endocytosis or harvested and subsequently incubated with a 
membrane permeable dye. These studies have shown that the V-ATPase is responsible 
for acidification (28, 33, 34). Van Dyke and colleagues examined the counterions 
required for endosomal acidification, finding that the organelles primarily relied on Cl- 
for acidification, but also displayed a permeability to Na+ and a substantial H+ leak (23, 
34).  
In vivo methods used to characterize endosomal pH typically involve using a pH-
sensitive dye taken up by endocytosis, fluorescently-labeled compartment specific 
proteins, or expression of a GFP/GFP-variant attached to an endosomal-specific 
membrane protein. These studies have shown that early endosomes tend to have a pH of 
5.9-6.8 and late endosomes range between 5.0-6.0 (2).  Additionally, several proteins 
have been found that contribute to the maintenance of endosomal acidification, some of 
which may provide a counterion current. These proteins include some members of the 
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ClC family, the Cl- channel Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR), and sodium-proton exchangers (NHEs). These family members will be 
discussed in detail in the next sections. 
 
The diverse family of ClC transporters and channels 
The ClC family is a diverse group of Cl- channels and secondary active 
transporters. ClCs are well conserved and found in yeast, bacteria, archaea, plants, and 
invertebrates. There are nine isoforms in mammals, located in the plasma membrane and 
intracellularly, where they participate in a wide range of physiological functions. ClC 
family members play critical roles in the cell and their mutations cause various diseases 
(35). ClC-0, the first known member of the family, was characterized by White and 
Miller as a voltage-gated anion channel in the electric organ of the Torpedo ray, but an 
additional ten years passed before it was identified and cloned by Jentsch et al. (36, 37). 
Crystal structures of both prokaryotic and eukaryotic ClCs reveal that they are 
homodimers with a functional ion-translocating pathway in each monomer (3, 38-40) 
(Figure 2). Surprisingly, while all mammalian isoforms share the same basic structure, 
half of the family members function as channels and the rest are 2Cl-/H+ antiporters. This 
distinction between Cl- channels and transporters was discovered by Accardi and Miller 
in the bacterial ecClC (41), and confirmed a year later in the eukaryotic homologs ClC-4 
and -5 (42, 43). Subsequent studies demonstrated the same antiporter function for ClC-6 








In addition to being separated into channels and transporters, these two groups of 
the ClC family are also spatially segregated. The channels, ClC-1, -2, -Ka, and -Kb, are 
found in the plasma membrane while the transporters, ClC-3 to ClC-7, are found 
intracellularly within endocytic organelles (Figure 3). The antiporter ClC-3 is found 
primarily in endosomes and synaptic vesicles, ClC-4 and ClC-5 in endosomes, ClC-6 in 
neuronal late endosomes, and ClC-7 in lysosomes (35). Additionally, four of the 
mammalian ClCs (ClC-Ka and -Kb, ClC-2, and ClC-7) possess auxiliary β subunits that 
are essential for their associated ClC’s function (46-48).   
 
 
Figure 2: Structure of CmClC 
Ribbon representation of the eukaryotic CmClC dimer from the side of the membrane. The 
CBS domains, found only in eukaryotic ClCs, are located below the TM domain and reside in 
the cytoplasm. The individual monomers are colored in blue and red, respectively.  Figure 







Crystal structures of the ClCs reveal that both channels and transporters have a 
similar basic architecture. Therefore, the structural mechanism used by ClCs to dictate 
channel versus transporter function is not entirely clear. In the transporters, there are 
three conserved Cl- binding sites, the external, central, and internal sites, which are 
thought to be responsible for anion transporting activity (3, 38-40). Mutating some of 
these key residues converts the transporter into a passive Cl- channel (39, 41), suggesting 
an importance of the pathway for channel vs. transporter distinction. A new structure 
Figure 2: The ClC family of channels and transporters 
An overview of the currently known expression patterns of mammalian ClC proteins, their 
presumed functions, and pathologies upon loss-of-function mutations. The proteins have been 
segregated into channels and antiporters. Any associated β-subunits are shown in red. 
Figure from Thomas Jentsch (2015). Full citation: (1). 
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recently published by the MacKinnon group suggests that a conserved loop in the Cl- 
transport pathway is shifted to widen the ion transport pathway in channels, removing the 
transporter activity (40). 
While the prokaryotic and eukaryotic ClCs have a similar structure, the eukaryotic 
proteins have an additional large carboxyterminus with two cystathionine-β-synthase 
(CBS) domains that presumably regulate protein activity and trafficking, although their 
function is not well understood (1). The domains interact with both the transmembrane 
portion of their respective subunit and each other, in addition to interacting with the CBS 
domains of the partner monomer (3). Some studies have shown that the binding of ATP 
affects the activity of several ClCs in different fashions (some are inhibited, while others 
are activated), but their role regulating ClC activity is not yet clear (49). However, many 
human disease-causing mutations reside in these domains, highlighting their importance 
in function of ClCs.  
 
ClC-5 facilitates Cl--dependent acidification in early endosomes 
Cl- has long been hypothesized to be an important counterion in the endosomal 
pathway, a model supported by considerable experimental data. Much of Cl--related 
counterion research has examined the properties of ClC-5, a 2Cl-/H+ antiporter (42, 43, 
50, 51). ClC-5 has a restricted tissue distribution and is found primarily in epithelia, most 
prominently in kidney and intestine, with some expression in the brain and liver (52). The 
transporter is predominately localized to early endosomes and found transiently in the 
plasma membrane. Mutations in ClC-5 cause Dent’s disease, characterized by recurrent 
kidney stones, nephrocalcinosis, and possibly renal failure (53). On a cellular level, the 
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absence of the transporter leads to a broad defect in proximal tubular endocytosis, 
potentially due to a loss in acidification of renal endosomes (54).  
Several early papers characterized endosomal pH in ClC-5 knockout mice, 
observing a more basic luminal pH when the protein was absent (50, 51, 53). In one 
experiment, the Verkman group fed a pH sensitive dye attached to transferrin, a 
glycoprotein that trafficks to early/recycling endosomes, to wild-type (WT) and ClC-5 
KO proximal tubule cell cultures (50). Initial pH in transferrin-labeled endosomes was 
~7.2, decreasing to 6.0 and 6.5 in WT and ClC-5 deficient cells, respectively. 
Additionally, the ClC-5 deficient cells had a lower endosomal Cl- concentration 
compared to WT cells, suggesting that the protein moves Cl- into the organelle. In 
contrast, acidification and Cl- accumulation were not impaired in late endosomes or the 
Golgi. Therefore, ClC-5 was proposed to be necessary for proper acidification of early 
endosomes and efficient endocytosis.  
To determine if Cl-/H+ antiport is essential for acidification, the Jentsch lab 
created a knock-in mouse containing a mutation that converts ClC-5 from a transporter to 
a chloride channel (“Unc” mouse) (51). In comparison to the reduced acidification in KO 
endosomes, the Unc and WT acidified to a similar level, indicating that a Cl- shunt 
provides a sufficient counterion current and the transporting activity of ClC-5 is not 
required for acidification. However, the Unc mouse displayed the same endocytosis 
defects as the KO mouse, specifically proteinuria, impaired receptor-mediated and fluid-
phase endocytosis, and reduced levels of endocytic receptors. Because a single internal 
point mutation is unlikely to cause enough of a structural change in ClC5 to disrupt its 
macromolecular interactions, it is likely that the concentration of luminal Cl- is essential 
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for the proper function of the endosome (3). The Verkman group noted that KO 
endosomes had a lower internal Cl- concentration compared to WT (50), although the Cl- 
concentration in Unc endosomes was not measured.  
Recently, even the mechanism by which ClC-5 functions has been questioned. In 
contrast to the proposal that ClC-5 provides chloride to assist in acidification, recent work 
by Smith and Lippiatt observed that ClC-5 only facilitates outwardly rectifying currents 
when overexpressed at the plasma membrane of HEK293 cells (55). Outward rectification 
implies that ClC-5 is moving Cl- out of the organelle lumen and moving H+ into the 
organelle, starkly contrasting the proposed role of Cl- acting as an electrical shunt for the 
proton pump, and contradictory to the aforementioned experimental data showing that the 
concentration of Cl- is higher in ClC-5 expressing endosomes compared to KO (51). 
Therefore, this group is suggesting that ClC-5 is involved in endosomal acidification by 
exchanging endosomal Cl- for H+, the opposite of proving a counterion for the V-type 
ATPase (55, 56). However, these experiments were conducted on transporters expressed 
at the plasma membrane, and it is possible that ClC-5 behaves differently when expressed 
in the endosomes. Thus, although ClC-5 is involved in endosomal acidification, much 
remains unknown about how it functions in the organelle. 
 
Additional proteins with known and suggested roles in endosomal acidification 
While ClC-5 is important to endosomal acidification, it is predominately 
expressed in kidney and intestine, and the counterion mechanisms other tissues use to 
achieve sufficient acidification are unclear. ClC-3 and ClC-4 are closely related family 
members, sharing about 80% sequence identity with ClC-5, and are also localized to 
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endosomal compartments (57). ClC-4, has a broad tissue distribution and is thought to be 
localized to endosomal compartments. Anti-sense c-DNA knockdowns of ClC-4 in 
cultured epithelial cells resulted in more alkalized endosomes with a reduction in 
receptor-mediated uptake of transferrin, an iron binding glycoprotein, hinting it may play 
a similar role as ClC-5 (58). The same group, by breeding Mus spretus with Mus 
musculus, created male hybrids that were ClC-4 null, due to the different chromosomal 
localization of the ClCn4 gene (59). These mice were infertile, but displayed no 
additional aberrant phenotypes. Cell lines, generated from both null and WT, again 
showed more alkalized endosomes with a reduced receptor-mediated uptake of transferrin 
when ClC-4 was absent. However, conventionally created ClC-4 knockout mice from the 
Jentsch lab showed no defect in endocytosis (60). Additionally, no disease phenotype 
resulting from a ClC-4 mutation has been reported in humans. Thus, the physiological 
function of the transporter remains unclear.  
ClC-3 is widely expressed and primarily resides in intracellular trafficking 
vesicles, specifically in endsosomes, synaptic vesicles (SVs), and synaptic-like 
microvesicles (57). During membrane recycling, ClC-3 also transiently appears at the 
plasma membrane (61). ClC-3 KO mice display severe degeneration of the retina and 
neuronal tissue, specifically in the hippocampus, although the molecular mechanism 
resulting in this phenotype remains undetermined (62-64). Among an array of functions 
attributed to ClC-3, some of which have been disproved over the years, it has been 
suggested to play a role in the acidification of endosomes and SVs, transport vesicles that 
store neurotransmitters for release at the neuronal synapse. Using cultured hepatocytes 
from ClC-3 KO mice, Hara-Chikuma et al. found reduced acidification and decreased 
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luminal Cl- in the early and late endosomes of KO compared to WT (65). Additionally, 
they found the inverse effect when ClC-3A was overexpressed in Chinese hamster ovary 
cells, observing slightly more acidic endosomes with a higher concentration of luminal 
Cl- when compared to the control. In addition to affecting the pH of endosomes, isolated 
ClC-3 KO SVs also display reduced acidification compared to WT (62). However, the 
loss of ClC-3 coincides with a decrease in a glutamate transporter, vGLUT1, and a 
respective decrease in SV glutamate uptake (62). Recent studies have shown that instead 
of ClC-3, vGLUT1 is responsible for the majority of observed Cl- conductance in SVs 
(66, 67). In an elegant set of experiments, Preobraschenski et al. used both purified 
vGLUT1 reconstituted in proteoliposomes and proteoliposome/SV fusion vesicles to 
address the controversial role of the transporter, employing a system that allows strict 
control over external and internal buffer composition (67). They found that vGLUT1 
contains two anion binding sites that facilitate the movement of glutamate or Cl- and a 
flexible cation binding site that allows H+ antiport or K+/H+ exchange. Therefore, ClC-3 
does not appear to be the primary source of Cl- in SV acidification, but its role in 
ensuring proper trafficking of vGLUT1 is still not well understood. Additionally, the role 
that ClC-3 still appears to play in endosomal acidification has not been extensively 
explored. 
The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a Cl- 
channel whose malfunction results in the multisystemic disease cystic fibrosis (68). 
CFTR belongs to the ATP-binding cassette (ABC) transporter family but, unlike most 
members that function as transport ATPases, it is the only one that functions as an ion 
channel (69, 70). This channel is cAMP-regulated and expressed in the epithelial cells of 
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various tissues (71). CFTR is an attractive candidate for an organellular anion shunt, 
although its role in this position has been highly debated (70). Using immortalized 
epithelial cells from cystic fibrosis and healthy patients, one study found that a lack of 
CFTR resulted in small increases in pH in the TGN and endosomes, which could explain 
some symptoms that CF patients display (72). However, subsequent studies from several 
groups have directly contradicted those claims and concluded that CFTR does not affect 
endosomal pH levels, nor does it participate in TGN luminal pH (reviewed in (70)).  
The family of Na+/H+ exchangers (NHEs) are secondary active ion transporters 
that assist in cytosolic and organellar pH homeostasis, Na+ absorption, and cell volume 
(73). The 13 family members (NHE1-9, NHA1-2, and SLC9C1-2) are localized to the 
plasma membrane and intracellular organelles. In general, the plasma membrane NHE 
isoforms (NHE1-5) exchange Na+ for H+ in a 1:1 manner, typically moving extracellular 
Na+ into the cytoplasm, although the reverse ion movement also occurs in certain tissues 
(74, 75). The intracellular NHEs, NHE6 and NHE9, localized to early and recycling 
endosomes assist in pH regulation and luminal cation levels by exchanging H+ generated 
by the V-ATPase for either Na+ or K+ ions (74). Loss-of-function mutations in NHE6 or 
NHE9 result in hyper-acidified endosomes (76) and mutations in these proteins have been 
linked to autism and other neurodevelopmental disorders (73-75). Thus, while endosomal 
NHEs assist in the regulation of luminal pH, they do so by exchanging H+ in an 
electroneutral fashion, and do not provide a counterion to assist in V-ATPase facilitated 
acidification.  
In summary, while much is known about endosomal acidification, the precise 
mechanisms and proteins responsible for counterion transport are not fully understood. 
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Additional study in this field will expand upon the general knowledge in the study of ion 
channels and transporters, potentially suggesting mechanisms by which cells regulate 
their organellar pH. 
 
CCVs display Cl--dependent acidification via an unidentified protein 
To study the counterions important for acidification, it is advantageous to 
examine the properties of isolated organelles, an approach that allows precise control 
over buffer conditions. However, endosomes are very heterogenous due to their constant, 
rapid maturation and isolating a well-defined, consistent population is challenging. 
However, a subpopulation of early endosomes, clathrin-coated vesicles (CCVs), may 
provide an interesting way to circumvent this problem. CCVs are responsible for 
trafficking proteins to various locations in the cell, including newly synthesized proteins 
from the TGN to either endosomes or the plasma membrane, and the endocytosis of 
proteins from the plasma membrane to endosomes. Clathrin is a coat protein that 
promotes the curvature of the membrane to create vesicles from donor membranes. CCVs 
were first described by Roth and Porter in 1964, who observed bristle-like coats at 
invaginations of the plasma membrane (clathrin pits) and on vesicles in the cytosol in 
electron micrographs (77). The assembly unit of clathrin is the triskelion, which is 
composed of three clathrin heavy chains and three clathrin light chains (78). Triskelia 
attach to both cargo-bound adaptor proteins on a patch of the membrane and one another, 
forming a rounded lattice of hexagons and pentagons that draws the membrane out into a 
bud shape (79). After scission from the membrane, the result is a basket-like structure 
surrounding the vesicle. The coat is subsequently removed by specialized proteins to 
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allow the vesicle to fuse with another compartment. As a primary source of cargo to and 
from early endosomes, these vesicles represent a sub-population of early endosomes and 
studying their acidification properties could provide a more readily isolatable population 
for studying endosomal counterion requirements.  
In the 1980s, several papers reported that CCVs contained a Cl--transporting 
protein important for V-ATPase facilitated acidification (21, 22, 24, 80). In the first study 
to report this activity, Xie and colleagues were monitoring the ionic requirements and 
energy source of a H+-translocating ATPase, later determined to be the V-ATPase, in 
brain CCVs (24). Vesicle acidification was monitored using acridine orange (AO), a 
metachromic dye whose absorbance decreases when vesicular pH becomes more acidic. 
They found that ATP-driven H+ translocation occurs when Cl- or Br- are present in the 
bathing media or, to a lesser extent, when the membrane potential (Δψ) is dissipated by 
potassium (K+) and valinomycin, an ionophore that moves K+ freely across the 
membrane. These results were confirmed by other groups using both bovine brain and rat 
liver CCVs (21, 22).  
Xie et al. further characterized the Cl- transporting protein by examining its 
biochemical properties in proteoliposomes. The group solubilizing uncoated CCVs in 
detergent, column-separated the sample into 12 fractions, and after a glycerol gradient, 
reconstituted each fraction into liposomes (80, 81). To evaluate functional protein, they 
measured radiolabeled Cl- uptake of all proteolipsomes, finding maximal activity in the 
later portion of the fractions (80). In addition to isolating fractions containing Cl- 
transporting activity, they found several fractions possessing V-ATPase activity that 
acidified the proteoliposomes when K+ was provided as a counterion in the presence of 
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valinomycin. When the ATPase fraction was co-reconstituted with the Cl--transporting 
fraction, the proteoliposomes acidified in the presence of Cl-, similar to the activity 
observed in CCVs. However, this protein was not identified. 
In the second chapter of my thesis, using CCVs as our endosomal model system, 
we investigated the role of Cl- transport with the intention of identifying the protein 
responsible for facilitating acidification. We aimed to take advantage of the technological 
advancements made over the last 20 years that have significantly increased the ability of 
mass spectrometry to identify membrane proteins (82). This approach is advantageous in 
that it makes no assumption as to the identity of the CCV Cl- transporting protein. 
Although none have been suggested to be important for CCV acidification, ClC-3,-4, and 




Lysosomes are dynamic signaling centers that rely on pH for function 
Lysosomes, the terminal organelle of the endocytic pathway, are acidic 
compartments that degrade macromolecules into their basic building blocks for the cell to 
recycle. Greek for ‘digestive body’, lysosomes were first identified by Christian De Duve 
and colleagues in the early 1950s while investigating acid phosphatase activity in 
fractionated rat liver homogenate (84). They observed that enzymatic activity of a 
specific fraction increased after several days, indicating that the phosphatase was likely 
contained inside an additional compartment or sac that degraded over time (85). 
Subsequent studies confirmed the presence of these compartments (lysosomes) using 
biochemical and electron microscope techniques. Currently, over 60 soluble hydrolases 
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have been discovered to reside in the lysosome and are responsible for breaking down 
various macromolecules, including carbohydrates, amino acids, lipids, and nucleic acids, 
or engulfed bacteria and viruses (86). In addition to digestive enzymes, lysosomes rely on 
many integral lysosomal membrane proteins to perform various functions, including 
luminal acidification, protein import from the cytosol, membrane fusion, and transport of 
basic catabolites from the lumen to the cytoplasm.  
Lysosomes are found in nearly every mammalian cell type and are typically 
defined by an extremely acidic pH, degradative function, the presence of specific 
membrane proteins, and physical appearance (87). They are cytoplasmic dense bodies 
surrounded by a delimiting membrane that can appear spherical, ovoid, or tubular in 
shape (87). Lysosomes, the most acidic organelles in the cell, maintain an internal pH of 
4.0-5.0 that is critical their catabolic functions. While lysosomes have long been 
primarily classified as sites for degradation and recycling, recent discoveries have 
expanded their cellular role, and they appear to function as signaling centers that monitor 
and regulate lysosomal status, autophagy, and cellular metabolism (27).  
Lysosomes receive cargo from various sources, including vesicles originating 
from the endocytic pathway, phagocytosis, and autophagy. The first involves sorting and 
trafficking cargo through the endosomal pathway, as has been discussed in earlier 
sections. This pathway also provides both the digestive enzymes and the integral 
membrane proteins required for creating and maintaining lysosomal function. 
Phagocytosis is a process where specialized cells engulf a large, extracellular particle, 
such as pathogens or cell debris, at the plasma membrane by forming an endocytic 
compartment called a phagosome (88). Once internalized, the phagosome fuses with 
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lysosomes to form a phagolysosome and the engulfed material is rapidly degraded. 
Autophagy, specifically macroautophagy, is an intracellular process where the cell 
engulfs cytoplasmic constituents into a structure entitled the autophagosome, which then 
fuses with lysosomes to break down the luminal contents (89). This response is crucial 
for the degradation of malfunctioning organelles and for providing cellular energy under 
starvation conditions.  
Given the crucial roles performed by the lysosome, malfunctions in lysosomal-
related proteins can result in a range of moderate to severe disorders, collectively known 
as lysosomal storage diseases (LSDs). They are characterized by a massive accumulation 
of materials in enlarged, dysfunctional lysosomal compartments. LSDs can be caused by 
a defect in trafficking, degradation, ion homeostasis, or catabolite export (27). Because 
lysosomal functions are closely coupled, a defect in one role of the lysosomes affects its 
other functions, exacerbating and amplifying the problem in a cyclic fashion. For 
example, the malfunction of a hydrolase could result in the accumulation of undigested 
material. This buildup of internal solutes enlarges the compartment and increases the 
osmolarity, causing improper ionic regulation, which then further reduces the catabolic 
abilities of the lysosome and increases the internal material accumulation (27). There are 
approximately 50 identified lysosomal storage diseases, many of which result from 
defects in a specific hydrolase (90). 
The acidic pH of lysosomes is required for the optimal function of the internal 
hydrolases and H+ also provide the energy to pump catabolites out of the lysosomal 
lumen. Most lysosomal hydrolases are active only in highly acidic solutions, requiring the 
lysosome to maintain a pH around 4.5 for optimal function (91). It is well established that 
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lysosomal pH is created and maintained by the V-ATPase (20, 92), but the identity of the 
required counterions, ions that move to compensate for the membrane voltage created by 
the V-ATPase pumping protons into the lumen, is unclear and highly debated (26, 93). 
Various studies examining the counterions utilized in isolated and in vivo lysosomes have 
yielded varying and, at times, conflicting results.  
 
Acidification and counterion study in isolated lysosomes 
Lysosomes are a much more easily isolated organelle than endosomes and early 
studies of their acidification properties involved evaluating their biochemical properties 
in vitro. Initially these studies focused on characterizing the acidification properties of the 
then unknown V-ATPase, but inevitably shifted to evaluating the counterions required to 
facilitate acidification (20, 23, 44, 92, 94). The acidification properties of isolated rat 
liver lysosomes were first characterized by Dell’Antonne, who evaluated acidification 
with acridine orange, a membrane permeable, pH sensitive dye, finding that lysosomes 
relied on Cl- for acidification (92). The lysosomes displayed no acidification when Cl- 
was substituted with SO4
2-, but this activity could be rescued by adding Cl- to the system. 
Subsequent experiments by Okhuma et al. confirmed these observations using isolated 
lysosomes containing the pH sensitive FITC-dextran dye (20). In these experiments, 
removing external Cl- from the bathing media substantially slowed and reduced 
acidification, but exchanging the cation had little effect. Additional studies have 
confirmed these results (23, 44, 94, 95), arguing that anions act as the primary 
counterions in lysosomal acidification.  
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While cations may also act as counterions, their contribution is harder to decipher 
because the positively charged ions must leave the lysosomal lumen to facilitate bulk 
acidification, and luminal buffer is very difficult to modify while retaining functional 
organelles. However, ion permeability can be studied by monitoring changes in the 
steady-state fluorescence of a pH-sensitive dye, indicative of the movement of H+, upon 
addition of an ionophore, a small molecule that creates a pathway for a specific ion(s) to 
traverse the membrane. If one ion is highly membrane permeable, then providing a 
counterion, using an ionophore, will make it favorable for the permeable species to 
traverse the membrane. Okhuma et al. used lysosomes loaded with FITC-dextran to 
investigate ion permeability (20). To isolated lysosomes, they added valinomycin to 
allow K+ to act as a counterion, but observed little change in fluorescence, indicating that 
H+ were not highly permeable to the membrane. Subsequent addition of the H+ ionophore 
FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone) to the reaction resulted in a 
rapid increase in fluorescence, indicating the movement of K+ into and H+ out of the 
lysosomal lumen. Performing the experiment with the ionophore addition order reversed 
yielded the same outcome and, because neither ionophore individually facilitated large 
ion movements, this indicates that the permeability of H+ and K+ across the lysosomal 
membrane is low. 
Additional experiments investigating ion permeability were performed by 
monitoring changes in the membrane potential using voltage sensitive dyes. A commonly 
employed voltage-sensitive dye is Dis-C3(5), a positively charged dye that accumulates in 
the membrane of compartments with negative transmembrane voltages, resulting in the 
quenching of fluorescence. In experiments by Harikumar and Reeves, the fluorescence 
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signal of the dye increased upon addition of K+ to the lysosome, even in the absence of 
valinomycin, indicating the cation can partially dissipate membrane potential and has a 
small permeability in lysosomes (19). Okuma et al. reported a slightly higher K+ 
permeability, but this is likely due to differences in their methodology. Their experiments 
were conducted with tritosomes, lysosomes with altered buoyant density due to the 
addition of triton WT-1339, a detergent that can change K+ permeability (18). Cuppoletti 
et al. used merocyanine 540, an anionic potential-sensitive dye, to see that Cl- was able to 
reduce ATP-induced luminal-positive membrane potential, whereas no change occurred 
upon SO4
- addition (95). They reported that K+ can facilitate acidification when the 
luminal concentration of K+ is higher than the external buffer. They too performed these 
experiments on tritosomes, so the actual magnitude of K+ permeability is unclear. Van 
Dyke generated a comprehensive investigation of endosomal and lysosomal acidification 
(23). She found that lysosomal acidification was reduced when either K+ or Cl- was 
replaced with another ion, indicating the importance of both ions. Additionally, the most 
acidification was seen when both K+ and Na+ were present. The combined results from 
these experiments on isolated lysosomes indicate that both Cl- and K+ are permeable to 
the membrane and assist in acidification (18, 19, 23), although Cl- appears to function as 
the primary counterion.  
 
Candidate proteins that may facilitate counterion flux 
Given the Cl--dependent acidification properties of lysosomes, the Cl- transporting 
proteins CFTR and ClC-7 have been suggested as the primary candidates for providing 
counterion flux, although their roles are highly debated (26, 93). Additionally, recent 
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work is revealing the increasingly important role that cations play regarding lysosomal 
pH and ion homeostasis. Transmembrane protein 175 (TMEM175), transient receptor 
potential channel mucolipin subfamily 1 (TRPML1) and two-pore channels 1-2 (TPC1-2) 
(K+, Ca2+, and Na+ channels, respectively) have been found to influence lysosomal pH 
under certain conditions. The role of these channels and transporters will be described in 
the following sections. 
 
CFTR 
As mentioned in the endosome section, CFTR is a c-AMP regulated Cl- channel 
whose malfunction causes the multisystemic disease cystic fibrosis (71). Di et al. 
suggested that CFTR acts as an organellular anion shunt to assist with lysosomal 
acidification after observing that alveolar macrophages from CFTR-null mice had 
phagolysosomes with a more alkaline pH compared to WT (96). However, this study 
measured pH with fluorescein-based probes, which have poor sensitivity at the low pH 
values of the lysosome. Follow up studies from several groups using a small molecule 
inhibitor of CFTR and more quantitative pH measurements reported no pH changes (70, 
94, 97). Additionally, CFTR is only expressed in a limited number of tissues and, if it 
were important for lysosomal acidification, would only affect a small subset of 
organelles. Thus, while the intracellular role(s) of CFTR may still be debated, it is 
unlikely to facilitate lysosomal acidification. 
 
CLC-7 
ClC-7 facilitates acidification in isolated lysosomes 
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Due to their distribution throughout the endosomal pathway, intracellular ClCs 
have long been suggested to be involved in the acidification of various endocytic 
organelles. ClC-7, a 2Cl-/H+ transporter found in lysosomes, has been a particularly 
attractive protein to provide counterions given the need for Cl- in isolated lysosomal 
acidification. ClC-7’s role in isolated lysosomes was characterized by Graves et al. when 
studying Cl- flux across the membrane (44). While numerous experiments on isolated 
lysosomes have suggested Cl--dependent lysosomal acidification, none provided direct 
evidence that Cl- moved across the membrane. Graves et al. used isolated rat lysosomes 
to demonstrate this flux by monitoring the uptake of 36Cl- into lysosomes. After finding 
that the rate of uptake was enhanced in acidic conditions, they measured reversal 
potentials in isolated lysosomes to determine that the primary pathway of Cl- flux was not 
via a channel, but instead through a transporter exchanging two Cl- ions for one H+ 
moving in the opposite direction. To identify the protein, they used siRNA to transiently 
knockdown ClC-7 in HeLa cells and found that the Cl- flux was abolished, demonstrating 
that ClC-7 is the primary pathway of Cl- movement into lysosomes. Additionally, the 
knockdown cells appear to have less acidic lysosomes when evaluated using a qualitative, 
pH-sensitive dye. When combined with isolated lysosomal data indicating the importance 
of Cl- in acidification, these experiments suggest that Cl- acts as a major lysosomal 
counterion using ClC-7 to move across the membrane. 
 
Loss of ClC-7 causes osteopetrosis and neurodegeneration: 
ClC-7 is a broadly expressed transporter that is localized to late endosomes and 
lysosomes (98, 99). ClC-7 KO mice are gravely ill, only living a maximum of 6-7 weeks 
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past birth, and suffer from retarded growth, deformation, retinal degeneration, lysosomal 
storage disease, and neurodegeneration (99, 100). Analysis of the disease pathology 
revealed the KO mice suffered from severe osteopetrosis, or hypercalcification of bone, 
explaining the stunted growth and deformation. This disease occurs upon a loss of 
function in osteoclasts, multinucleated cells responsible for bone resorption (101). In WT 
animals, osteoclasts attach to the bone matrix and form an acidic external compartment 
that uses hydrolytic enzymes to degrade bone. It is acidified by the fusion of acidic 
lysosome-related organelles to a polarized portion of the plasma membrane, called the 
ruffled border, which has similar features to the lysosomal membrane. In KO animals, the 
osteoclasts were unable to resorb bone, due to an underdeveloped ruffled border that was 
under-acidified when measured with the qualitative, pH dye acridine orange (99). These 
data suggest that because ClC-7 is localized to the ruffled border, a lysosomal-like 
membrane, and the compartment is underacidified, the transporter likely contributes 
counterions to assist in its acidification and may act similarly in lysosomes.  
 
ClC-7 is not required for lysosomal acidification in live cells? 
Although ClC-7 appears important for lysosomal pH, measurements in live cell 
ClC-7 KO lysosomes complicate its presumed role. In 2005, Kasper et al. showed that 
while ClC-7 KO mice have neurodegeneration and accumulate electron-dense storage 
materials in lysosomes, the lysosomal pH in cultured neurons was unchanged when 
measured with a quantitative fluorescent dye (100). Several papers have reported a 
similar unchanged pH in ClC-7 KO lysosomes (47, 94, 102). Additionally, mice lacking 
osteopetrosis-associated transmembrane protein 1 (Ostm1), ClC7’s beta subunit required 
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for proper trafficking to the lysosomes, also developed LSD and neurodegeneration, but 
maintained an unchanged lysosomal pH (47).  
After observing that knocking out ClC-7 did not result in a lysosomal pH change, 
the Grinstein lab sought to study counterion conductances in the lysosomes of live 
cultured macrophages, as opposed to isolated lysosomes. To assess the ionic dependence 
of acidification, the external buffer composition of the lysosomes, in this case the cytosol, 
must be controlled. To achieve this, Steinberg et al. stimulated the plasma membrane 
P2X7 receptor for a prolonged period of time, opening small, well-defined pores that 
allow for the selective permeabilization and dialysis of cytosolic ions (94). To test for the 
importance of Cl- in lysosomal acidification, they dialyzed the cells in Cl--free media and 
neutralized the pH of the lysosome using the ionophore FCCP. After removing FCCP and 
resealing the membrane, they found that lysosomes reacidified similarly in the presence 
or absence of cytosolic Cl-, arguing that the anion is not necessary for acidification. 
However, quantitative chemical analysis showed that cytoplasm dialysis only reduced Cl- 
concentration from 70 mM to 9 mM, a concentration sufficient to allow lysosomal 
acidification in isolated lysosomes (23). Thus, the need for cytosolic Cl- in lysosomal 
acidification is still in question.  
 
Importance of ClC-7 as a transporter vs. channel 
To further explore the role of ClC-7 in the lysosome, Weinert et al. introduced a 
single point mutation to the gating glutamate in ClC-7 to convert the protein from an 
antiporter to an uncoupled Cl- uniporter (Unc) (102). The Unc mice displayed more mild 
osteopetrosis and had no change in coat color, but still possessed severe LSD and 
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neurodegeneration symptoms. The acidification behavior of the lysosomes was 
complicated. Isolated Unc lysosomes acidified to a greater extent than WT, whereas KO 
organelles had a much smaller acidification capacity, similar to the no external Cl- buffer 
control. However, the lysosomal pH measured in fibroblasts cultured from the Unc, WT, 
and KO was similar between all cells. They also suggest that the KO and Unc lysosomes 
appeared to accumulate less luminal Cl- than WT mice, although this experiment was 
conducted with fibroblasts grown in a low Cl- media while using a novel Cl- sensor 
whose sensitivity range could not be calibrated to measure higher Cl- concentrations.   
Results from the Unc mutant indicate that proper lysosome and osteoclast 
function not only require that ClC-7 mediates Cl-, but must exchange Cl- for H+. The 
authors postulate that proper lysosomal function depends on an appropriate luminal Cl- 
concentration. The Jentsch lab further investigated the role of ClC-7 in lysosomal 
degradation using pulse-chase endocytosis experiments on renal cells isolated from mice 
carrying a chimeric deletion of ClC-7. A side-by-side comparison showed that WT and 
ClC-7 deficient cells could endocytose protein similarly, but the material was not 
properly degraded and accumulated in the KO cells, indicating that ClC-7 is important for 
lysosomal degradation of proteins (103). The authors mention that in vitro biochemical 
studies of Cathepsin C, a lysosomal protease, has [Cl-]-dependent activity (104, 105), 
arguing that the regulation of intralysosomal [Cl-] may be a central role for ClC-7.  
To explore the importance of various parameters of lysosomal acidification, 
Ishida et al. created a mathematical model of acidification that incorporates the in vitro 
results from isolated lysosomes along with several transporters and channels (106). They 
simulate the presence of various combinations of Na+, K+, and Cl- ions and 
33 
 
channels/transporters in the lysosomal membrane, finding that only Cl- can function as a 
counterion to achieve robust acidification over a wide range of starting luminal and 
cytosolic ion concentrations. Additionally, not only does a Cl- transporter acidify the 
lysosome to a more acidic pH than a channel, but only a transporter can explain some of 
the experimental results seen in isolated lysosomes. They predict that K+ can function as 
a counterion, but only if a K+ channel is present and luminal [K+] is high, a currently 
unknown value due to a lack of physiological indicators. They also simulate the effects of 
relying on only one counterion pathway, finding that it may result in a change in 
lysosomal volume. The influx of Cl- as a counterion could result in lysosomal swelling, 
whereas efflux of cations likely leads to shrinking since H+ are continuously exported 
when coupled to catabolite export, implicating that a combination of counterion pathways 
may work best to maintain lysosomal physiology. Therefore, employing both 
mechanisms may be important to balance these opposite osmotic forces. 
Since the ClC-7 antiporter is predicted to facilitate a higher luminal Cl- 
concentration than a channel, this property suggests that the concentration of luminal [Cl-
] may be important. In a recent paper, Chakraborty et al. suggest a link between luminal 
[Cl-] and lysosomal degradation capacity using a recently developed DNA-based, 
fluorescent Cl- reporter that allows for ion measurements in a living organism (107). 
Using live C. elegans, they observed that reducing the high levels of Cl- (~120 mM) 
lowered the degradation capabilities of the lysosome. Additionally, they observe that 
luminal Cl- is depleted in mammalian cell culture models of LSDs. To link high luminal 
[Cl-] to lysosomal function, they show that the enzymatic capabilities of Cathepsin C and 
Arylsulfatase B, enzymes previous shown in vitro to have [Cl-]-dependent enzymatic 
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activity (105), were reduced when lysosomal [Cl-] concentration was lowered using the 
Cl- channel blocker 5-nitro-2-(3-phenylproyl-amino) benzoic acid (NBBP). While these 
results need additional verification, they suggest an interesting role of luminal Cl- and a 
potential physiological reason for why a Cl- shunt does not sufficiently substitute for 
ClC-7. 
 
Cation channels that may assist in lysosomal acidification 
In addition to Cl-, cations are also permeable to the lysosomal membrane and are 
likely to participate in acidification. As described above, Steinberg et al. attempted to 
determine the ionic dependence of Cl- in lysosomal acidification by reversibly dialyzing 
the cytoplasm. Additionally, they devised a method to selectively dialyze the lysosomal 
compartments to investigate the cation contribution as well (94). They activated P2X7 
receptors to permeabilize the cytoplasm, as explained above. After inactivating the 
channels and resealing the membrane, they used osmotic swelling induced by glycyl-L-
phenylalanine 2-napthylamide (GPN), small peptide that is specifically cleaved by 
Cathepsin C upon entering the lysosomal compartment, to increase osmolarity and 
partially rupture the lysosome. Loss of lysosomal membrane integrity allows buffer 
exchange with the cytosol and surprisingly, once the peptide is rinsed out, the lysosomal 
membrane appears to reseal and reacidify while retaining a previously loaded fluorescent 
dye. These ratiometric dyes monitor lysosomal pH, indicating that replacing cytosolic Cl- 
with impermeant anions did not significantly alter acidification, although residual 
cytosolic Cl- is likely present. However, the lysosomes did utilize K+ and, to a lesser 
extent, Na+ to facilitate acidification. Although lysosomes are known to store Ca2+, which 
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may act as a counterion, its omission had no discernible effect on the rate of 
reacidification. Additionally, the substitution of Cl- for cations allowed for acidification 
as well. Thus, these experiments, in agreement with data from other isolated lysosome 
measurements, argue that lysosomes may use both cations and anions to acidify, although 
they assert that cations act as the primary counterion while Cl- acts in a secondary 
fashion. The authors also note that osmotic changes related to the influx/efflux of 
counterions may also influence the lysosome and employing both mechanisms may be 
important to balance these opposite osmotic forces. 
Therefore, while the role of cations in lysosomal acidification is becoming more 
apparent, and candidates for the cation-transporting protein are becoming more 
established, none have been shown to regulate lysosomal pH in quiescent conditions. 
However, there are several candidate channels, including TMEM175, TRPML1 and 
TPC1-2, which appear to primarily transport K+, Ca2+ and Na+ (respectively).  
TRPML1 (also known as MCOLN1) is a cation channel that is ubiquity expressed 
and located predominately on late endosomes and lysosomal (LEL) membranes (108). 
Mutations in the protein cause the lysosomal storage disorder mucolipidosis type IV 
(MLIV), an autosomal recessive disease that manifests as a gradually progressing 
neurodegenerative disorder (108). It is an inwardly rectifying channel (inward meaning 
cations are moving out of the lumen), permeable to Ca2+, Fe2+, Zn2+, Na+, and K+, but 
impermeable to H+ (109). Currently, TRPML1 is thought to mediate the release of Ca2+ 
in response to regulatory changes in LEL-specific phosphoinositides or other cellular 
signals, resulting in fusion/fission events (27). Its influence on lysosomal pH is unclear, 
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and studies from patients with mutated TRPML1 report that pH is lowered, unchanged, 
or increased (26).  
Two-pore channels 1 and 2 (TPC1 and TPC2) are ubiquitously expressed 
transmembrane channels that come together to form a highly selective Na+ channel 
complex on endolysosomal membranes (110-112). The TPCs receive physiological 
inputs from both the inside and outside of the lysosome, including luminal H+, lysosomal 
Δψ, cytosolic ATP, extracellular nutrients, lysosome-attached protein kinases, LEL-
specific phosphoinositides, and Mg2+ ions (27). TPC1 is highly sensitive to luminal pH, 
becoming hyperpolarized when pH shifts to more basic pH (112). It is postulated that the 
increase in Na+ conductance depolarizes the membrane and makes H+ pumping more 
favorable (27, 110, 112). Thus, the pH-Δψ feedback loop may assist in the stability of 
lysosomal pH or may help with setting the resting Δψ during organellular maturation. In 
TPC KO macrophages, the pH is only slightly alkalinized by ~0.1 pH units, when 
compared to WT, which is consistent with previously published work arguing that TPC 
has little activity in nutrient-replete cells (110). Upon nutrient starvation, the KO 
lysosomes are significantly alkalinized by ~0.6 pH units, whereas the WT lysosomes 
remain similar to the fed state. This lysosomal pH increase may be due to the lack of 
TPCs’ depolarizing abilities, which seem to contribute to pH stability. Therefore, it is 
likely that TPC helps influence lysosomal pH indirectly, rather than providing a cation as 
a counterion. 
While TRPML1 and TPC1-2 are important for maintaining the homeostasis of the 
lysosome, neither of the two seem to be the primary cation contributor for acidification. 
These conclusions are supported by counterion conductance experiments, where cation 
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permeability experiments argue that the primary cation is likely to be from K+ (18, 19, 
23). Recently, two K+ channels, TMEM175 and Ca2+-activated potassium (BK) channels, 
have been suggested to be responsible for lysosomal K+ permeability (113, 114). Cang et 
al. evaluated the effects of TMEM175 on lysosomal pH by knocking out the protein 
using CRISPR (113). The KO and control lysosomal pH are similar, but starvation 
caused the KO lysosomes to become alkalinized by ~0.7 pH units, whereas the control 
lysosomal pH was unchanged. These results suggest a role for the protein in lysosomal 
pH stability. However, the steady-state lysosomal pH was unchanged. Alternatively, 
experiments by Cao et al. with the BK channels do not detect the K+ permeability from 
TMEM175, but they suggest that the BK channels are a voltage-dependent K+ required 
for refilling lysosomal Ca2+ stores (114). More experimentation is needed to determine 
the exact contribution of these proteins for both lysosomal K+ membrane permeability 
and how they may contribute to lysosomal pH maintenance.  
Thus, although several candidate channels have been suggested to act as the main 
contributors to the lysosomal counterion pathway, none appear to be crucial for 
maintaining steady state lysosomal pH under quiescent conditions. 
 
Other roles for ClC-7: tissue/condition specific? 
While the data on the role of ClC-7 is conflicting, one possibility is that ClC-7 is 
significantly more important in certain cell types or conditions than others. One example 
of this comes from the Maxfield lab, who studied the ability of microglia, the main 
immune cells of the brain, to clear Alzheimer’s amyloid fibrils (115). Under 
nonpathological conditions, the cells are inactivated and maintain their lysosomes at an 
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unusually high pH near ~6.0. While these cells could internalize fibrillar Alzheimer’s 
amyloid β peptides (fAβ), they only partially digested the material. However, activation 
by macrophage colony-stimulating factor (MCSF) induced lysosomal acidification, 
reduced luminal pH to ~pH 5.0, and increased the level of fAβ peptide degradation. 
Majumdar et al. found that inactivated cells express ClC-7, but it is mistargeted and 
degraded due to low levels of Ostm1 (115). Upon activation, expression of both Ostm1 
and ClC-7 increases and the Ostm1/ClC-7 interaction allows for proper lysosomal 
trafficking. siRNA knockdown of ClC-7 blocks lysosomal acidification and fAβ 
degradation in activated mouse microglia, indicating that proper ClC-7 targeting is 
important for lowering lysosomal pH. These results suggest a dynamic mechanism of 
lysosomal pH regulation and activity, dependent on the presence of ClC-7, which may be 
tissue specific.  
 
Other roles for ClC-7: protein/protein interactions 
To further elucidate the role of ClC-7, the Jentsch lab generated a transport-
deficient (Td) ClC-7 mouse, which expresses a ClC-7 mutation that has been 
electrophysiologically shown to have no ion conductance (116). They found that similar 
to KO, the Td mouse experienced no change in lysosomal pH, had reduced luminal Cl-, 
and displayed severe osteopetrosis (102, 116). The severity of the osteopetrosis further 
strengths the proposition that the Unc ClC-7 provides an electrical shunt to partially 
recover osteoclast function. However, the presence of the Td mutant protein was 
sufficient to recover hair pigmentation and mice had a normal coat color, indicating a 
more signaling based role for ClC-7. While the Td was unable to prevent LSD and CNS 
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degeneration, there was no increase in neurodegeneration in specific portions of the brain 
like the ClC-7 Unc mutant, suggesting a strict regulation of luminal Cl- concentration is 
critical in this tissue. However, it is possible the Td mutant may mediate some low level 
of current below their detection limit of 3% of WT, an alternative explanation as to the 
recovered hair pigmentation and less severe neurodegeneration (compared to Unc). Yet, 
if the Td mutant does not conduct ions, then these results indicate that ClC-7 KO 
phenotypes cannot be regarded as solely due to a loss of ion transport activity and show 
that ClC-7 is likely required for both ion transport and protein-protein interactions. 
A potential new role of ClC-7 in lysosomal physiology has been hinted at in a 
paper studying the effects of a drug that inhibits the endolysosomal lipid kinase PIKfyve 
(phosphatidylinositol-3-phosphate 5-kinase) (117). The enzyme phosphorylates the D-5 
position in phosphatidylinositol-3-phosphate (PI3P) at the late endosome, generating 
PI(3,5)P2, which assists in endolysosomal trafficking (118). Additionally, PIKfyve has 
also been shown to phosphorylate and interact with other lysosomal proteins. The whole-
body knockout of the gene is embryonic lethal, but knockdown or drug inhibition of 
PIKfyve results in cytosolic vacuoles (119). Gayle et al. found that the PIKfyve inhibitor 
Apilimod has selective cytotoxic activity in B-cell non-Hodgkin lymphoma (B-NHL) 
compared to normal cells (117). Interestingly, a genome-wide CRISPR screen revealed 
that this killing effect was abolished when transcription factor EB (TFEB), a master 
transcriptional regulator of lysosomal biogenesis, and the endolysosomal genes CLC-7, 
Ostm1, and Snx10 were knocked out. In agreement with the loss of the killing activity, 
CRISPR knockouts of ClC-7 or Ostm1 displayed no vacuole formation. Although the 
signaling pathway and mechanism by which PIKfyve interacts with these proteins is 
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unknown, it hints at a potential role for ClC-7 in kinase signaling and/or protein-protein 
interactions. 
 
What is the role of ClC-7? 
Given the various reports on ClC-7, its role in acidification and the lysosome in 
general is unclear. The osteopetrosis and other lysosomal storage disease symptoms from 
knockout of the protein clearly show its physiological importance. Results from multiple 
studies using isolated lysosomes depend on Cl- to act as a counterion in V-ATPase 
facilitated acidification, which was confirmed when ClC-7 was knocked down in both 
microglia and HeLa cells, and yielded lysosomes that appeared to have a more basic pH. 
However, quantitative measurements from several different studies evaluating lysosomal 
pH of ClC-7 KO primary cells reveal no significant pH change compared to WT, even 
though the mice themselves have severe osteopetrosis, lysosomal storage defects, and 
only live a maximum of 6 weeks (94, 99, 100, 102, 116). Several possibilities may 
explain this discrepancy. First, the HeLa cell ClC-7 knockdown (KD) experiments were 
performed using only one siRNA and measured with a non-quantitative dye, casting 
doubt on the results (44). However, unpublished data from our lab indicates this result is 
reproducible when performed with a pool of siRNAs and measured with a quantitative, 
pH-sensitive dye (S.B. Lioi and J.A. Mindell, unpublished results). Secondly, the in vivo 
effects on lysosomal pH have been observed when ClC-7 is knocked down via siRNAs. It 
is possible that KO mice have established a mechanism to compensate for the loss of 
ClC-7 that a short-term knockdown has not/cannot develop, potentially due to insufficient 
time. For example, the ClC-7 KO mouse has been shown to retarget other members of the 
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ClC family, ClC-3 and ClC-6, to lysosomes (120). Third, the mechanism by which 
various tissues and cell types compensate for the loss of ClC-7 is unknown. Perhaps 
tissues/cell types most affected by a loss of ClC-7, such as microglia and bone, either 
compensate differently or place a higher demand on their lysosomes than macrophages 
and fibroblasts, where KO lysosomal pH has primarily been evaluated. Finally, perhaps 
the role that ClC-7 plays in certain cell types becomes apparent when the lysosomes are 
exposed to a substantially more demanding environment, similar to the role of TPCs 
during nutrient deprivation.  
 
Is ClC-7 important for lysosomal pH maintenance? 
In the third chapter of my thesis, I explored the effects of ClC-7 on lysosomal 
acidification using hepatocytes isolated from a liver-specific ClC-7 KO mouse. This 
approach allowed us to evaluate the acidification of isolated lysosomes in parallel to 
measuring lysosomal pH in primary hepatocytes, a cell type where ClC-7 KO pH has not 
been previously characterized. If lysosomal pH in the WT and KO are similar, we 
postulate that the role ClC-7 plays in lysosomal pH maintenance could become apparent 
when the workload demand on lysosomes is increased. To test this, we stressed 
lysosomes using autophagy, a catabolic mechanism used to degrade dysfunctional or 
unnecessary cellular components, to increase the volume of material targeted to the 
lysosome. Additionally, we tested the ability of ClC-7 KO hepatocytes to regenerate an 
acidic pH after alkalization by a weak base.  
Autophagy is an intracellular degradation system that plays a variety of roles in 
physiological pathways in the cell. Of the many autophagy subsets, the most common 
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form is macroautophagy (henceforth referred to as autophagy), where cells consume 
protein aggregates and damaged organelles for clearance and also in response to 
starvation. During autophagy, fragments of membrane surround protein aggregates and 
damaged organelles, forming a double-sided membrane vesicle called an autophagosome 
(89). After formation, the autophagosome fuse with either an endosome (which then fuses 
to a lysosome) or a lysosome, delivering the sequestered cytosolic proteins and organelles 
for degradation. Autophagy is primarily regulated by mTOR, the mechanistic target of 
rapamycin, an evolutionarily conserved serine/threonine kinase that regulates cell growth 
and division in response to energy levels, growth signals, and nutrients (particularly 
amino acids) (121, 122). mTOR is found in two complexes, mTORC1 and mTORC2, 
which regulate many processes within the cell. mTORC1 resides in its inactivated form 
on the lysosomal membrane, where it receives a multitude of microenvironmental inputs, 
resulting in a wide range of outputs. In response to starvation, mTORC1 disassociates 
from the membrane, triggering a cascade of signals resulting in changes in enzyme 
phosphorylation status, protein localization, and mRNA translation (123). Recently, the 
position that mTORC1 occupies at the lysosomes has been found to be important and 
various proteins, including the V-ATPase itself, interact with mTOR and sense amino 
acids levels, as well as the general metabolic state of the lysosome (121, 122).  
The effects of autophagy on lysosomal pH are understudied and not well 
characterized. Zoncu et al. performed the first set of experiments on HEK293 cultured 
cells, where cells were incubated for 50 min in the presence of amino acids, amino acid 
esters, or no amino acids at all (121). They observed no significant change in lysosomal 
pH. The second experiments were performed by Cang et al. and evaluated the effects of 
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starvation in mouse peritoneal macrophages (110). They found that after two hours of 
starvation, the distribution of lysosomal pHs slightly broadened in the starved cells, but 
they still maintained the same average pH. However, upon disruption of TPC1/2, pH was 
shifted to become more alkaline. The same group also showed that RAW macrophages 
had no change in pH upon lysosomal starvation (113). All three sets of experiments used 
a quantitative, pH-sensitive dye to evaluate lysosomal pH. In a fourth set of experiments, 
Zhou et al. tested the effects of starvation and chemicals that affect mTOR on MEF cells 
for three hours (124). They monitored lysosomal pH using a qualitative dye that 
accumulates in acidic compartments (the more acidic, the more dye accumulation and the 
brighter the fluorescence). They found that starvation and treatment with Torin-1 and 
PP242, mTOR inhibitors, drastically increased fluorescence in cellular organelle 
compartments. Exposure to rapamycin, a less potent mTOR inhibitor, partially increased 
fluorescence as well. These experiments show that lysosomal pH is increased during 
autophagy. In summary, experiments evaluating the effect of starvation on lysosomes 
have been performed in a variety of ways using all different cell types, yielding differing 
and somewhat conflicting results. Therefore, the effects of autophagy on lysosomal pH of 
hepatocytes, with and without functional ClC-7, will be explored. 
 
Characterizing a de novo ClC-7 mutation in patients 
In addition to studying the effects of a ClC-7 knockout, we have also investigated 
the effects of a de novo mutation of ClC-7 on lysosomal pH. This work was done in 
collaboration with several research groups who are members of the NIH undiagnosed 
disease program. As previously mentioned, lysosomal storage diseases (LSDs) are rare, 
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metabolic disorders caused by deleterious mutations in lysosomal-related proteins (125). 
Symptoms vary greatly depending on the tissue-specific expression and function of the 
gene, but are typically characterized by an accumulation of undigested products in the 
lysosome, which subsequently alter cellular function. Disease-causing mutations in ClC-7 
are primarily characterized by the symptoms of osteopetrosis and neurodegeneration (99, 
100, 126). In humans, Albers-Schonberg disease, or autosomal dominant osteopetrosis 
type II, is the most common form of osteopetrosis caused by mutations in ClC-7 (127). 
Of the more than 40 different reported mutations in ClC-7, found in various positions 
within the transporter, all result in osteopetrosis (128). In chapter 4, we report a novel 
mutation in only one allele of ClC-7 that results in patients with severe lysosomal storage 
disease phenotypes and partial albinism, but no osteopetrosis. The patients possess highly 
vacuolated cells throughout the body. Because the other ClC-7 allele is unmodified, the 
single point mutation in the other allele suggests some sort of gain of function mutation, 
and we explore its cellular and biophysical effects. 
 
Aims of the thesis: 
This thesis explores the role of Cl- as a counterion and the proteins that transporter during 
endosomal acidification. In chapter 2, we look at the Cl--dependent acidification of 
clathrin-coated vesicles, a subset of early endosomes. Next, we explored the role of ClC-
7 in two capacities. In chapter 3, we describe the creation of a ClC-7 liver specific KO 
and investigated additional roles that ClC-7 may play in lysosomal pH maintenance. In 
chapter 4, we characterized a novel mutation in ClC-7 where, unlike every other reported 
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Characterizing chloride-dependent acidification in brain clathrin-coated vesicles 
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ABSTRACT: 
Endocytic organelles maintain their characteristic internal pH using the V-type ATPase, a 
membrane protein that pumps protons (H+) into the organelle lumen. Accumulation of H+ 
generates a voltage across the membrane; an additional ion, known as a counterion, must 
move to dissipate any charge buildup. Chloride (Cl-) has been hypothesized to be an 
important counterion in the endosomal pathway, a model supported by substantial 
experimental data. However, the role of counterion movement in endosomes is still 
poorly understood, largely due to their heterogeneous composition and the difficulty of 
isolating a well-defined population. Fortunately, a more readily isolatable sub-population 
of early endosomes, clathrin-coated vesicles (CCVs), has been shown to use external Cl- 
to allow V-type ATPase-dependent acidification. We aimed to confirm the vesicle 
counterion requirements and extend the studies to probe the role of Cl- transport in 
endosomal acidification using a CCV model system and identify the Cl- protein. Our 
sample of highly enriched bovine brain CCVs exhibited V-ATPase facilitated 
acidification in the presence of external Cl- that was independent of the monovalent 
cations present.  We attempted to characterize and identify the protein responsible for Cl- 
transport using various methods, but were unsuccessful. A previous study determined that 
brain CCVs are mostly composed of synaptic vesicles (SVs) based on membrane protein 
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content similarity. We functionally tested this conclusion, finding that brain CCVs 
acidify similarly to SVs in the presence of glutamate, and we were unable to extract an 
acidifying sub-population of CCVs that contained no characteristic SV proteins using 
immunoprecipitation and density gradient-based approaches. Mass spectroscopy indicates 
that CCVs contain many SVs-related proteins including vGLUT1, a SV glutamate 
transporter with a known Cl- permeability. Thus, we used a functional approach to show 
that most CCVs are SVs and the source of Cl--dependent acidification in brain CCVs is 
likely to be vGLUT1, although CCVs in other tissues are likely to utilize different 




Cells utilize the endosomal pathway to perform vital functions including protein 
sorting, trafficking, and cell signaling. The initial step of the pathway involves endocytic 
vesicles, largely originating from clathrin-coated vesicles (CCVs), merging with early 
endosomes. Early endosomes mature into late endosomes, which ultimately mature into 
lysosomes, the terminal organelle of the endocytic pathway. These organelles 
progressively become more acidic and each compartment strictly maintains an internal 
pH essential for its function. Acidic luminal pH is generated and maintained by the V-
type ATPase (V-ATPase), a multi-subunit membrane protein that utilizes the free energy 
of ATP hydrolysis to pump protons (H+) into the organelle against its electrochemical 
gradient (4). The action of the V-ATPase is electrogenic: H+-pumping generates a voltage 
across the membrane and an additional ion, known as a counterion, must move to 
dissipate the charge buildup and allow additional proton pumping (18, 19). The 
counterion could be an anion moving into the organelle lumen, a cation exiting the 
lumen, or a combination of both.  Although various organelles appear to utilize the same 
V-ATPase for luminal acidification, they all maintain different internal pH values. 
Investigating the counterion requirements of organelles could provide useful not only for 
understanding the ions and proteins involved, but could also hint at how organelles sense 
and maintain their specific internal pH, a question that has persisted in the field for 40 
years. One possibility is that the regulation and movement of counterions helps determine 
the internal pH levels, although the identity of the counterion(s) used in different 
organelles is not well understood. Substantial experimental data generated from 
endosomal and lysosomal studies suggest that chloride (Cl-) is an important counterion in 
49 
 
the endocytic pathway (20, 26, 51), but there is still debate over the identity of the 
counterion(s). Counterion movement in endosomes is particularly challenging to study, 
largely due to their extremely heterogeneous composition and the difficulty of isolating a 
consistent, distinct population. To study counterions in a well-defined endosomal system, 
we evaluated clathrin-coated vesicles (CCVs), a sub-population of early endosomes. 
Previously, Xie, et al. observed that isolated brain CCVs required external Cl- to 
acidify (24). Subsequent studies by Van Dyke and colleagues confirmed this Cl 
dependent acidification activity in both bovine brain and rat liver CCVs (21, 22). 
Expanding on their previous work, Xie et al. solubilized, column-separated, and 
reconstituted CCV protein fractions into proteoliposomes, identifying a specific fraction 
that facilitated Cl- movement across the membrane (80, 81). Co-reconstitution of the Cl- 
transporting fraction with a V-ATPase containing fraction yielded proteoliposomes that 
acidify upon addition of ATP in the presence of Cl-, similar to the activity observed in 
CCVs (80). However, this protein was not identified. Using CCVs as our endosomal 
model system, we investigated the role of Cl- transport during acidification with the 
intention of identifying the protein responsible for facilitating counterion movement. We 
aimed to take advantage of the technological advancements made over the last 20 years 
that have significantly increased the ability of mass spectrometry to identify membrane 
proteins (82). This approach is advantageous in that it makes no assumption as to the 
identity of the CCV Cl- transporting protein, although several members of the ClC family 
are likely candidates. The ClC proteins are a family of Cl- transporting proteins composed 
of two distinct subclasses: intracellular channels, localized to the plasma membrane, and 
2Cl-/H+ transporters that reside in specific organelles along the endocytic pathway (35).  
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ClC-3,-4, and -5, located in endosomes and transport vesicles, all contain sorting motifs 
that allow them to at least transiently associate with clathrin (83). ClC-5 is localized to 
early endosomes and has been shown to facilitate Cl- movement in endosomes to assist in 
acidification (51, 129). However, it has a restricted tissue distribution and is found 
primarily in epithelia, most prominently in kidney and intestine (52). ClC-4 is broadly 
expressed and also localized to endosomes, but details of ClC-4’s physiology and 
mechanism remain unclear (1, 58). ClC-3 is reported to be present in synaptic vesicles of 
neurons, synaptic-like microvesicles of endocrine cells, and the endosomal compartments 
of most tissues, where it has been implicated to be important for acidification (1, 65, 
130). However, no reports have directly suggested that a ClC is involved in facilitating 
CCV acidification. The cystic fibrosis transmembrane conductance regulator (CFTR), a 
cAMP-regulated Cl- channel expressed primarily in epithelial cells, has also been 
suggested to be involved in facilitating endosomal pH, but recent studies indicate that it is 
unlikely to play a role in endosomal acidification (70). 
Identifying a common CCV Cl- transporting protein is made more complicated 
when considering that the composition and acidification of CCVs may be tissue 
dependent (21, 22, 24). While both liver and brain CCVs display Cl- facilitated 
acidification, a majority of brain vesicles have been shown to be primarily composed of 
synaptic vesicles (SVs) on the basis of membrane protein content similarities (131). SVs, 
while also formed via clathrin-mediated endocytosis, do not traffic cargo like CCVs but 
instead store neurotransmitters for use in neuronal signaling. SVs also contain a Cl- 
permeability, suggested to be mediated by either ClC-3 or the SV-specific glutamate 
transporter, vGLUT1 (62, 66, 67). However, recently vGLUT1 has been definitively 
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shown to conduct Cl- and, if a large overlap exists between brain CCVs and SVs, could 
be contributing to the Cl- dependent acidification observed in CCVs (66, 67). Still, 
because liver CCVs also exhibit Cl- dependent acidification, a tissue with no notable 
vGLUT1 expression (132), the identity of the Cl- transporter responsible for CCV 
acidification in brain and liver is still debatable.  
We sought to reproduce the Cl- dependent acidification results published by Xie et 
al. (24) and extend these studies by identifying the protein responsible. We successfully 
isolated brain CCVs and observed robust, Cl--dependent acidification, but could not 
further characterize the protein due to technical difficulties. Instead, we sought to 
determine if our sample of brain CCVs contained SVs, as has been previously suggested 
(131), by probing for and successfully detecting two synaptic proteins. We employed 
both immunoprecipitation and density gradient based approaches to isolate a population 
of acidifying CCVs that contained no SV proteins, but could not obtain a subpopulation 
that satisfied those conditions. Thus, using a different, functionally-based approach, we 
too conclude that a majority of CCVs are SVs, confirming conclusions made by Maycox 
and colleagues (131). Mass spectroscopy of CCVs reveal substantial levels of vGLUT1, 
strongly suggesting that this protein contributes to the CCV Cl- dependence observed in 







Methods and Materials: 
 
Materials:   
Fresh bovine brains were obtained from J.W. Treuth & Sons (Baltimore, MD, USA).  
All chemicals were purchased from Sigma, unless designated otherwise.  
Leupeptin hemisulfate and pepstatin A were from MP Biomedicals. Tubes and rotors 
were from Beckman-Coulter. Dounce homogenizers were from Wheaton. Detergents 
were purchased from Avanti or Anatrace. Lipids were purchased from Avanti. NuPage 
novex 4-12% Bis-Tris protein gels (NP0322BOX), PageRuler Plus prestained protein 
ladder (10-250 kDa) (26619), Pierce BCA protein assay kit (23225), and Protein G 
Dynabeads (10003D) were purchased from Thermo Scientific. 
 
Antibodies: 
Antibodies, with the dilution used for western blots in parenthesis:   
Santa Cruz: clathrin heavy chain, sc-12734 (1:2000); clathrin light chain, sc-12735 
(1:1000); Lamp1, sc-17768 (1:3333); synaptophysin 1, sc-55507 (1:3333). From Thermo: 
HRP goat α-mouse, #32430 (1:10000); HRP goat α-rabbit, #32460 (1:100000). BD 
transduction labs: Hsp60, #611562 (1:10000). Aves labs: synaptotagmin1, STG (1:3000); 
HRP goat α-chicken, H-1004 (1:10000). For westerns, PDVF blots were blocked with 5% 
milk and primary/secondary blocking steps were performed with 2.5-5% milk 
(Carnation).  
 
Clathrin-coated vesicle isolation:  
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Clathrin-coated vesicles (CCVs) were isolated based on the methods of Nandi, et 
al. (133). Fresh bovine brains were obtained from a local slaughterhouse and placed on 
ice upon arrival (all solutions and brains were kept at 4°C or on ice, unless otherwise 
specified). 4-5 bovine brains were defatted and the meninges were removed. Brains were 
placed in a sieve and washed with 3.5 L of PBS (pH 7.0). Total brain mass was typically 
800-1000 g. Brains were roughly minced and the sample homogenized with an equal 
volume of Buffer A (ex: 900 g of brain requires 900 mL of buffer) in a Waring blender 
with three 10-sec bursts at maximum speed. Buffer A was composed of 100 mM MES, 1 
mM EGTA, 0.5 mM MgCl2, pH 6.75, and contained protease inhibitors added right 
before using the buffer: AEBSF (0.02 mg/ml), leupeptin (0.0005 mg/ml), and pepstatin 
(0.001 mg/ml). The homogenate was centrifuged for 57 min at 22,000 x g. Avoiding the 
pellet, the supernatant was collected and filtered through gauze/cheesecloth to remove 
particulates and then spun at 100,000 x g for 1 hr to obtain a crude vesicle pellet. Pellets 
were resuspended in Buffer A with a Dounce homogenizer (size ‘A’ dounce). The 
suspension was centrifuged at 10,000 x g for 10 min to eliminate aggregated material. 
The high-speed spin (using 140,000 x g), resuspension, and low speed spin sequence was 
repeated 2 additional times. The resulting supernatant was then layered over a single step 
gradient of an 8% sucrose-deuterium buffer (containing buffer A salts) and centrifuged at 
80,000 x g for 2 hrs at 17°C on a swinging bucket rotor (Beckman SW28). The pellet was 
washed and resuspended in buffer A. The solution was spun at 10,000 x g for 10 min to 
clear aggregate material and the supernatant was collected. This CCV sample was either 
stored at 4°C for several days or supplemented with 200 mM of sucrose, aliquoted, flash-
frozen, and stored at -80°C for a minimum of 3 months with no loss of function. To scale 
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up the protocol, 12-15 brains were processed, stored sample overnight at 4°C after 
resuspending the pellet from the first 100,000 x g spin, and finished the protocol 
following day. 
 
Thin section electron microscopy  
250 µg of CCVs were pelleted by centrifuging for 30 minutes at 60,000 x g. 
Supernatant was removed and the sample was fixed with 4% glutaraldehyde in a 0.1 N 
sodium cacodylate buffer. After adding the buffer, one drop of albumin was added to the 
samples and they sat at room temperature for 1 hour. Samples were stored overnight at 
4°C or until processed and mounted by the NINDS EM facility and imaged on an 
electron microscope. 
 
Monitoring CCV acidification: 
CCV total protein concentration was determined using a BCA assay (Thermo). 
CCV acidification experiments were performed in a FluoroMax-3 spectrophotometer. 75-
90 ug of CCVs were added to a buffer containing 10 mM Hepes (pH 7.0 with NaOH), 10 
mM MgSO4, 100 mM cation/anion salt (ex: KCl), 200 mM sucrose, and 8 µM acridine 
orange. Similar to methods in (24), acridine orange fluorescence was excited at 492 nm 
and emission measured at 540 nm. Reactions were initiated with 1 mM Mg-ATP (pH 7.0) 
and 1 µM FCCP, 2 µM bafilomycin, and 1 µM valinomycin (all final concentrations) 
were added where indicated. Results were normalized to the first value measured after 
ATP addition and, because of slight variation in the activity of different CCV preps, only 
normalized to equivalent experiments performed on the same day.  
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To evaluate acidification of CCVs using synaptic vesicles acidification 
conditions, vesicles were added to either a sucrose buffer (10 µM acridine orange, 320 
mM sucrose, 4 mM KCl, 4 mM MgSO4, and 10 mM Hepes-KOH, pH 7.4) or a KCl 
buffer (10 µM acridine orange, 150 mM KCl, 4 mM MgSO4, and 10 mM Hepes-KOH, 
pH 7.4). 1.5 mM Mg-ATP, 150 mM KCl, 1 mM Kglutamate, and 1 µM FCCP (all final 
concentrations) were added when indicated.  
 
CCV partial reconstitution: 
Solubilization and reconstitution methods were modified from Xie et al. (80). 
1mL of concentrated CCVs (10-15 mg/ml) were combined with 0.34mL of 3M Tris-Cl 
(pH 8.5) and incubated on ice for 30 min. Sample was diluted with 1.68 mL of H2O and 
centrifuged at 65,000 rpm for 1 hr (Beckman TLA 100.3 rotor). Pellets were dounce 
homogenized in 1.3 mLs of ice-cold 4% sodium cholate with 5 mM DTT and incubated 
on ice for 15 min to remove contaminants. 1.7 mLs of ice-cold H2O was added to the 
sample, incubated for 15 min, and spun for 1hr. Pellets were washed with 3.2 mLs of 5 
mM DTT and repelleted. Pellets were dounce homogenized in 1.5 mls of detergent 
(concentrations listed at end of paragraph), 10 mM DTT, 30mM Tris-Cl (pH 7.5), and 0.5 
mM EDTA and incubated on ice for 45 min. 0.3 mLs of glycerol was added, sample was 
mixed well, and then centrifuged for 50 min. Solubilized proteins were in the supernatant. 
Stock solutions of detergents were added to the vesicles, with a final concentration 
selected based on the CMC. Listed are the final concentrations of all detergents screened. 
1%: C9G, C10G, LDAO, cymal-6, cymal-7, cyclofos-7, and fos-choline-12. 1.8%: 
Deoxycholate. 3%: C8G, C8M, 0.5%: C12E9. Optimized solubility was test using 2% and 
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6% C9G, 2% cyclofos-6, 1% and 2.5% cyclofos-7, 1% and 4% fos-choline-12, 1% and 
4% LDAO, and 1.8% and 4% deoxcholate. 
Reconstitution of the transporter was performed by combining 104 µl of buffer B 
(5.6% sodium cholate, 28% glycerol, 430 mM potassium gluconate), 20 µl of Buffer C 
(0.6 M DTT, 66 mM magnesium gluconate), and 120 µl of lipids (phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine, & cholesterol at a mass ratio of 4.34: 
2.76: 0.2: 2.7 and used at concentrations ranging from 12.5-25 µg/µl; lipids were 
suspended in 1% sodium cholate, 1 mM DTT, 10 mM Tris-Mes (pH 7.0)). Samples were 
incubated at room temperature for 5 minutes, frozen in dry ice-ethanol, thawed, and 
incubated at room temperature for 45 min. Samples were diluted with 40 mLs of room 
temperature dilution buffer (150 mM KCl, 50 mM Tris-Mes (pH 7.0), 3 mM magnesium 
gluconate), and centrifuged at 200,000 x g for 1 hr at 17°C.  
Proteoliposome acidification was evaluated using the methods described in 
‘monitoring CCV acidification’. Cl- movement across the proteoliposome membrane was 
assessed by monitoring fluorescence changes in the Cl- sensitive dye 6-Methoxy-N-(3-
Sulfopropyl)Quinolinium (SPQ). Proteolipsomes were diluted into inside buffer (300 µM 
SPQ, 225 mM KCl, 20 mM Tris-Mes (pH 7.0), and 3 mM Mg gluconate), freeze-thawed 
3x, and sonicated to change the internal buffer. Proteoliposomes were pelleted and 
resuspended twice to remove external dye and resuspended in inside buffer without SPQ. 
At the start of the experiment, proteoliposomes were added to outside buffer (25 mM 
Kgluconate, 2 mM Tris-Mes, 3 mM MgGluconate, and sucrose to match osmolarity of 




Immunoprecipitation with dynabeads: 
 50 µl of protein-G dynabeads of magnetically pelleted beads were resuspended in 
an antibody solution consisting of 9 µg of Clathrin X-22 (Thermo, MA1-065) in 200 µl 
of PBS + 0.02% Tween20 (PBS+T) and incubated for 15 minutes with rotation at room 
temperature. Antibody solution was removed from pelleted beads, which were then 
rinsed once with PBS+T. Beads were resuspended in 250 µl of 6 µg/µl CCVs in buffer A 
and incubated for 1 hr at room temperature (rotating). Beads were pelleted, supernatant 
removed, and resuspended in PBS. The wash step was repeated 2 additional times. Beads 
were moved to a fresh tube and sample was eluted by adding 26 µl of 50 mM glycine (pH 
2.8) and rotating for 2 min. Once eluted, sample pH was neutralized with addition of 3 µl 
of 2 M Tris (pH 7.0).  
 
Density Centrifugation Gradients: 
Nycodenz step gradient: gradient solutions, solubilized in either D2O or H2O, 
contained 1x buffer A, 8% sucrose, and 23%, 26%, 30%, or 34% nycodenz (w/v). Each 
layer contained 2.2 mLs per step, bottom-loaded by adding steps of increasing density. 1 
part CCVs in 1x buffer A and 250 mM sucrose were mixed with 2 parts of a 45% 
nycodenz solution and layered underneath the gradient. The gradient was spun on a 
swinging bucket rotor (Beckman SW41) for 2 hrs at 95000 x g at 4°C  
8-26% sucrose step gradient: gradient solutions consisted of buffer A, solubilized 
in D2O, and one of the following concentrations of sucrose: 8%, 10%, 14%, 18%, 22%, 
and 26% (w/v). Each layer contained 2 mLs, top loaded by adding steps of decreasing 
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density, except the top 8% layer contained 0.5 mL. CCVs were layered on top and the 
gradient was spun for 2 hrs at 21600 rpm at 17°C with no brake (Beckman SW41).  
0.5 M and 0.7 M sucrose step gradient: CCVs were diluted to a total of 3 mLs 
with a solution of 320 mM sucrose and 4 mM Hepes and layered onto a 0.5 M and 0.7 M 
sucrose step gradient (both layers contained 10 mM Hepes (pH 7.0); 3 mLs per step). 
Gradient was spun for 1 hr on a Ti70.1 rotor (Beckman) for 38000 rpm at 4°C.  
Iodoxinal step gradient: Gradient solutions contained 1x buffer A, 0.24 M 
sucrose, and 20%, 24%, 28%, or 32% optiprep (company; 50% w/v stock solution). The 
gradient contained 2.5 mLs/step, layered by adding decreasingly density solutions with 
CCVs applied to the top. The gradient was spun for 100 min at 25300 x g at 4°C 
(Beckman SW41). 
1 mL samples were fractionated either from the bottom with a peristaltic pump or 
manually with a pipette from the top of the gradient (pipetting from the top only 
performed when a loose pellet was present at the bottom of the gradient).         
 
Mass spectrometry of CCV sample:  
In-gel samples were digested with trypsin at 37°C for 18 hr. Tryptic peptides were 
extracted then desalted before injected into a nano-LC/MS/MS system where an Ultimate 
3000 HPLC (Thermo-Dionex) was coupled to an Orbitrap Elite mass spectrometer 
(Thermo Scientific) via an Easy-Spray ion source (Thermo Scientific). Peptides were 
separated on a ES800 Easy-Spray column (75 μm inner diameter, 15 cm length, 3 μm 
C18 beads; Thermo Scientific) with a 25 min linear gradient of 2–27% mobile phase B 
(mobile phase A: 2% acetonitrile, 0.1% formic acid; mobile phase B: 98% acetonitrile, 
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0.1% formic acid). The HPLC flow rate was 300 nl/min. Thermo Scientific Orbitrap Elite 
mass spectrometer was operated in positive data-dependent LC-MS/MS mode. The 
resolution of the survey scan was set at 60k at m/z 400. The m/z range for MS scans was 
300–2000. For MS/MS data acquisition, the minimum signal intensity required was 3e4, 
the top two most abundant ions were selected for product ion analysis, the isolation width 
was 1.9 m/z, and the dynamic exclusion window was 7 sec. Xcalibur RAW files were 
converted to peak list files in mgf format using Mascot Distiller (version 2.4.3.3). 
Database search was performed using Mascot Daemon (2.4.0) against NCBInr_Bovine 





Clathrin-coated vesicle isolation and characterization    
We isolated bovine brain CCVs using a previously described method (133). A 
western blot containing samples extracted at the beginning and end of the preparation 
indicates that the clathrin heavy chain was highly enriched in the final sample when 
compared to the initial brain supernatant (Fig 1), suggesting successful CCV isolation. 
Comparing immunoblotted CCVs to identical SDS-PAGE samples shows that the 
clathrin heavy chain clearly corresponds to a band near 180 kDa, the known molecular 
weight for the heavy chain (Fig 1). Thin section electron microscopy (EM) images show 
frequent vesicles surrounded by a rod-like lattice with a diameter between 50-80 nm, 
characteristic of vesicles coated with clathrin (Fig. 2A and 2B) (134). In addition to 
coated vesicles, the sample also contained some large, non-coated vesicles (Fig. 2B), 
whose diameters ranged between 60-250 nm. While the extent of this contamination is 
difficult to quantitatively assess with EM, some contamination in a CCV prep is common 
(22, 135). Likely contaminants of an organelle prep are other organelles due to their 
similar sizes and densities. Using western blots to evaluate sample purity, we found that 
CCVs were highly enriched in clathrin and showed no detectable signal for markers of 
lysosomes and mitochondria (Fig. 1). Based on these data, we successfully isolated a 








CCVs acidify in a Cl--dependent manner 
Figure 1: The isolated CCV sample is 
highly enriched in clathrin and is not 
contaminated by lysosomes or 
mitochondria. 
Identical PDVF western blots contain 
whole brain lysate (lane 1), clarified 
brain lysate (supernatant from whole 
brain lysate after 22000g spin) (lane 
2), and the final CCV sample (lane 3). 
Westerns were probed with antibodies 
against clathrin, Hsp60, and Lamp1, 
proteins typically found in CCVs, 
mitochondria, and lysosomes 
(respectively). Blots were overexposed 
to ensure purity. Included is the 
commassie-stained protein gel with a 
molecular weight ladder (M) included. 
A B 
Figure 2: Thin section electron microscopy images show the CCV sample is enriched in CCVs.  
(A) The image depicts CCVs with their typical lattice structure. An individual vesicle is shown 
in the blue box. (B) The image displays the typical distribution of the sample, showing an 




We characterized the Cl--dependent acidification properties of the CCV sample 
using the membrane permeable, pH sensitive dye acridine orange. The dye is thought to 
become protonated and subsequently membrane-impermeable when in an acidic 
compartment, self-quenching as it accumulates, which then qualitatively indicates 
vesicular acidification (136). Upon addition of ATP, CCVs in a bathing buffer with 
100mM KCl rapidly acidified to a stable level within 2-3 minutes (Fig 3A). Addition of 
FCCP, a proton ionophore, returned fluorescence back to its initial intensity, 
demonstrating that fluorescence loss is reversible and the result of a change in the H+ 
gradient. Acidification was inhibited when CCVs were incubated with bafilomycin, an 
inhibitor of the V-ATPase, indicating that the V-ATPase is responsible for generating the 
pH gradient. CCV acidification was stable, robust, and consistent, with very little 
variation between different CCV brain preparations. The CCV sample acidified to the 
same extent after being stored for more than 3 months at -80°C and retained at least 50% 










Figure 3: Acidification of 
CCVs in the presence of 
various inhibitors and ions 
indicates acidification 
requires the presence of Cl- 
 
(A) A representative trace is 
shown where CCVs were 
added to a 10mM Hepes buffer 
(pH 7.0) that contained 100mM 
KCl and 8 uM acridine orange. 
The experiment was initiated 
with 1mM ATP and a decrease 
in fluorescence emission 
indicates acidification. Identical 
experiments were performed in 
the presence or absence of 2uM 
bafilomycin, an inhibitor of the 
V-type ATPase. 1uM FCCP is 
a proton ionophore, was added 
where indicated. The spike seen 
when FCCP is added is a 
machine artifact due to pausing 
the fluorometer. The vertical 
axis depicts arbitrary 
fluorescent units measuring 
emission at 540 nm (A.U. 540) 
and the horizontal axis 
represents time in seconds. 
(B) CCV acidification was 
tested in buffers where K+ is 
substituted for sodium, choline 
or lithium, but chloride remains 
in the buffer.  
(C) CCV acidification tested in 
buffers were K+ constantly 
remains in the external buffer 
but chloride is substituted for 
Br-, SO4
-, or gluconate, A 




While CCVs in a KCl buffer acidify, vesicles in a salt-free buffer display no 
measurable acidification (Fig. 3C). To determine the ionic requirements of CCV 
acidification, we tested the relative contributions of K+ and Cl- by measuring activity in 
their absence.  Acidification appeared unchanged when K+ was substituted with choline, 
sodium or lithium (Fig. 3B), indicating that acidification does not depend on the cation. 
In contrast to the robust acidification in KCl, no acidification was observed when Cl- was 
substituted with gluconate, phosphate, or sulfate, results very similar to the salt-free and 
+bafilomycin controls (Fig 3C).  Substituting Cl- with Br- slightly enhanced the rate of 
acidification and, while the increase was not anticipated, it is unsurprising that Br- can 
substitute for Cl- considering most Cl- channels/transporters tend to discriminate poorly 
between the two anions (44, 57, 137). Therefore, we have confirmed the previous 
findings that brain CCV acidification requires external Cl- and appears to be cation 
independent.   
 
CCVs are not amenable to internal buffer exchange via freeze-thaw sonication methods 
Given the robust CCV acidification, we sought to characterize these results in a 
more quantitative fashion. Acridine orange cannot indicate the magnitude of the pH 
change, nor can it indicate initial or final pH values. The ability to control CCV internal 
buffer composition and load a membrane impermeable dye would allow for such 
measurements, and could potentially designate if Cl- is moved across the membrane via a 
channel or a couple transporter. A typical method for modifying internal buffer 
composition is to freeze-thaw (FT) vesicles several times and then sonicate, which 
produces unilamellar vesicles that should contain the bathing buffer (44). We performed 
a 3x freeze-thaw and subsequent sonication (FTS) cycle on CCVs, finding they acidified 
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to the same extent as unmodified vesicles when measured by acridine orange (data not 
shown). However, we detected no fluorescent signal when CCVs were FTS in a solution 
containing the membrane impermeable dye fluorescein, indicating no dye incorporation. 
We hypothesized that the clathrin coat was preventing the CCVs from breaking open and 
fusing during the freeze-thaw step and removed the coating protein by incubating vesicles 
in 0.5M Tris (138). SDS-PAGE shows that Tris-treatment freed a substantial portion of 
the clathrin from pelleted vesicles, implying that many vesicles no longer retained their 
clathrin coat (Fig 4A). We used electron microscopy (EM) to evaluate the preparation 
and ensure the vesicular structure was being modified by the FTS cycle. Consistent with 
the SDS-PAGE results, many vesicles lost their coat after Tris incubation (Supplemental 
1A-B). The freeze-thaw sample contained large, multilamellar vesicles and subsequent 
sonication reduced vesicular size and yielded smaller, unilamellar vesicles (Supplemental 
1C-D). These data indicate the amenability of uncoated vesicles to structural 
modifications and therefore internal buffer modification may be possible. We evaluated 
the functional effects of Tris, Tris-FT, and Tris-FTS treatments on vesicles by measuring 
acidification in acridine orange. We found that increased modifications progressively 
decreased the vesicles’ ability to acidify (Fig 4B) and, while this loss of function was 
substantial, enough activity remained to attempt internal dye incorporation. 
Unfortunately, no measurable dye incorporation occurred even after a wide range of dyes, 
buffers, and loading conditions were tested. The absence of dye may be attributed to a 
lack of tightly resealed vesicles, possibly due to a high concentration of membrane 
proteins, too little internal dye incorporation, or the inability of the Cl- transporter to 
withstand the FTS conditions. The remaining acidification we observed after FTS may be 
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those residual uncoated vesicles that were protected from the harsh FTS step. Ultimately, 
we were unable to modify the internal buffer solution of the CCVs while retaining 






















Figure 4: Incubation with Tris partially removes the clathrin coat and further 
structural modification affects vesicular acidification 
(A) CCVs were treated with 0.5M Tris for one hour at 4°C to remove their clathrin coat, 
pelleted at high speed, and the supernatant and pellet were compared. Shown is an SDS-
PAGE with standard molecular weights marked. The second lane shows the starting CCV 
sample, the third lane is the CCV supernatant, and the fourth lane are pelleted vesicles. (B) 
The acidification of untreated CCV is compared to vesicles stripped of clathrin using 0.5M 
Tris, stripped and freeze-thawed 3x, or stripped, freeze-thawed 3x, and sonicated. 
Acidification conditions are the same as those described in Fig. 3 
 
A   B   
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Partial reconstitution of CCVs using various detergents 
An alternative approach to studying the properties of the Cl- transporting protein 
is to solubilize, isolate, and reconstitute the protein into proteoliposomes. Previously Xie, 
et al. solubilized uncoated vesicles in C12E9 and successfully reconstituted a partially 
purified Cl- transporting fraction into proteoliposomes, but did not identify the protein 
(80). As a first step toward identification, we omitted the purification step and directly 
reconstituted solubilized uncoated vesicle proteins into liposomes, a method previously 
used to reconstitute the V-ATPase from CCVs (139, 140). We evaluated successful 
incorporation by assaying ATP-initiated acidification, which would only occur if both the 
V-ATPase and the Cl- transporting protein were properly reconstituted into 
proteoliposomes. Additionally, we monitored the functionality of the Cl- transporting 
protein by loaded the proteolipsomes with 225mM KCl and the Cl- sensitive dye 6-
Methoxy-N-(3-Sulfopropyl)Quinolinium (SPQ), whose fluorescence decreases in the 
presence of Cl-. These vesicles were placed in an external buffer without Cl- and we 
initiated the experiment with the addition of Valinomycin, an ionophore that allows K+ to 
freely cross the membrane to act as a counterion. If a Cl- transporter is present, K+ acts as 
a counterion to allow movement of the anion out of the lumen, resulting in an increase in 
the fluorescent signal. Unfortunately, no fluorescent changes were observed in either 
assay and we hypothesized this may be due to a low concentration of reconstituted 
protein. Indeed, an SDS-PAGE of the proteoliposomes indicates little protein 
incorporation. To optimize reconstitution, we solubilized uncoated vesicles in various 
detergents and compared levels of solubilized protein on an SDS-PAGE (Fig 5). 
Cyclofos-6, cyclofos-7, fos-cholate-12, deoxycholate, LDAO, and C9G all appeared to 
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solubilize protein than C12E9, the starting detergent (Fig 5, cyclofos-6 not shown but was 
very similar to cyclofos-7).  After optimizing different concentrations of these selected 
detergents, we determined that cyclofos-6, fos-cholate-12, and deoxycholate allowed for 
the most reconstituted protein again using SDS-PAGE. However, no SPQ fluorescence 
changes were detected after assaying for Cl- transporting activity in these optimized 





Figure 5: CCV solubilization in various detergents 
 
Uncoated CCVs were treated with various detergents, spun at high speed, and 
supernatants were run on an SDS-PAGE. The first lane contains a molecular weight 
marker, the second contains starting CCVs, and the third contains proteins solubilized in 







Examining CCV acidification using synaptic vesicle acidification conditions 
Both brain and liver CCVs acidify in the presence of Cl- (21, 22, 24), suggesting a 
general mechanism of CCV, and perhaps early endosome, acidification. However, 
experiments published by Maycox et al. show that brain CCVs are primarily composed of 
SVs on the basis of extremely similar membrane protein content in both populations 
(131). Their conclusions, while convincing, contain no functional comparisons of the two 
populations; nor did their work exclude the possibility of a small sub-population of non-
SV CCVs. Our CCV sample, isolated using a somewhat different protocol than Maycox 
et al., appears to have a different protein distribution upon comparison of our SDS-PAGE 
results. Therefore, we investigated if our brain CCV sample also contained SVs by 
immunoblotting against two characteristic SV proteins, synaptophysin-1 and 
synaptotagmin-1 (Fig 6). We detected a substantial signal for each protein, suggesting 
that a significant portion of the sample could be SVs. Since SVs contain a V-ATPase and 
Figure 6: Immunoblotted CCV 
samples probed with antibodies against 
either synaptophysin-1 or 
synaptotagmin-1. 
 
The SDS-PAGE on the right shows a 
protein ladder, with standard molecular 
weights marked, and a lane containing 
isolated CCVs. ‘A’ is a PDVF membrane 
with the CCV sample probed with a-
synaptophysin; ‘B’ is the identical sample 
probed against synaptotagmin. 
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acidify in the presence of glutamate and low concentrations of Cl-, we further explored 
the overlap of the two vesicle populations by tested CCV acidification employing the 
same experimental parameters previously used to test SV acidification (141). The 
addition of 1mM glutamate to CCVs in 4mM KCl caused a small increase in the 
magnitude and rate of acidification, while addition of 150mM KCl greatly enhanced both 
rate and magnitude (Fig 7A). These results were extremely similar to those observed for 
SVs under identical conditions  (141), suggest that CCVs could use glutamate as a 
counterion. We then tested if, like SVs, CCVs require a small concentration of Cl- to 
utilize glutamate for acidification, finding that glutamate was unable to induce 
acidification when 0mM KCl was present, but similarly increased the rate of acidification 
in the presence of either 2mM or 4 mM KCl (Fig 7B). Again, CCVs and SVs have very 
similar acidification profiles (141). However, these results also show that glutamate 
either only acts like a counterion when Cl- is present or its presence somehow changes 
the activity of the transporter. The striking similarities between SVs and brain CCVs 
acidification properties prompted the following questions: was the Cl--dependent 
acidification from CCVs, SVs, or some combination of both? What percentage of the 
















Figure 7: CCVs can partially acidify in the presence of glutamate and varying KCl 
concentrations. 
 
(A) CCV acidification was measured with acridine orange, as in Fig.3, but the starting buffer 
contained 4 mM KCl buffer. Marked are additions of 1mM ATP, 1 mM glutamate (glut), 150 
mM KCl, and 1µM FCCP. Two of the traces are overlaid to allow a better comparison. The 
label shows the addition order of KCl, glutamate, and/or FCCP. 
(B) CCV acidification using the same conditions as (A) except the buffer contained 0, 2, or 4 
mM KCl. The points where ATP, KCl, glutamate, and FCCP were added are marked. 
Sample addition order for all was: ATP, glutamate, KCl, FCCP. 
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Attempts to separate CCVs and SVs using immunoprecipitation and density gradients 
To determine if Cl--dependent acidification is a property of brain CCVs and/or 
SVs, we attempted to isolate a subpopulation of acidifying vesicles from CCVs that did 
not contain SVs. We employed immunoprecipitation, a technique that precipitates a 
protein or protein complex out of solution using an antibody that binds specifically its 
target, to isolate a subpopulation of CCVs. Using a clathrin antibody as the bait, we 
evaluated if SVs were also extracted by monitoring the presence of synaptophysin. 
Western blot analysis indicates we successfully immunoprecipitated a small amount of a 
clathrin labeled sample, but synaptophysin was also present (Fig 8).  We were unable to 
confirm the functionality of the isolated sample because neither the bead-bound sample 
nor glycine-eluted samples acidified when tested with the acridine orange assay, although 
the harshness of the acidic glycine likely explains the lack of activity in the latter. To 
explore if targeting different locations of the clathrin lattice or SVs themselves would 
pull-down a unique vesicle population, we performed immunoprecipitation with two 
additional clathrin antibodies and the synaptophysin antibody, but SDS-PAGE showed no 
protein was pulled-down from the overall CCV sample. Thus, immunoprecipitation did 











If SVs and CCVs are different populations of vesicles, then it is possible they 
might have different physical properties, like density. We employed density gradient 
centrifugation, a technique that separates heterogeneous samples based on the physical 
properties of mass, size, and/or density, to seek a difference between SVs and CCVs. We 
designed gradient compositions based on previous protocols used to isolate CCVs, SVs, 
or other similar organelles, selecting sucrose, iodixonal, and/or nycodenz as the gradient 
materials. After fractionating samples of a spun gradient, we evaluated the protein 
Figure 8: Immunoprecipitation of CCVs using a clathrin antibody attached to protein G 
dynabeads. 
SDS-PAGE and westerns show CCVs incubated with either a clathrin or synaptophysin 
antibody attached to magnetic dynabeads. Lane 1 contained the starting CCVs sample, lane 2 
contained the CCV supernatant after dynabead incubation, lane 3 contained the antibody 
attached to the dynabeads, and lane 4 contained the sample eluted off the beads (including the 




distribution of the samples using SDS-PAGE, monitored the presence of synaptophysin 
with westerns, and measured their acidification with the acridine orange assay.  Gradients 
typically yielded three outcomes. The first, and most frequent, was no apparent 
separation of proteins across the gradient (Supplemental figure 2), indicating that the 
CCVs and SVs are not separated. The second was an asymmetrical distribution of several 
CCV proteins, implying a separation of the sample into subsets, but synaptophysin was 
evenly distributed throughout the gradient (Fig 9A-B), indicating that no subset of CCVs 
was separated from SVs. The third was an asymmetrical distribution of synaptophysin, 
but the no/low synaptophysin samples tended to have very little protein and did not 
acidify (Fig 10A-B). Because of the reduction in the number of proteins, the non-
acidifying CCVs may be empty baskets, spontaneously formed clathrin coats that lack an 
internal membrane (138). Therefore, we were unable to separate acidifying CCVs from 
SV markers, likely because that population is very small or too physically like SVs to 
extract. Our results agree with previous work from Maycox et al. arguing that CCVs are 
















Figure 9: Sucrose gradient to separate CCV marker and SV markers. 
 
(A) CCVs layered on top of a 0.5M and 0.7M sucrose step gradient were spun and 
fractionated. The SDS-PAGE gel, with labeled molecular weight markers, contains 
fractions of CCVs, ordered by increasingly high concentrations of sucrose. The final 2 
samples are the resuspended gradient pellet and the starting CCVs. Below the SDS-PAGE 
is a western blot of the same samples probed with an antibody against synaptophysin. (B) 
Acidification of representative fractions from the gradient were tested under the same 








Mass spectrometry reveals CCV- and SV-specific proteins 
We attempted to identify a possible Cl--transporting protein using mass 
spectrometry (MS) analysis. Because clathrin and its related adaptor proteins are such 
substantial portions of the protein sample, we uncoated the vesicles using Tris to increase 
the percentage of membrane proteins in the sample. We split the initial vesicle sample in 
half and evaluated it two different ways. We analyzed half of the sample to evaluate the 
overall levels of protein in the vesicles. We ran the other half on SDS-PAGE to separate 
the sample based on mass, split it into different 8 samples, and analyzed them 
Figure 10: Iodixanol gradient to separate CCV marker and SV markers and 
acidification. 
 
(A) CCVs layered on top of a 0.5M and 0.7M sucrose step gradient were spun and 
fractionated. The SDS-PAGE gel, with labeled molecular weight markers, contains 
fractions of CCVs, ordered by decreasing concentration of iodixanol. The starting CCVs 
are the last sample. The initial sample was so dilute it was not properly normalized. 
Below the SDS-PAGE is a western blot of the same samples probed with an antibody 
against synaptophysin. (B) Acidification of representative fractions from the gradient 




individually to increase the likelihood of detecting low abundance proteins (supplemental 
graph 1). In both the individual and total protein samples, we found many of the expected 
structural components of CCVs, including the clathrin heavy and light chains, adaptor 
proteins, coating and uncoating proteins, components of the V-type ATPase, and proteins 
relating to microtubules.  Additionally, we identified many neuronal specific proteins 
such as neurofilaments, synaptosomal associated proteins, and SV-specific SNAREs. 
Similar to the SV westerns, we also detected synaptophysin-1 and synaptotagmin-1 (Fig 
6). We examined the samples for Cl- transporting proteins, finding vGLUT-1 in both the 
individual and overall samples. One individual sample contained ClC-4, a 2 Cl-/H+ 
transporter that may have some importance in endosomal acidification (58), but that 
remains unclear. One individual sample contained the Na+-driven Cl-/bicarbonate 
exchanger, although it is unlikely to influence CCV acidification given that there is 
neither Na+ nor bicarbonate in most of our experiments. Interestingly, we did not detect 
ClC-3, a protein known to be present in SVs but rarely identified using MS, implying that 
even though MS methods for detecting membrane proteins is improving, they remain 











A consistent, highly regulated internal pH is vital to the function of many 
organelles. Endosomal organelles are acidified by the V-ATPase, a membrane protein 
that pumps H+ into the lumen. H+ movement across the membrane is an electrogenic 
action that requires an ionic shunt or counterion to dissipate and prevent voltage 
accumulation.  In this study, we examined the ions required to facilitate acidification in 
brain CCVs and explored their similarity to SVs. While Cl- appears to function as the 
counterion in CCV acidification, the identity of the Cl- transporting protein remains 
unclear (21, 22, 24). Our data are consistent with a previously proposed model showing 
that brain CCVs are primarily composed of SVs and thus the Cl- transporting protein is 
most likely vGLUT1, a SV-specific glutamate transporter (67, 131). However, similar Cl-
-dependent acidification has been observed in liver CCVs, and the identity/function of 
that Cl- transporting protein remains unknown.  
Cl- has long been implicated as a counterion in endosomal acidification and we 
sought to investigate its role by characterizing isolated CCVs in a well-defined ionic 
environment. Our sample of highly enriched CCVs relies on the V-ATPase to acidify the 
vesicular lumen, without any observable contribution from potentially contaminating 
mitochondrial or plasma membrane ATPases (Fig 3A). We showed that external Cl- was 
necessary for CCV acidification and substituting Cl- with gluconate, phosphate, or sulfate 
yields no acidification, similar to the salt-free and +bafilomycin controls (Fig 3B).  We 
also found that Br- could substitute for Cl- and facilitated acidification to an even greater 
extent.  While the enhancement of acidification was surprising, that Br- can substitute for 
Cl- was not since many Cl- transporting proteins are typically unable to discriminate 
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between the two ions (44, 137). These data agree nicely with the results from previous 
brain CCV experiments (22, 24), except the enhancement of acidification from Br- was 
only seen by our group and by Van Dyke et al. when testing uncoated brain vesicles (22). 
However, since Br- is present in cells at such a low concentration, its effects on CCV 
acidification in vivo are likely negligible.  
We also explored the role of cations in CCV acidification by pairing Cl- with K+, 
Na+, Li+, or choline, demonstrating that none of these cations are required for the 
acidification of CCVs (Fig 3B). Our results are similar to those previously observed in 
brain CCVs, where another group observed no substantial change when K+ was substitute 
for Na+ (22). However, they found that the substitution of Li+ or choline for K+ caused a 
decreased rate of acidification whereas our results are much cleaner and show no 
acidification reliance on the cation. We are unsure what caused this difference because 
our isolation protocols and SDS-PAGE results are very similar. However, while 
acknowledging that electron microscopy images are not quantitative, their sample 
appears to have more of the large, uncoated vesicle contaminants than ours, which may 
have contributed to the discrepancy. Thus, we have presented evidence that even more 
clearly highlights that brain CCV acidification appears to be independent of the external 
cation and requires Cl-.   
To further characterize the properties of the Cl- transporting protein, we used two 
separate approaches. First, we attempted to modify the internal buffer composition of 
uncoated vesicles using freeze-thaw sonication, which yielded structurally altered 
vesicles but no internal dye incorporation occurred (Supplemental figure 1).  Second, we 
attempted a partial isolation and reconstitution of the Cl- transporting protein, which led 
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us to optimize and improve existing reconstitution conditions, but no Cl- movement 
across the proteoliposome membrane was detected (Fig 5). The lack of transporter 
function was surprising, given the robust CCV acidification and that reconstitution 
success reported by others (80, 139, 140). Potentially a step in our 
solubilization/reconstitution conditions prevented the Cl- transporting protein from 
functioning or the final concentration of the transporter was too small to yield detectable 
Cl- movement. Therefore, additional properties of the transporter remain uncharacterized. 
While CCVs in both brain and liver exhibit Cl- dependent acidification, Maycox et 
al. showed that brain CCVs are primarily composed of recycling SVs based on membrane 
protein content similarities. However, they provided no functional data to support this 
overlap, nor did they exclude the possibility of a small sub-fraction of non-SV CCVs 
existing in the sample. Our CCV sample was isolated using a slightly different protocol 
than Maycox et al. and appeared to have a somewhat different SDS-PAGE protein 
pattern, which led us to question if our acidification was from CCVs, SVs or both (131). 
We found our CCV sample positively tested for synaptic vesicle proteins when evaluated 
with immunoblotting and mass spectroscopy (Fig 6, supplemental graph 1).  Further, 
when evaluated with conditions mimicking those used to examine glutamate-induced 
acidification in SVs, CCVs produced remarkably similar results (Fig 7) (141), again 
indicating that these two populations are alike. To investigate the overlap between CCVs 
and SVs, we tried to isolate a sub-population of acidifying CCVs that contained no SV 
markers using immunoprecipitation and density-gradient based approaches. 
Immunoprecipitating a subpopulation of CCVs was unsuccessful because the isolated 
sample contained both clathrin and synaptophysin (Fig 8). The results from separating 
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CCVs from SVs using density gradients were slightly more informative and yielded one 
of two general outcomes (Fig 9). The first was an asymmetric separation of CCVs 
proteins, indicating some separation into subsets, but synaptophysin remained evenly 
distributed throughout the gradient. The second was an asymmetric distribution of CCV 
proteins in addition to a gradient of synaptophysin concentration, with the no/low 
synaptophysin samples containing very little protein and no observable acidification. This 
result suggests two possibilities, either all acidifying vesicles contain synaptophysin or 
the low protein samples are empty clathrin baskets, a spontaneously formed clathrin coat 
without a lipid membrane (138). Because empty baskets can be common in clathrin 
preps, the latter option is quite likely, but this does not exclude the possibility that the 
former is also correct. Thus, by taking a functional approach and using a different set of 
criteria and experiments than Maycox and colleagues, we too have shown that CCVs and 
SVs have a remarkably similar composition based on the similar acidification pattern of 
CCVs and SVs, the presence of synaptophysin in most CCV samples, and mass 
spectroscopy results showing the presence of many SV-specific proteins.  
The prevalence of SVs in our CCV sample argues that the protein facilitating the 
observed Cl- dependent acidification is likely to be vGLUT1. This transporter contains a 
Cl- permeability and requires a small concentration of Cl- to facilitate glutamate uptake, 
similar to the acidification properties that we observed in CCVs (Fig 7) (67, 141). 
However, vGLUT1 is a neuronally expressed protein and CCVs are ubiquitously present 
through the body. If both liver and brain CCVs need Cl- to acidify, do they use the same 
protein or are the Cl- proteins/counterion requirements organ specific? It is also possible 
we were unable to isolate the subset of non-SV brain CCVs that use a different Cl- 
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transporting protein, potentially because of its extreme similarities to coated SVs or 
because they are a very small portion of the overall vesicle pool. Besides vGLUT1, our 
mass spectroscopy results suggested one additional Cl- transporting protein, ClC-4. 
However, the protein was in low abundance and its role in endosomal acidification 
remains unclear. One possibility is that a potential small subset of CCVs that are not SVs 
may employ ClC-4 to acidification, but that would require further testing. Liver CCVs 
have a slightly different counterion requirement profile in that they do not require Cl- for 
acidification, but its presence greatly enhances the extent of acidification (21). If the 
anion/cation utilization is tissue-dependent, then is Cl- facilitated acidification necessary 
or just useful based on specific situations/cell type? Historically, CCVs have been 
isolated from liver and brain due to the ease of obtaining these larger organs. Exploration 
into the CCVs from other organs could provide insight into the role of Cl- and 



















Supplemental Figure 1: Electron microscopy images of CCVs treated in various 
ways 
Shown are representative EM images of CCVs treated in different ways. All CCV 
samples originated from the same stock and sample removed at the mentioned 
intervals. CCVs were were stripped of clathrin; stripped and freeze-thawed 3x; or 
stripped, freeze-thawed 3x, and sonicated. Included for each condition is a magnified 














Supplemental graph 1  
This is a microsoft excel file with the mass spectrometry sequencing of the entire CCV 
sample (total sample) and of the individual CCV fractions from the same CCV starting 
material (fractions 1-8).    
 
  
Decreasing nycodenz Decreasing nycodenz 
D2O H2O 
Supplemental Figure 2: Nycodenz step gradients of CCVs 
 
CCVs were spun on a 23-34% sucrose step gradient solubilized in either D20 (left) or 
H20 (right) and alternating fractionated samples were run on an SDS-PAGE gel in 
order of decreasing density.  





Probing the role of ClC-7 in hepatocyte lysosomal pH maintenance 
 
Contributing authors: Mary R. Weston, Anorawul Amin, and Joseph A. Mindell 
 
ABSTRACT 
Lysosomes, the terminal organelles of the endocytic pathway, maintain a characteristic 
internal pH essential for their function. This acidic luminal pH is generated and 
maintained by the V-type ATPase, a membrane protein that pumps protons into the 
organelle against their electrochemical gradient using energy provided from ATP 
hydrolysis. H+-pumping generates a voltage across the membrane; an additional ion, 
known as a counterion, must move to dissipate this charge buildup and allow bulk 
acidification. Given that lysosomal acidification is Cl- dependent, and that the lysosomal 
protein ClC-7, a Cl-/H+ antiporter, moves Cl- into lysosomes, this protein has been 
suggested to mediate such counterion movement. In this context, it is surprising that ClC-
7 knockout (KO) mouse lysosomes in primary cultures seem to acidify to the same extent 
as wild type (WT), even though the mice have osteopetrosis and massive lysosomal 
storage defects. We generated mice with a liver-specific ClC-7 KO to test these results in 
isolated lysosomes and live cells in parallel. Isolated WT lysosomes relied on Cl- for 
acidification and KO displayed little to no acidification. We employed a robust, 
quantitative method to measure lysosomal pH in live cells using the ratiometric dye 
Oregon Green 488 covalently linked to dextran. We measured a similar lysosomal pH 
both WT and ClC-7 KO hepatocytes that was unaffected by the length of culturing time 
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(3-72 hrs). To evaluate if increasing metabolic demand on the lysosomes asymmetrically 
affected WT and KO pH by inducing autophagy, a catabolic mechanism used to degrade 
dysfunctional or unnecessary cellular components. Both WT and KO hepatocytes 
experience a similar, small increase in lysosomal pH upon amino acid starvation. 
Alkalinizing lysosomes with NH4Cl and monitoring reacidification did not reveal a 
difference in WT and KO lysosomes, as both reacidified to initial levels faster than we 
could monitor. Thus, while ClC-7 obviously affects the state of lysosomes, we were 
unable to detect a pH change in KO lysosomes in living cells when exposed to 




Lysosomes, the terminal organelles of the endocytic pathway, are responsible for 
breaking down macromolecules and resupplying the cell with basic metabolites. These 
specialized organelles, the most acidic in the cell, contain various hydrolyases which 
function at a pH optima between 4.0-5.0. This acidic luminal pH is generated and 
maintained by the V-type ATPase, a membrane protein that harnesses the energy of ATP 
hydrolysis to unidirectionally pump protons into the organelle against their 
electrochemical gradient (4). An accumulation of protons generates a voltage across the 
membrane unless an additional ion, known as a counterion, simultaneously moves to 
dissipate charge buildup and allow bulk acidification. The counterion could be a 
cytoplasmic anion entering the organelle, a luminal cation exiting the organelle, or a 
combination of both. The identity of the counterion(s) responsible for lysosomal 
acidification is debated (26, 93), but Cl- appears to be important based on functional 
studies in isolated lysosomes (20, 23, 44, 92, 94). In one such study, Okhuma et al. used 
isolated lysosomes containing the pH sensitive FITC-dextran dye to explore the effects 
different ions had on acidification (20). In these experiments, removing external Cl- from 
the bathing media substantially slowed and reduced acidification, but exchanging the 
cation had little effect, arguing that anions function as counterions. Later Graves et al. 
established that the primary pathway for Cl- flux in the lysosome is from a transporter 
exchanging two Cl- ions for one proton moving the opposite direction (44). The 
lysosomal-specific chloride transporter was demonstrated to be ClC-7, a 2Cl-/H+ 
antiporter, knocking down (KD) its expression in HeLa cells yielded lysosomes that 
appeared to have a more basic pH when assessed with a non-quantitative, pH-sensitive 
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dye. Together, these experiments argue that ClC-7 mediates counterion movement in 
lysosomes. However, quantitative measurements from several different studies evaluating 
the lysosomal pH of ClC-7 knock out (KO) primary cells reveal no significant pH change 
compared to wild-type (WT), even though the mice themselves have severe osteopetrosis, 
lysosomal storage defects, and only live 3-5 weeks (94, 99, 100, 102, 116). 
Several possibilities may explain this discrepancy. First, the ClC-7 KD 
experiments were performed using only one siRNA and measured with a non-quantitative 
dye, casting doubt on the results (44). However, unpublished data from our lab indicates 
this result is reproducible when performed with a pool of siRNAs and measured with a 
quantitative, pH-sensitive dye (S.B. Lioi and J.A. Mindell, unpublished results). 
Secondly, knockout mice may have various mechanisms that compensate for the loss of 
ClC-7 and allow for proper lysosomal acidification. For example, the ClC-7 KO mouse 
has been shown to retarget other members of the ClC family, ClC-3 and ClC-6, to 
lysosomes (120). Third, the mechanism by which various tissues and cell types 
compensate for the loss of ClC-7 is unknown. Perhaps tissues most affected by a loss of 
ClC-7, such as brain and bone, either compensate differently or place a higher demand on 
their lysosomes then macrophages and fibroblasts, where KO lysosomal pH has primarily 
been evaluated. 
To determine the effects of ClC-7 on lysosomal acidification, we created a liver-
specific ClC-7 KO mouse. This approach allowed us to evaluate the acidification of 
isolated lysosomes in parallel to measuring lysosomal pH in primary hepatocytes, a cell 
type where ClC-7 KO pH has not been previously characterized. KO mice had a similar 
life span and were visually similar to WT, but both the entire body weight and the liver 
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weight of the KO were about 25-30% heavier than WT. Similar to published results, we 
observed that isolated lysosomes exhibited Cl--dependent acidification that was absent in 
KO lysosomes. However, like published literature, the lysosomal pH in live WT and KO 
hepatocytes were very similar. We postulated that the role ClC-7 plays in lysosomal pH 
maintenance could become apparent when the workload demand on lysosomes is 
increased. To test this, we stressed lysosomes by inducing autophagy, a catabolic 
mechanism used to degrade dysfunctional or unnecessary cellular components, to 
increase the volume of material targeted to the lysosome (89). Additionally, we tested the 
ability of ClC-7 KO hepatocytes to regenerate an acidic pH after alkalization by a weak 
base. Yet, in all metabolic conditions tested, the lysosomal pH of KO primary 
hepatocytes matched that of the WT. Thus, while ClC-7 is clearly important in lysosomal 




METHODS AND MATERIALS 
 
All chemicals were purchased from sigma unless other designated. 
 
ClC-7 liver specific KO mouse generation 
Wild-type C57BL/6 and homozygous Alb-Cre+ transgenic mice were obtained from 
Jackson Laboratory. The lox-ClC-7 mice were developed by Xenogen technologies. 
Several crossings of the Alb-Cre+ and lox-ClC-7 generated homozygous Alb-Cre+/lox-
ClC-7 mice (confirmed via genotyping). RNA was isolated from fresh livers using the 
RNA PureLink kit (ThermoFischer Scientific). RNA was converted to cDNA (iScript; 
Biorad) and amplified with the SsoAdvance kit (Biorad) on a C1000 thermal cycler 
(Biorad, CFX96 RealTime). ClC-7 primers used were: forward (5'-
CGCCAGTCTCATTCTGCACT-3') and reverse (5'-GCTTCTCGTTGTGTGGAATCT-
3'). 18s rRNA control primers used were: (F: 5’-TGTGCCGCTAGAGGTGAAATT-3’, 
R: 5’-TGGCAAATGCTTTCGCTTT-3’). 
 
Liver/kidney lysosomal preparation from rat or liver 
Fluorescein isothiocyanate-dextran (70 kDa FITC-dextran (Sigma) in 1X PBS) 
was injected into a rat or mouse (10 mg/100 g of body weight of rat; and 10 mg/mouse) 
intraperitoneally and subsequently starved overnight (~12-14 hours). The isolated liver or 
kidney obtained from the euthanized rat or mouse was minced and then homogenized 
(Homogenizer Motor Drives, Glas-Col) with HM buffer (ice cold 10 mM HEPES, 1 mM 
K2-EDTA, 0.25 M sucrose, pH 7.0) at 4°C. As in (20), the homogenate was centrifuged 
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at 800 xg for 10min. The supernatant was collected and centrifuged again for 10 min at 
20,000 xg to isolate the light mitochondrial fraction (LMF). A percoll:LMF mixture (4:5 
ratio) was centrifuged at 35,000 x g for 90 min (without break) at 4°C. The gradient was 
fractionated (0.8 mL for rat liver; 0.4 mL and 0.2 mL of mouse liver and kidney, 
respectively) from the bottom using an Econo pump (Biorad). Collected fractions were 
spun at 100,000 X g for 60 m, at 4°C to remove the percoll from lysosomes. Protein 
concentration was determined using a BCA colorimetric assay kit (ThermoFisher 
Scientific). Lysosome-rich fractions were confirmed by fluorescence spectroscopy 
(excitation 490 nm; emission 520 nm) (Jobin Yvon FluoroMax-3 spectrofluorimeter).   
 
Proton-driven 36Cl- uptake:  
Protocols were followed as in (44). 100 μg the lysosome-rich fraction was freeze thawed 
3x and sonicated with internal buffer (5 mM NaCl, 10 mM KCH3SO3, 20 mM citrate; pH 
4.0). The external solution was exchanged using a sephadex G-50 column equilibrated 
with external buffer (5 mM Na36Cl, 10 mM KCH3SO3, 1 mM NaVO3, and 20 mM 
HEPES at pH 7.0). H+-driven 36Cl- uptake was initiated by addition of 1 μM valinomycin. 
At indicated times, the reaction was terminated by addition of a 20x volume of ice cold 
quench buffer (5 mM NaCl, 10 mM KCH3SO3, 1 mM NaVO3, and 20 mM HEPES at pH 
7.0) and rapid filtration through a 200-nm nitrocellulose filter (Millipore). The filter was 
washed 2x with quench buffer, the filter was dissolved in FilterCount liquid scintillation 
cocktail (PerkinElmer) and the 36Cl- internalized by the proteoliposomes was counted 





100 µg of the lysosome-rich fraction was suspended in 1.25 mL of buffer (100 mM of 
KCL/K2SO4/ChCl/K-Gluconate, 10 mM MgSO4, 250 mM sucrose and 10 mM 
HEPES/KOH, pH 7.0) in a glass cuvette at room temperature. FITC-dextran emission 
(excitation 490 nm; emission 520 nm) was monitored as a function of time and 1 mM 
Mg2+-ATP and 1 µM FCCP were designated. Fluorescence intensity was normalized to 
the value measured right after addition of Mg2+-ATP.  
 
Hepatocyte isolation 
A 24G catheter was injected into the IVC vein of the liver of an CO2
 sacrificed 
mouse and ~35 mLs of hepatocyte wash media with 1x penicillin/streptomycin (Gibco 
17704024, ThermoFisher 15140122) was perfused into the liver. The SVC vein was 
cleaved to increase the flow of media. After losing its color, ~30 mLs of EGTA buffer 
was perfused until the liver turned white, then wash media with 0.1% collagenase (Type 
IV; Gibco 17104019) was perfused until the liver because mushy (25-35 mLs). The liver 
was moved to a sterile hood (where all experiments occur henceforth), finely chopped, 
and suspended in 21 mLs of 0.067% collagenase in wash media. The liver solution was 
incubated at 37°C for 10-15 minute (with gentle inversion every couple minutes) and 
then filtered through a 70 µM cell strainer. 20 mLs of wash buffer was added to the cell 
solution and centrifuged for 5 min at 65xg. The supernatant was discarded, the cell pellet 
gently resuspended in 50 mLs of wash media, and then spun at 65xg for 5 min. This wash 
step was repeated an additional time and the final cell pellet was resuspended in 11 mLs 
of wash media. 10 mLs of a percoll solution (9 mLs percoll + 1 mL 10x PBS) was added 
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to the cell solution and spun at 200 g for 10 min with low acceleration and low brake. 
The supernatant was removed and the pellet resuspended in 25 mLs of wash media. After 
a final 65xg for 5 min, the supernatant was discarded and cells were resuspended in wash 
media (3-4 mLs). Cells were plated onto collagen-coated plates or slides (Collagen: 
corning 354249 with final concentration of 5.77 μg/mL; Nunc Lab-Tek II slides 155382) 
in 2% FBS DMEM (Gibco 17104019) and maintained in at 37°C with 5% CO2. 
 
Measuring the lysosomal pH of live cells  
Confocal images of Oregon Green 488 loaded cells were collected using a FITC 
filter on a Ziess AIRY and deconvolved at something using X camera.  
To evaluate lysosomal pH, cells were incubated overnight in DMEM containing 4 
mg/mL Oregon green 488 10,000 MW dextran (ThermoFisher Scientific D7170). Upon 
dextran removal, cells were rinsed 3x with PBS, and chased in dye-free media for 4 
hours. Ratiometric, fluorescent images were collected using a Ziess widefield microscope 
and a CCD camera (Photometrics CoolSNAP HQ2). Excitation bandpass filters 440/40 
and 485/20 were used to excite the Oregon Green 488 fluorophore, and a 506nm dichroic 
filter with a bandpass filter 534/42 were used to collect the emission from both excitation 
wavelengths. Cells were imaged in medium 2 (in mM: 150 NaCl, 5 KCl, 1 CaCl2, 1 
MgCl2, 20 hepes, 10 glucose, 30 sucrose; pH 7.4 with HCl) (142). Greater than 15 
cells/experimental condition were imaged. Hepatocytes were incubated for 15-20 min in 
32 nM bafilomycin in imaging media (Sigma B1793) where noted. An Oregon Green 
calibration curve was determined by incubating cells with buffers titrated at half pH unit 
increments, from pH 4.0-7.0 +/- 0.01, and 10 µM each of Monensin and Nigericin (Sigma 
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M5273, N7143). The calibration buffers contained imaging media and a designated 
buffer (for pH 4.0-5.5, 50 mM Tris-maleate; for pH 6.0, 25 mM Na2HPO4 and 25 mM 
Tris-maleate; for pH 6.5-7.0, 50 mM Tris-maleate). Cells were incubated for five minutes 
prior to imaging to allow for pH equilibration across all membranes. The well was rinsed 
thoroughly after each pH measurement before the next pH buffer was added.  
 For starvation-induced autophagy, Oregon green 488 loaded cells were incubated 
in EBSS (Sigma E2888) for 2-3 hrs prior to imaging. For chemically induced autophagy, 
cells in growth media were incubated for 1-2.5 hr with either 2.2-4.4 μM rapamycin or 
250-500 nM Torin-1 (Tocris 4247). Lysosomes were alkalized by adding either 5 or 10 
mM NH4Cl in imaging media and incubating with cells for 2-3 min. Cells were rinsed 3-
4x with imaging media to removed NH4Cl. 
 
Image analysis 
Images were analyzed using either MetaMorph Imaging software or Slicer2D, a 
Matlab-based program created for lysosomal analysis by the CIT group under the 
direction of Huey Cheung at NIH. In short, after applying a wavelet filter and 
thresholding for spots whose intensities were in the top 80%, lysosomes were identified 
as individual objects in each 440 and 490 image. Identified objects from each image were 
reconciled with the other image to ensure the same objects were being evaluated in both 
images. The original images were background subtracted (using average intensity of the 
lowest 5% of intensities) and then the average and total intensity for each object was 
measured. The fluorescence ratio (490/440) was calculated using the total fluorescent 
intensity of each object. The lysosomal pH was calculated using cells with greater than 
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10 lysosomes. To convert ratio to pH, lysosomal values from each individual pH 
calibration tested were averaged and the data fit to a four-parameter sigmoidal equation. 
The pH values for individual cells were interpolated using the sigmodal equation values 
obtained from fitting to the pH calibration curve. 
 
Westerns and Immunofluorescence: 
Cells were solubilized in RIPA buffer (Sigma R0278) with protease inhibitors. 
For westerns, PVDF membranes were blocked in 5% BSA. Primary antibodies were used 
at 1:1000 (Cell Signaling Technology; p70-S6K (#9202) and P-p70-S6K (#9205)) and a 
goat α-rabbit secondary at 1:7500 (ThermoScientific; 32460).  
For immunofluorescence, cells were fixed for 10 min in 3% PFA, permeabilized 
in 0.2% trition for 5 min, and quenched with 0.1 M glycine. Blocking steps were 
performed with 3% BSA. 1:200 Albumin (Bethyl Laboratories; A90-134A-16) and 
1:1000 donkey α-goat alexa fluor 488 (ThermoFisher; A-11055) were used for primary 







Characterizing the ClC-7 liver specific knockout mouse 
We investigated the effects of ClC-7 on lysosomal acidification by crossing a 
loxP-flanked ClC-7 mouse with a mouse expressing Cre recombinase under the liver-
specific albumin promoter, creating a liver-specific ClC-7 KO mouse (Fig 1A). The 
partial knockout strategy yields mice without osteopetrosis and other detrimental 
phenotypes associated with the full body ClC-7 knockout (99, 100, 102), while allowing 
us to investigate the impact of ClC-7 using both isolated lysosomes and primary cells 
from the same organ. Due to the lack of commercially available, reliable ClC-7 
antibodies, we used RT-PCR to measure the efficiency of knockout. After normalizing 
WT expression to 100%, the KO mouse had undetectable expression of ClC-7 (Fig 2). 
The liver-specific KO and WT mice are visually similar with a comparable life span (Fig 
1B). However, KO mice have a shifted weight distribution, weighing 25-35% more than 
WT littermates (Fig 1B, 1D). Upon opening the chest cavity, the KO mice frequently had 
more fat lining the gut and a larger, fattier liver (Fig 1C). Although individual livers 

















Figure 1: Characterization of the ClC-7 liver-specific KO mice.  
Data and figure by Anowarul Amin 
(A) Schematic of ClC-7 liver-specific knockout shows loxP-flanked ClC-7 was combined 
with a cre-lox expressed under the liver specific promoter albumin. (B) Images depict the 
sizes of WT and KO mice. (C) Images show the relative sizes of WT and KO livers (circled). 
(D) Quantitative measures of (B) and (C) showing the average and standard deviation of the 
body weight and liver weight of WT and KO mouse, indicating a 30% and 25% increase in 




Previous work established that ClC-7 is the primary pathway for Cl- flux in the 
lysosome (44). To further confirm that KO lysosomes contained no ClC-7, we evaluated 
the ability of WT and KO lysosomes to move Cl- across their membrane using a H+-
driven Cl--uptake assay (Fig 3). In these experiments, lysosomes are exposed to an 
outwardly directed H+ gradient (pH 4.0 inside; pH 7.0 outside) and symmetrical Cl- on 
both sides of the membrane. If a H+-driven Cl- transporter was present, the H+ gradient 
would drive the uptake of outside 36Cl- into the lysosomal lumen. The transport assays 
show that isolated WT lysosomes were capable of H+ driven 36Cl--uptake, but KO 
lysosomes accumulated no measurable level of labeled substrate, demonstrating that ClC-
7 is knocked out. Additionally, previous ClC-7 KO models showed some retargeting of 
ClC-3 or -6 from the late endosome to the lysosome, suggesting a potential mechanism 
cells employ to compensate for loss of ClC-7 (120). The lack of Cl- uptake indicates that 



















Figure 2: ClC-7 KO mice do not express measurable 
ClC-7 mRNA 
Data and figure by Anowarul Amin. 
mRNA was extracted from WT and KO isolated livers and 
relative expression of WT and KO ClC-7 was measured 
using qRT-PCR. WT expression was normalized to 100% 
and KO mice express ~0% mRNA when compared to WT 
(n>3 livers for WT and KO each). 
 
Figure 3: Proton-driven 36Cl- flux is abolished in isolated KO hepatocytes 
Data and figure by Anowarul Amin 
Lysosomes containing 5 mM Cl-, pH 4.0 were added to a buffer with 5 mM 36Cl-, pH 7.0. 
Data are shown for WT (black) or ClC-7 KO (red) lysosomes measured after 1, 10, and 30 
seconds. Expression was normalized to 100% and KO mice express ~0% mRNA when 
compared to WT (n>3 livers for WT and KO each). 
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Isolated lysosomes rely on Cl- to facilitate acidification 
After comparing the physical features of the WT and ClC-7 KO mice, we studied 
the acidification properties of isolated liver lysosomes. We used freshly isolated 
organelles loaded with FITC-dextran, a pH sensitive dye that decreases when exposed to 
acidic conditions. Upon addition of ATP, WT lysosomes in a KCl buffer showed a loss of 
fluorescence, indicating a more acidic luminal pH (Fig 4A). The subsequent addition of 
FCCP, a H+ ionophore that allows the free movement of H+ across the membrane, 
increased fluorescence and confirmed that the signal loss upon ATP addition was due to 
an acidic shift in luminal pH. Lysosomes incubated with bafilomycin, an inhibitor of the 
V-ATPase, displayed no acidification, showing that the V-ATPase is primarily 
responsible for acidification. To determine the ionic requirements of acidification, Cl- 
was substituted for gluconate and SO4
2-, resulting in a ~50% and ~80% reduction of 
acidification, respectively. These results indicate that Cl- plays an important role in 
facilitating acidification. When K+ was substituted for choline, acidification was slightly 
enhanced, indicating that the cation is not essential for acidification. In contrast, KO mice 
lysosomes displayed little acidification upon addition of ATP, with the rate and 
magnitude of acidification being similar in KCl, ChCl, Kgluconate, and K2SO4 (Fig 4B). 
We evaluated the rate of acidification during the first 30 seconds after ATP was added, 
observing that while WT relies primarily on the anion to acidify, KO lysosomes 
experience little acidification in all buffers (Fig 4C). Thus, we find that WT utilizes Cl- to 
acidify while KO lysosomes have little to no acidification activity. Together, the 
experiments in isolated lysosomes strongly argue that ClC-7 is knocked out in the liver, 
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isolated lysosomes rely on Cl- to acidify via ClC-7, and no additional ClC transporters are 
functionally active in isolated KO lysosomes.  
 
Isolating and characterizing primary hepatocytes 
After establishing that ClC-7 clearly plays a role in the acidification of isolated 
liver lysosomes, we evaluated the effects of ClC-7 on lysosomal pH in hepatoctyes to 
provide as equivalent of a comparison as possible. We devised a hepatocyte isolation 
protocol, incorporating previously published methods, that consists of the perfusing of 
liver with collagenase, filtering out contaminates with a percoll gradient, and plating cells 
on collagen-coated plates/slides. The percoll gradient was necessary to obtain consistent, 
non-contaminated cells. Cultured hepatocytes were a largely homogenous population 
based on shape and size (Fig 5A). Our isolated cells appeared similar to cultured 
hepatocytes reported in literature based on cell appearance and the expected 
binucleated/quadnucleated cells were seen 24-48 hrs post-isolation (143). We tested the 
identity of the cells by immunostaining fixed cells for albumin, a hepatocyte-specific 
protein, and found positive expression in most cells (Fig 5B). Visually, there were no 































Figure 4: Isolated WT lysosomes utilize external Cl- to facilitate acidification but KO 
organelles display severely reduced acidification and no reliance on Cl- 
Data and figure by Anowarul Amin 
(A) Representative acidification traces of isolated lysosomes loaded with FITC-dextran in a 
10mM Hepes buffer (pH 7.0) with 100 mM of KCl (black), K2SO4 (green), choline-Cl (ChCl) 
(red), or K-gluconate (blue). Reactions were initiated with 1 mM ATP and a decrease in 
fluorescence indicates acidification. Reactions were normalized to the first time point after 
ATP addition. Where noted, lysosomes were incubated with 2 µM bafilomycin, a V-ATPase 
inhibitor, for 15 min prior to addition of ATP (pink trace). 1 µM FCCP, a proton ionophore, 
was added where indicated. (B) Quantification of isolated lysosomal acidification data for 
WT (black) and KO (red) are expressed as the rate of normalized fluorescence over the first 









Figure 5: Hepatocyte Images 
(A) Brightfield images of percoll 
isolated hepatocytes, many of 
which are binucleated.  
(B) PFA fixed KO hepatocytes 
probed with an albumin antibody 
and dapi was added to mark the 
nuclei. 
Figure 6: WT and KO hepatocytes uptake Oregon Green 488 and have similar 
lysosomal distributions 
Deconvolved AIRY scan confocal images of live WT and KO hepatocytes incubated 
with Oregon Green 488-dextran overnight. 
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Measuring lysosomal pH in primary hepatocytes 
After successfully isolating primary cells from the liver, we explored if ClC-7 was 
important for their steady state lysosomal pH. We employed a robust and quantitative 
method for pH measurement in live cells using the fluorescent, ratiometric dye Oregon 
Green 488 covalently attached to dextran. When incubated with cells, the dye is 
transported into the cell via endocytosis and subsequently trafficked through the 
endosomal pathway to the lysosome. We imaged WT and KO hepatocytes loaded with 
dye, observing a similar lysosomal distribution pattern (Fig 6). Oregon Green 488 emits a 
pH independent (excitation 440 nm) and pH dependent (excitation 490 nm) fluorescent 
value, the ratio of which can be correlated to a specific pH using an experimentally 
derived calibration curve (Fig 7A-B). We found that the steady-state lysosomal pH of the 
WT and KO was not significantly different, with respective values of 5.1 +/- 0.1 and 5.2 
+/- 0.1 (Fig 7C). Thus, like previously reported results, knocking out ClC-7 did not 
modify lysosomal pH. To ensure that increased hepatocyte culturing time did not affect 
lysosomal pH, we compared the effects of increasing culturing time to 72 hrs compared 
to the typical 48 hr time point. We found WT and KO lysosomal ratios were not only 
similar to each other, but comparable to the 48 hr time point as well (Fig 7D). These 






















Given that the whole-body ClC-7 KO mouse displays symptoms of lysosomal 
storage disease, that ClC-7 is a lysosomal membrane protein responsible for moving ions 
related to pH, and that isolated lysosomes rely on Cl- for acidification, the lack of a 
lysosomal pH change in cultured cells is surprising. We investigated if the similarity 
between WT and KO lysosomal pH is explained by a potential reduction in metabolic 
demand due to a change in the cellular environment. In our experiments, hepatocytes are 
transitioned from an organ to a cultured media, an environment that likely places less 
metabolic demand on the cells than tissue. If ClC-7 affects the rate of acidification, then 
plating KO hepatocytes in culturing media for more than 24 hrs may be enough time for 
the lysosomes to gradually attain a pH value similar to the WT. We investigated the 
effect of plating time by examining lysosomal pH after hepatocytes had been plated for 
only 3 or 6hrs (Fig 8). Because hepatocytes need an overnight incubation with Oregon 
Green 488 to accumulate enough dye to provide a reliable signal, we evaluated lysosomal 
Figure 7: WT and ClC-7 KO hepatocytes have similar steady-state lysosomal pH.  
Lysosomes loaded with Oregon green 488 dextran from WT and ClC-7 KO hepatocytes 
were imaged at two excitation wavelengths and the resulting values are a fluorescent ratio 
(analyzed with slicer2D) of the pH dependent value/pH independent value. (A)-(B) To 
convert fluorescent ratio to pH, hepatocytes were incubated with buffers every 0.5 pH units 
from 4.0-7.0. Calibration curves for WT (A) and ClC-7 KO (B) are shown. (C) Steady-
state lysosomal pH of WT (black) and KO-ClC-7 (red) hepatocytes loaded with Oregon 
green 488 were imaged and the ratio converted to pH using the values from (A) and (B). 
Lightly shaded points represent the average lysosomal pH for one cell (>12 
lysosomes/cell). The average and SEM for each condition are shown as the darkly shaded 
points. Hepatocytes incubated with 32 nM bafilomycin were imaged as a control. Cells had 
been isolated from the mouse approx. 48 hrs prior to being imaged. (D) Cells isolated at 
the same time as (C) were left for an additional 24 hrs before loading with dye and 
identically imaged the following day. The data are expressed in fluorescent ratio because 
no pH calibration curve was conducted on the 72 hr time points. 
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pH using the pH-sensitive dye FITC-dextran intraperitoneally injected into the mice the 
night prior to hepatocyte harvest. After 3 hrs of plating, the majority of hepatocytes 
remained fairly spherical, not unexpected given the short plating time. The lysosomal 
ratios of both cell types were high, representative of a more alkaline pH, potentially 
induced by the stress of removal from the liver. After 6 hours of plating, hepatocytes 
become flatter and the lysosomal ratio settled to a level similar to the ratio measured after 
24-30 hours of plating. Therefore, if length of time in culturing media does influence 





Figure 8: WT and KO hepatocytes imaged after short plating times have similar 
fluorescent ratios. 
The night prior to hepatocyte isolation, WT and KO mice were injected with 10 mg of FITC-
dextran. Hepatocytes were harvested, plated for either 3 or 6 hrs, and ratiometric imaging was 
performed to derive a fluorescent ratio (analyzed with Slicer2D) based on FITC fluorescence, 
similar to Fig 7. WT data are in black, KO are in red. 
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Evaluating the impact of various metabolic challenges on KO hepatocytic pH                            
A possible explanation for the discrepancy in ClC-7’s lysosomal role of ClC-7 is 
that KO lysosomes can acidify under quiescent conditions (like cell culture) using 
alternative pathways, but are unable to maintain proper pH under ‘stressful’ conditions, 
where protons are rapidly utilized and must be swiftly replenished to maintain internal 
pH. If true, then exposing cells to a taxing condition may asymmetrically affect WT and 
KO lysosomal pH and reveal a role for ClC-7. To test this hypothesis, we stressed 
lysosomes using autophagy, a catabolic mechanism that degrades dysfunctional or 
unnecessary cellular components. Autophagy is primarily regulated by mTOR, the 
mechanistic target of rapamycin, an evolutionarily conserved serine/threonine kinase that 
regulates cell growth and division in response to energy levels, growth signals, and 
nutrients (particularly amino acids) (121, 122). mTOR is found in the mTORC1 complex, 
where it resides in its inactivated form on the lysosomal membrane. In response to 
starvation, mTORC1 disassociates from the membrane, triggering a cascade of signals 
resulting in changes in enzyme phosphorylation status, protein localization, and mRNA 
translation (123). By inducing a large influx of cytosolic material into lysosomes using 
autophagy induction, we can then assess whether they maintain steady state lysosomal 
pH. We employed both starvation and chemical means to induce autophagy and 
evaluated activation by monitoring the phosphorylated form of p70-S6K (S6K). Using an 
antibody specific for general S6K as a control, we found that both media starvation and 
chemical inhibitors of mTOR caused a drastic reduction in phosphorylated p70-S6K, 
indicating induction of autophagy (Fig 9A). We tested the effects of autophagy on 
hepatocyte lysosomal pH, finding that WT and KO began at a ratio of 2.17 and 2.19 +/- 
109 
 
0.1 and shifted to a higher ratio of 2.50 and 2.45 +/- 0.1, respectively. Thus, we see a 
general trend where starvation-induced autophagy shifted the pH of the lysosomes to a 
higher ratio (Fig 9B), but there was no difference in the effect on WT and KO 
hepatocytes, signifying that absence of ClC-7 does not appear to influence lysosomal pH 
during autophagy. 
 We investigated whether ClC-7 influences the rate at which lysosomes can 
establish their pH by comparing the reacidification of alkalized WT lysosomes to KO. 
After imaging hepatocytes preloaded with FITC-dextran, we alkalized lysosomes using 
the membrane permeable, weak base ammonium chloride (NH4Cl) and imaged the same 
well again. After rinsing out the base, we imaged the cells an additional time to determine 
the extent of reacidification. Figure 10A shows an overlay of the ratios of WT and KO 
lysosomes when hepatocytes were treated with 5 mM NH4Cl. Both cell types rapidly 
reestablish their internal pH within 2 minutes, a rate faster than the parameters of the 
experiment could measure. Figure 10B shows the pre-, during, and post-NH4Cl treatment 
averages for multiple experiments. These data imply that ClC-7 is not required to 










Figure 9: Buffer induced starvation of WT and KO hepatocytes causes an increase in 
the lysosomal ratio.  
(A) KO hepatocyte lysates subjected to various autophagy-inducing conditions were 
immunoblotted against p70-S6K. Total p70-S6K expression serves as the control and 
autophagy induction is shown by the reduction/loss of phospho-p70-S6K. (B) WT (black) or 
KO (red) hepatocytes, containing lysosomal Oregon green 488, were imaged and processed 
as in Fig 7. Hepatocytes were incubated for 2 hrs in EBSS prior to imaging to induce 
autophagy. The untreated and starved hepatocytes were significantly different, as were the 













Figure 10: Alkalized WT and KO lysosomes rapidly reestablish lysosomal pH.  
WT (black) or KO (red) hepatocytes, pre-loaded with FITC-dextran (as in Fig. 8), were 
imaged prior to NH4Cl addition, in the presence of either 5 or 10 mM NH4Cl, and after 
NH4Cl had been removed and the cells rinsed 3x.  (A) An overlay of hepatocytic 
lysosomal ratios from WT and KO hepatocytes prior to, during, and after a 5 mM NH4Cl 
incubation. Each point is the average lysosomal ratio and SEM of the cells imaged at the 
labeled time (2-4 cells/time point). (B) Cumulative results from several NH4Cl 
experiments conducted in WT and KO hepatocytes. Within each group of experiments 
(>14 cells/condition), the first point is the average lysosomal ratio of all cells imaged prior 
to NH4Cl addition, the center point is average ratio in the presence of NH4Cl, and the last 
point is the average ratio once NH4Cl was washed out. The concentration of NH4Cl used 





The role that counterions play in maintaining lysosomal pH is crucial, but poorly 
understood.  Given that acidification in isolated lysosomes has been shown to be Cl--
dependent, and that the lysosomal transporter ClC-7 facilitates the movement of Cl- into 
lysosomes, this protein has been suggested to mediate such counterion movement. 
However, the role of ClC-7 in lysosomal homeostasis has been highly debated, with some 
groups finding that ClC-7 influences organelle pH, while others observe no change (44, 
94, 100, 102, 115). We bred a mouse containing a liver specific knockout of ClC-7 to 
investigate these claims, an approach that facilitates the testing of both isolated 
lysosomes and primary cells from the same tissue while avoiding the gravely ill 
phenotype accompanying the full body knockout. We reproduced the same conflicting 
results in our system; isolated lysosomes had no significant acidification upon loss of 
ClC-7, while primary KO hepatocyte lysosomes appeared to have the same pH as WT. 
We explored alternative roles ClC-7 may play on lysosomal pH maintenance during 
metabolically demanding conditions, finding that KO lysosomal pH matched WT pH 
regardless of the stress imposed on the hepatocytes. 
After obtaining the liver specific knockout of ClC-7, we evaluated any 
phenotypical changes compared to WT littermates. The KO mice had a similar 
appearance and lifespan as WT, but both the liver and the whole-body weight of the KO 
mice were an average of 25-35% heavier than WT (Fig 1B-D) with visible excess fat 
lining the inside of the gut. While the reason for this is unknown, it is possible the 
removal of ClC-7 somehow affects the metabolic status the liver. Mice with a deletion in 
Tsc-1, a negative regulator of the mTORC1 complex that regulates metabolic growth in 
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response to nutrient levels and other signals, also have a similar increase in liver size 
(144). Additionally, mice expressing a non-conducting mutation in ClC-7 exhibit 
increased autophagy markers, although the cellular basis and subsequent effects of this 
increase are unknown (116). Therefore, ClC-7 may be involved in some sort of response 
to autophagy, although this mechanism is unclear.  
We isolated lysosomes and examined the importance of external ions in 
facilitating acidification. In WT and KO lysosomes, no acidification was observed when 
lysosomes were incubated with bafilomycin, an inhibitor of the V-ATPase, indicating 
that the rotary protein was responsible for acidification (Fig 4). In WT, we observed 
acidification in the presence of KCl that was unchanged when K+ was substituted with 
choline, indicating that anions act as counterions to facilitate proton pumping. 
Conversely, keeping K+ in the system but replacing Cl- with sulfate or gluconate greatly 
reduced acidification ~80% and ~50%, respectively. In KO lysosomes, ChCl, KCl, and 
Kgluconate all facilitated a similar level of acidification that only reached, at most, 40% 
of the level of WT in the presence of Cl-. When evaluating the rate of acidification during 
the first 30sec, KO lysosomes experienced a similar level of acidification in all ionic 
buffers tested, indicating a baseline acidification that was not reliant on the presence of 
Cl-. Thus, WT lysosomes depend primarily on Cl- for acidification and KO lysosomes 
lose the ability to robustly acidify. 
After evaluating acidification in isolated lysosomes, we harvested primary cells 
from the liver to directly compare acidification properties between organelles in live cells 
and those that have been isolated. Given that we observe no 36Cl- uptake in isolated KO 
lysosomes, we deduced that there must be little expression of functional, compensating 
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ClCs in the liver lysosomes, unlike a previously characterized ClC-7 KO model (Fig 3) 
(120). We evaluated the steady state lysosomal pH of hepatocytes, a cell type where the 
absence of ClC-7 has not been previously characterized, finding that ClC-7 KO 
hepatocyte lysosomes acidified to the same extent as WT when evaluated with the pH 
sensitive dye Oregon Green 488 (Fig 7C). These perplexing results do not match those 
observed in isolated lysosomes, but are similar to have previously published results from 
live cells (fibroblasts and macrophages) (47, 100, 102). 
We explored the possibility that ClC-7 affects the rate of lysosomal acidification, 
hypothesizing that a cultured media environment may be less metabolically demanding 
than the liver. Since the 24-48 hrs of plating could allow KO lysosomes to gradually 
reach a pH value similar to the WT, we varied the length of time WT and KO hepatocytes 
were plated from 3 hrs to 72 hrs (Fig 3D, Fig 4). While the fluorescent ratio of both cells 
types was increased at the 3hr time point, corresponding to a more basic pH, we 
continually observed similar pH values for WT and KO lysosomes at all time points. 
Given the more basic pH of the early time points, it is difficult to detect a difference 
between WT and KO cells that are simultaneously adjusting to a culturing media 
environment.  Therefore, no discernible impact of ClC-7 on lysosomal pH was detected 
when examining different lengths of plating time. 
We investigated other situations where ClC-7 may be important for lysosomal pH. 
One possibility is that ClC-7 knockout lysosomes can acidify under quiescent conditions, 
like cell culture, but are unable to maintain the appropriate acidic pH in an environment 
where a high demand is placed on the lysosomes. We used starvation induced autophagy 
to direct a large influx of macromolecules to the lysosome, increasing the metabolic 
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demand placed on the organelle. While the lysosomal pH of both WT and KO become 
slightly more basic during autophagy, the shifts were similar in both cell types. Although 
this experiment did not reveal a role of ClC-7, expanding these studies by varying the 
length of starvation and induction method of autophagy may yield additional findings. 
Further, the pH lysosomes maintain during autophagy is not well characterized, but the 
only experiments of this nature were described from three different groups using various 
cells types and starvation induction methods. In contrast to our observation of more basic 
pH, they report that lysosomal pH was either unchanged or became more acidic (110, 
121, 124), indicating that characterizing pH in various cell types could provide valuable 
in future work. 
Finally, we examined if ClC-7 assists in lysosomal pH maintenance when pH is 
increased by an abnormal amount. We used the weak base NH4Cl to alkalize lysosomes 
and assessed if the KO organelles could reacidify at the same rate, or to the same extent, 
as WT. We found that even after alkalization of lysosomes to a quite basic pH, both WT 
and KO rapidly reacidified to initial levels within two minutes (Fig 10A). Resolving 
acidification activity faster than two minutes was not possible due to technical 
difficulties, but monitoring lysosomal pH as NH4Cl is being removed could yield 
different results. Yet, if ClC-7 is playing a role in reacidifying lysosomes, the cell can 
compensate for its loss effectively and reacidify quickly.  
Although both WT and KO lysosomes alkalized to a similar pH value during 
treatment with NH4Cl, treatment with bafilomycin, an inhibitor of the V-ATPase, yields a 
different result. We consistently observed that WT hepatocytes treated with bafilomycin 
become more alkalized than KO lysosomes (Figs 7C, 8, 9B). While the reason for this 
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differential shift is unknown, this effect may suggest something about the method cells 
use to compensate for a loss of ClC-7. Perhaps some sort of mechanism exists that 
clamps the lysosomal pH to a low value, resulting in a pH maintenance system that is less 
flexible/responsive, but keeps the lysosome at a sufficiently lower pH. If this system were 
to exist, that could explain the lower pH levels of hepatocyte KO lysosomes incubated 
with bafilomycin.  Treating hepatocytes with nM concentrations of NH4Cl that only 
slightly adjust the pH may expose a difference in the lysosomal state of WT and KO 
cells.  
What is the role of ClC-7 in lysosomes? The Jentsch lab created mice containing 
an uncoupled ClC-7 (Unc), a point mutation that changes it from a transporter to a 
channel, and observed the animals have a normal coat color and more mild osteopetrosis, 
but still have severe lysosomal storage disease (LSD) symptoms like the KO (102). 
Assuming that the single point mutation does not substantially modify ClC-7’s 
architecture, a reasonable assumption based on ClC crystal structures (3), these results 
argue that the transporter activity of the protein is essential and a Cl- channel cannot 
substitute. The Jentsch lab has postulated that a specific concentration of Cl- is required 
for proper lysosomal function, pointing out that two hydrolyses have been shown to 
display [Cl-]-dependent activity (103-105, 107). Results from a mathematical model of 
lysosomal acidification indicate that a ClC-7 transporter generates higher lysosomal 
luminal [Cl-] than a channel (106) and, when combined with a recent paper arguing that 
high luminal Cl- is necessary for proper lysosomal function, suggests an important 
function for the transporter function of ClC-7.  
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However, ClC-7 still seems to be important for acidification, at least in some 
situations. Experiments performed by Maxfield et al. indicate that ClC-7 is important for 
lysosomal acidification in primary microglia and its knockdown yields more basic 
lysosomes (115). This could indicate a cell type dependent response where either the 
requirement for ClC-7 or the ability to compensate for a lack of ClC-7 varies between 
tissues. Interestingly, the times when ClC-7 has been observed to modify lysosomal pH 
in live cells are when the protein was knocked down, not completely removed, as shown 
by the Maxfield lab, the Graves et al. paper, and additional unpublished observations 
using U2OS cells from our lab (S.B. Lioi and J.A. Mindell). Perhaps knocking down 
ClC-7 partially affects the cell but its complete removal somehow triggers an unknown 
compensatory mechanism.   
ClC-7 is likely important in protein-protein interactions as well. The Jentsch lab 
generated a transport-deficient (Td) ClC-7 mouse, which expresses a ClC-7 with 
mutation that completely prevents ion conductance (116). The Td mouse had the same 
osteopetrosis and neurodegeneration defects as the KO, but had a normal coat color, 
indicating a signaling based role for ClC-7 (102, 116).  A potential new role of ClC-7 in 
lysosomal physiology has been hinted at in a paper studying the effects of a drug that 
inhibits the endolysosomal lipid kinase PIKfyve (phosphatidylinositol-3-phosphate 5-
kinase) (117). Gayle et al. found that the PIKfyve inhibitor Apilimod has selective 
cytotoxic activity in B-cell non-Hodgkin lymphoma (B-NHL) compared to normal cells 
(117), but a CRISPR knockout of ClC-7 or Ostm1 prevented the phenotypical formation 
of cytosolic vacuoles and abolished the killing effect. Although the signaling pathway 
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and mechanism by which PIKfyve interacts with these proteins is unknown, it hints at a 
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Lysosomes, the most acidic organelles in the endocytic pathway, are responsible for 
macromolecule degradation. The acidic pH is created and maintained by the V-ATPase, a 
rotary pump that uses ATP hydrolysis to pump protons into the organelle lumen. Proton 
pumping is electrogenic and movement of a neutralizing current (known as a counterion) 
must occur simultaneously to allow proper acidification. ClC-7, a 2Cl-/H+ antiporter 
located in the lysosomal membrane, is the primary pathway of Cl- into the organelle and is 
thought to provide an anion as a neutralizing counterion to assist in acidification, although 
this role has been highly debated. In this paper, we present two patients with an identical 
pathogenic de novo variant in CLCN7, a single missense mutation of Y715C, as revealed 
by whole exome and genome sequencing. The patients display hypopigmentation, a delay 
in gross and fine motor skills, abnormal liver/spleen/kidneys, and failure to thrive. 
However, unlike every other reported ClC-7 mutation in humans, they display no 
osteopetrosis. Fibroblasts isolated from both patients contain large vacuoles scattered 
through the cytoplasm, but they do not stain for lysosomal markers. However, patients 
possess a vast increase in the number of lysosomal-like compartments that do stain for 
Lamp1. Lysosomal pH in cultured patient fibroblasts are more acidic than the neonatal 
controls and heterologous expression of the mutant ClC-7 in Xenopus oocytes revealed 
substantial increases in transport activity. These results suggest a gain-of-function of this 
Cl-/H+ antiporter, causing dysregulation of the acidification of lysosomes and lysosome-






Lysosomes are the terminal organelles of the endocytic pathway that are 
responsible for macromolecule degradation. They rely on a precise, acidic luminal pH for 
optimal function, including enzymatic activity and the coupled transport of intracellular 
catabolites. Defects in lysosomal channels or transporters can lead to a variety of 
physiological disruptions, including neurodegeneration and lysosomal storage disease (99, 
100, 125, 126). Lysosomal acidification is maintained by various ion channels and 
transporters that control movement of H+, Cl-, and possibly other ions across the lysosomal 
membrane (26, 27, 44, 145). The rotary pump V-ATPase is responsible for the active 
accumulation of H+ to maintain acidic pH, but luminal acidification also requires a 
neutralizing current, referred to as the counterion pathway (4, 26, 91). This may be in the 
form of a cation exiting the lysosome or an anion entering the lumen.   
CLCN7, encoding ClC-7, is a member of the ClC gene family of Cl− channels and 
Cl−/H+ exchangers (146, 147).  Four of the nine mammalian ClC proteins are plasma 
membrane Cl- channels (ClC-1, -2, -Ka, -Kb) (148-151), while the rest are antiporters (ClC-
3, -4, -5, -6, -7), all of which are localized to various organelles along the endolysosomal 
pathway (58, 62, 99, 120, 147, 152, 153). Specifically, ClC-7 is found in late endosomes 
and lysosomes, where it provides the primary permeation pathway for Cl- through the 
lysosomal membrane (44). Inactivating mutations in CLCN7 and its β-subunit Ostm1 cause 
both autosomal dominant and recessive forms of osteopetrosis and neurodegeneration (47, 
126). In humans, Albers-Schonberg disease, or autosomal dominant osteopetrosis type II, 
is the most common form of osteopetrosis caused by mutations in ClC-7 (127). Of the more 
than 40 different reported missense, disease-causing mutations in ClC-7, occurring in 
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various locations throughout the protein, all have resulted in osteopetrosis (to varying 
degrees of severity) (128) and no gain-of-function ClC-7 mutations have been described. 
Here we describe two patients who presented with cutaneous albinism, global 
developmental delay, hepatosplenomegaly, and failure to thrive, but without osteopetrosis; 
one child also had gut dysmotility leading to total parenteral nutrition dependence. Electron 
microscopy of the gut, liver and skin tissue revealed accumulation of autophagic vacuoles 
and abnormal lysosomal morphology. Whole exome and genome sequencing revealed an 
identical pathogenic de novo variant in CLCN7 in both patients. Similar phenotypical 
results are seen in a CRISPR mouse containing the same mutation.   Measurement of 
lysosomal pH revealed increased acidity in vivo in fibroblasts cultured from the both 
patients compared to a neonatal control. Heterologous expression of the mutant ClC-7 in 
Xenopus oocytes revealed substantial increases in transport activity, suggesting a gain-of-
function of this chloride/proton antiporter, causing rampant dysregulation of the 
acidification of lysosomes and lysosome-related organelles.   
 
 
MATERIALS AND METHODS 
Patients 
Proband 1 was enrolled in the NIH Undiagnosed Diseases Program (154, 155) and admitted 
to the National Institutes of Health Clinical Center (NIH-CC) under clinical protocol 15-
HG-0130, "Clinical and Genetic Evaluation of Patients with Undiagnosed Disorders 
Through the Undiagnosed Diseases Network", approved by the National Human Genome 
Research Institute (NHGRI) Institutional Review Board (IRB). Written informed consent 
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For Proband 1 and her family, genomic DNA was extracted from whole blood using the 
Gentra Puregene Blood Kit (Qiagen, Valencia, CA). Whole Genome Sequencing was 
performed using the Illumina HiSeq X sequencing platform and aligned to human reference 
GRCh37. Variants were filtered based on allele frequencies in the UDP (156-158), cohort 
(<0.06) Sanger dideoxy sequencing was performed by Macrogen (Rockville, MD, USA); 
the sequences were analyzed with Sequencher v.5.0.1 (Gene Codesm Ann Arbor, MI, 
USA).  
 
Tissue and Cell Studies 
Standard procedures were used for light and electron microscopy. Primary dermal 
fibroblasts were cultured from forearm skin-punch biopsies as described (159). 
Melanocytes were derived from the same skin biopsy and processed as described in 
Supplemental Methods. Control fibroblasts and melanocytes were purchased from ATCC 
(PCS201-012) and Corriel (GM23972A). Fibroblasts from a patient with NPC were 
obtained from Dr. Forbes Porter (NIH) served as a positive control for acidification studies. 
 
For Lysotracker studies, cultured fibroblasts were plated at 6,000 cells/well into 96-well 
cell-culture microplates [GBO #655090] and incubated with 83.3 nM LysoTracker Red 
DND-99 (Thermo Fisher Scientific, L7528) at 37°C for 1 hour. They were imaged on an 
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InCell Analyzer 2200, using the Dapi, Texas Red, and Brightfield channels, with intensity 
of LysoTracker per cell used as an outcome measure. Primary patient fibroblasts were 
compared to positive-staining NPC-25 fibroblasts and 3 negative control cell lines (Coriel 
GM23972A; ATCC PCS201-012; ATCC neonatal WT, etc). Immunofluorescent studies 
employed the following primary antibodies: Lamp1 (H4A3, DSHB), Lamp2 (DSHB, 
H4B4), and CD63 (DSHB, H5C6) for lysosomes. Alexa Fluors 488 and 594 (donkey-anti-
mouse, ThermoFisher Scientific) were used as secondary antibodies. Hoescht 33342 
(ThermoFisher Scientific) was used to visualize the nucleus. 
 
To measure lysosomal pH, 50,000 cells were incubated with 3.5 mg/mL Oregon green 
488 10,000 MW dextran (ThermoFisher Scientific D7170) overnight on chambered 
coverglass slides (Nunc Lab-Tek II; 155382PK) Upon dextran removal, cells were rinsed 
3x with PBS, and chased in dye-free media for 4 hours. Ratiometric, fluorescent images 
were collected using a Ziess Observer Z.1 widefield microscope and a CCD camera 
(Photometrics CoolSNAP HQ2). Excitation bandpass filters 440/40 and 485/20 were 
used to excite the Oregon Green 488 fluorophore, and a 506nm dichroic filter with a 
bandpass filter 534/42 was used to collect the emission at both excitation wavelengths. 
Cells were imaged in medium 2 (in mM: 150 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 20 hepes, 
10 glucose, 30 sucrose; pH 7.4 with HCl) (142). Greater than 15 cells/experimental 
condition were imaged. An Oregon Green calibration curve was determined by 
incubating cells with buffers titrated at half pH unit increments, from pH 4.0-7.0 +/- 0.01, 
and 10µM each of Monensin and Nigericin (Sigma M5273, N7143). The calibration 
buffers contained imaging media and a designated buffer (for pH 4.0-5.5, 50mM Tris-
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maleate; for pH 6.0, 25mM Na2HPO4 and 25mM Tris-maleate; for pH 6.5-7.0, 50mM 
Tris-maleate). Cells were incubated for five minutes prior to imaging to allow for pH 
equilibration across all membranes. The well was rinsed thoroughly after each pH 
measurement before the next pH buffer was added. Images were analyzed using the 
Matlab-based program Slicer2D, created for lysosomal analysis by the CIT group under 
the direction of Calvin Johnson and Huey Cheung at NIH (details in Chapter 3). To 
convert ratio to pH, lysosomes from each pH value were averaged and data fit to a four-
parameter sigmoidal equation. The pH values for individual cells were interpolated using 
the sigmodal equation values. For chloroquine treatments, the designated concentration of 
drug (Sigma C6628) was incubated with the cells overnight. 
 
Electrophysiology analysis  
Expression constructs  
c-Myc-tagged CLC-7 and c-myc-tagged OSTM1 constructs (RC203450 and RC209871, 
respectively, from ORIGENE) were subcloned into pGEM-HE2 vector for heterologous 
expression in Xenopus laevis oocytes. Y715C point mutation was made using the 
Quikchange II site directed mutagenesis kit (Agilent Technologies). All constructs were 
confirmed by sequencing the complete ORF. 
 
Voltage-clamp Xenopus laevis oocytes 
Xenopus laevis oocytes were injected with cRNA (23 ng for myc-tagged ClC-7 constructs 
and additional 23 ng for myc-tagged Ostm1) which was transcribed with the mMessage 
Machine kit (Ambion) from pGEM HE-2 vector. After a 5-day incubation at 17°C, 
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currents were measured using standard two-electrode voltage techniques (OC-725C; 
Warner Instruments) in ND96 (96 mM NaCl, 2 mM KCl, 5 mM HEPES, 1 mM MgCl2, 
and 1.8 mM CaCl2 at pH 7.6 with NaOH). Microelectrode resistances were 0.1–1 MΩ 
when filled with 3M KCl. All experiments were performed at room temperature (~22°C). 
 
Detection of Surface Protein 
Surface expression of protein was determined 6 days after cRNA injection by surface 
using the procedure of Silberberg et al (2005) with slight modifications (160). 5 d after 
injection of cRNA, oocytes were incubated for 30 min at room temperature with Sulfo-
NHS-LC-Biotin (0.5 mg/ml; Pierce Chemical Co.) in ND96 buffer containing (in mM) 96 
NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, pH 7.6. After washing six times in ND96 
buffer, oocytes were homogenized in 400 μl of buffer H containing (in mM) 100 NaCl, 
20 Tris.Cl, pH 7.4, 1% Triton X-100, 5 μl/ml protease inhibitor cocktail (Roche). 
Homogenization and all subsequent steps were performed at 4°C. After centrifugation at 
16,000 g for 2 min, a 20-μl aliquot of the supernatant (total protein) was mixed with 
equal volume of 2× LDS sample buffer plus reducing agent: 50% 4× LDS sample buffer 
(Invitrogen), 20% 2-mercaptoethanol, 100 mM DTT. The remaining supernatant was 
diluted 1:1 with buffer H plus 60 μl of nuetravidin agarose beads (Thermo Fisher) and 
then tumbled gently overnight at 4°C. The nuetravidin agarose beads were washed six 
times with buffer H with a 2-min centrifugation (16,000 g) between each wash. At the 
end of the final wash, 30 μl of 1× LDS sample buffer plus reducing agent was added to 
the beads and samples were heated at 95°C for 10 min. Following a 2-min centrifugation 
(16,000 g), the supernatant (surface protein) and total protein (collected earlier) were 
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separated in a 10% Nu-Page Bis-Tris gel (Invitrogen) using a Nupage MOPS SDS 
Running Buffer (Invitrogen). PageRuler Plus (Thermo Fisher) was used as the protein 
molecular weight marker. Protein in the gel was transferred to PVDF membrane (Life 
Technologies) where the NuPAGE transfer buffer (Life Technologies) with 20% 
methanol. The nitrocellulose membrane was probed with mouse anti-myc antibody 
(Santa Cruz Biotechnology) diluted 1:1000 in TBST containing (in mM) 150 NaCl, 25 
mM Tris-base, 0.1% Tween-20, 5% milk (Carnation), and CLC-7 expression was 
detected using ECL Super Signal West Femto Western blotting detection reagents 
(Thermo Fisher). The mutant Shaker potassium channels was used as a control lacked 






Proband 1 (Fig. 1A) was a 22-month-old white female with intrauterine growth 
retardation born at 36 weeks’ gestation having white hair, eyebrows, and eyelashes but 
pigmented irides. At 2 months, total parenteral nutrition was instituted for poor weight 
gain, vomiting, and diarrhea, and hepatosplenomegaly was noted. Skeletal survey (9 
months) showed right hip dislocation and segmentation abnormalities of T1 and T2 (not 
shown).  
On admissions to the NIH Clinical Center at 18 and 22 months, weight, length, and 
head circumference were at the third percentile for age. The face was nondysmorphic (Fg. 
1A).  There were delays in gross and fine motor skills with poor head control, but social 
interactions were normal. Muscle mass was decreased in the lower extremities, with limited 
range of motion in the ankles, diffuse hypermobility of the upper extremities, and 
generalized hypotonia. Visual acuity was 1.3 cy/cm (Teller Acuity Cards) or 20/600 
(Snellen), with an optokinetic nystagmus response; fixation was central, steady, and 
maintained. The eyelashes displayed poliosis and the pupils were responsive to light. 
Ocular motility, visual pursuit, and saccades were normal. The retinas had no cherry red 
spots, but an electroretinogram showed scotopic amplitudes 40% of normal and photopic 
response amplitudes 50% of normal. Auditory steady state response thresholds predicted a 
profound hearing loss at 2000 Hz and 4000 Hz in the right ear; the neurodiagnostic auditory 
brain response was effectively absent.  
Ultrasound showed enlarged liver and spleen, increased liver echogenicity 
compatible with steatosis or glycogen storage, and poor cortical-medullary differentiation 
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in the kidneys (Fig. 1C). MRI showed delayed myelination similar to that at 5 months of 
age, a thin posterior corpus callosum, hyperintensity of the brainstem, particularly in the 
subthalamic nuclei, and atrophy of the cerebellar vermis and hemispheres (Fig. 1E). Skull, 
spine, long bone, hands and feet radiographs were normal, with no sign of osteopetrosis. 
Hemoglobin was 7.4 g/dL (normal, 10.2-12.7); serum sodium was 146 mmol/L (normal, 
136-145), serum chloride was 114 mmol/L (normal, 98-107), and there was generalized 
aminoaciduria, but serum liver function tests were normal. Electron microscopy of liver, 
duodenal and skin biopsies showed cytoplasmic inclusions containing amorphous floccular 
material suggestive of storage (Fig. 1G).  
Proband 2 (Fig. 1B) was a 14-month-old Ghanaian male born whose prenatal 
ultrasound revealed shortened long bones, prefrontal edema, and polyhydramnios. At birth 
after 37 weeks’ gestation, weight and length were appropriate, skin and hair were 
hypopigmented, and ankyloglossia was present. Ophthalmological exam at 6 weeks was 
unremarkable. At 4 months, weight and length had fallen below the second percentile, with 
head circumference at the fifth to tenth percentile. Development was appropriate for age.  
At 8 months, the anterior fontanelle measured 2x2 cm, and there was complete head 
lag. Posterior auricular papules, epicanthal folds, hypertelorism, thickened gingivae, short 
sternum, and single palmar creases were noted. The skin was decorated with nevi and café-
au-lait macules. The liver was echogenic, suggesting steatosis. A polymorphic pericentric 
inversion was present on chromosome 9 (p11q13). SNP microarray and extensive genetic 
and biochemical studies were normal. Urine oligosaccharide analysis suggested a 
mucopolysaccharidosis or mucolipidosis, but urine free sialic acid and glycosaminoglycans 
were normal.  
130 
 
After 8 months of age, the infant had poor growth, diarrhea with hypoalbuminemia, 
fevers, dehydration, and metabolic acidosis; at 11 months, a gastrostomy tube was placed. 
At 12 months, the kidneys had doubled in size and showed poor corticomedullary 
differentiation (Fig. 1D); hepatomegaly was present but not splenomegaly. There was no 
radiographic evidence of dysostosis multiplex or osteopetrosis on skeletal survey. Brain 
MRI showed delayed myelination, prominent subarachnoid spaces and abnormal signal 
intensity in the cerebral peduncles, pons and brainstem, but no leukodystrophy (Fig. 1F). 
A renal biopsy revealed marked distention of the medullary interstitium by lipid-laden 
macrophages; electron microscopy showed lipid inclusions in mesangial cells, medial 
myocytes, and some tubular epithelial cells, with rare inclusions in podocytes and 
endothelial cells of small arteries (Fig. 1H). At 13 months, the boy had tachycardia, 
sustained clonus, and myoclonic jerks involving the lower extremities.  
 
WES identifies a de novo mutation in CLCN7.  
Whole exome sequencing (WES) of both patient cases identified a de novo variant in 
CLCN7, a single point mutation in one allele that mutates Tyr715 to cysteine 
(NM_001287.5: c.2144A>G, p.Tyr715Cys; RCV000412760.1) (Fig 2A). 
Dideoxynucelotide sequencing of whole blood DNA from the parents and unaffected 
sibling of Proband 1 confirmed the de novo pattern of variance (Fig. 2B).  First pass 
analysis of the whole genome sequencing using Carpe Novo software revealed no 
additional clinically relevant variants. The heterozygous variant is located in a highly 
conserved amino acid portion within the C-terminal, cytoplasmic CBS domain and is 
distinct from any previously documented mutations (Fig. 2A and C). The Y715C 
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mutation is predicted to be pathogenic by various in silico analyses. Further confirming 
the sequencing results, a CLCN7 Y713C heterozygous knock-in CRISPR mouse also 
manifests splenomegaly and hair hypopigmentation, but does not appear to have 
osteopetrosis (data not shown). Given that all previously known missense or loss of 
function mutations of ClC-7 lead to some form of osteopetrosis, which is absent from 
both patients, we hypothesized that the pathogenic effects of the heterozygous Y715C 
mutation might result from a gain-of-function mutation in the protein.   
Figure 1: Clinical and histological features of Proband 1 and Proband 2 
Figure from the UDP clinical group 
(A) Proband 1 has cutaneous albinism with normally pigmented irides and no facial 
dysmorphisms. (B) Proband 2 has hypopigmentation compared to his African parents. (C) 
Abdominal ultrasound of the left (i) and right (ii) kidney of Proband 1, enlarged to over 10 cm 
in length. (D) Abdominal ultrasound the left (i) and right (ii) kidney of Proband 2, enlarged to 
over 10 cm in length. (E), (F) Brain MRIs of Proband 1 at 20 months (E) and Proband 2 (F) at 
12 months. Both MRIs show delayed myelination, a thin posterior corpus callosum, 
hyperintensity of the subthalamic nuclei, and cerebellar atrophy. (G) Transmission electron 
micrographs showing abnormal cytoplasmic inclusions (arrowhead), sometimes containing 
amorphous floccular storage material (double arrowhead), in the macrophages of the liver and 
histiocytes of the duodenum. Similar cytoplasmic inclusions were found in the skin of Proband 
1. Scale bar = 1µm. (H) Transmission electron micrograph showing storage in the kidney of 
Proband 2. There are numerous interstitial macrophages filled with abundant cytoplasmic 





















Figure 2: de novo mutation in CLCN7 located in the CBS domain 
Figure from the NIH sequencing group (A-B) and the Mindell lab (C) 
(A) Figure shows the exons and protein domains of ClCN7 with reside 715 highlighted below 
the red arrow and markings indicating pathogenic variants. (B) Sequence alignment of the 
small region flanking amino acid 715 comparing Proband 1 to her parents and unaffected 
sibling. Proband 2 is shown below with the same mutation as Proband 1. (C) Model of the 
eukaryotic cmClC homodimer with the crystal structure of ClC-7 with the mutated Y715C, 




Patient fibroblasts contain vacuoles surrounded by lysosomal markers  
Tissue biopsies from patients show lysosomal storage disease characterized by 
numerous large ‘vacuoles’. Similarly, fibroblasts cultured from both patients contain a 
striking number of vacuoles scattered throughout the cytoplasm (Fig. 3A). The vacuoles 
are varied in size; some cells contain a multitude of tiny vacuoles, others contain a couple 
large vacuoles that fill most the cytoplasm, and other cells contain a mixture of vacuole 
sizes (Fig 3B). Additionally, some patient fibroblasts appear substantially larger than 
controls and they typically have tiny vacuoles. Electron micrographs show that the 
vacuoles appeared to be empty (data not shown) and we have not been able to determine 
their contents. The vacuoles did not stain for the lysosomal membrane marker Lamp1 (Fig 
3C), nor for early or late endosomal markers (EEA1, Rab7) (data not shown). However, 
the vacuoles were surrounded by puncta of LAMP-1 staining, suggesting the presence of 
intact lysosomes. Similarly, Lysotracker red, a membrane permeable dye that accumulates 
in acidic compartments, appeared to primarily stain the areas around the vacuoles (Fig 5A).  
 
 
Figure 3: Fibroblasts isolated from Proband 1 and Proband 2 have cytoplasms filled 
with vacuoles 
Raluca-Elena Nicoli (A and C) and Mary Weston (B) contributed to this figure 
(A) Brightfield images of Proband 1 and Proband 2 fibroblasts with extreme vacuolization. 
(B) Brightfield images of Proband 1 showing the variation in vacuole size in individual 
cells. (i) shows large vacuoles (white arrow) and tiny vacuoles (yellow arrow). (ii-iv) show 
examples of a small, a mixture of, and an extremely large vacuole, respectively. (C) 












Electrophysiological characterization of the T715C ClC-7 mutant 
To assess if the disease-causing T715C mutation changed the transporting properties of the 
protein, we expressed human ClC-7 (along with its β-subunit Ostm1) with or without the 
T715C mutation in Xenopus oocytes after introducing additional mutations that redirect the 
transporter to the plasma membrane (128). Oocytes expressing WT ClC-7 had strongly 
outwardly rectifying currents that are activated ~+20 mV, similar to published results (128) 
(Fig 4A-B). The T715C mutant was also outwardly rectifying, but was activated closer to 
0 mV and had a substantial (~3-fold) increase in the outward currents compared to WT 
(Fig. 4A-B), a highly reproducible result when measured on 3 separate batches of oocytes 
(Fig 4D). Surface biotinylation experiments indicated that similar amounts of WT and 
mutant protein are trafficked to the plasma membrane (Figure 4C), verifying that the 
increase in mutant current is not from a different levels of protein expression. We obtained 
the time constants of activation and deactivation from 0-80 mV, the potentials at which the 
protein is activated, by obtaining single-exponential fits of the rectifying current 15 ms 
after the voltage step to the respective voltage. These values, independent of the protein 
expression, fit to a single exponential and show that the mutant currents have a faster 
activation than WT and display larger and more slowly decaying tail currents at positive 
voltages (Figure 4E-D). Changing the external Cl- concentration revealed similar shifts in 
reversal potential for WT and T715C currents (data not shown), suggesting that the 2:1 Cl-
/H+ stoichiometry of the WT transporter is unchanged in the mutant protein (128). If ClC-
7 is an important component of the lysosomal acidification mechanism, then the observed 
increase in Cl- current in the mutant transporter could facilitate increased H+ transport into 














Figure 4: Electrophysiology of ClCN7 Y715C Mutant 
Alissa Becerril contributed this data. 
(A) I-V plot of the mean ± SEM of currents from one experiment reached after 2s plotted 
as a function of voltage (Y715C, n=6; WT, n=8; uninjected, n=3 oocytes from 1 batch).  
(B) Western blots of surface and total hClC-7 and Y715C expression. Total lysate (i) and 
neutravidin bead (ii) pulldown of +biotin/-biotin myc-tagged hCLC-7 WT, Y715C, and 
non-conducting Shaker K+ channel (positive control). Each lane in (i) contains 30 µL of 
total cell lysate obtained from 20 oocytes either pretreated with biotin or not. Each lane in 
(ii) contains neutravidin bead pulldown of (i) pretreated with biotin (+) or not (-). 
Molecular weight markers are in kDa. Oocytes were injected at the same time as those 
from (A).  
(C) Time constants of activation (τ) of hCLC-7 WT (blue) and Y715C (red) were obtained 
by single-exponential fits to the rectifying current from 15 ms after a voltage step to 
respective voltages. Shown are the mean ± SEM. Data obtained from the same oocytes as 
(A). 
(D) Time constants of deactivation (τ) of hCLC-7 WT (blue) and Y715C (red) were 
obtained from single-exponentials fits to tail currents 15 ms after a voltage step to -80 
mV, following a 2s pulse to respective voltages (mean ± SEM. Same oocytes as (A)).  








Lysosomal pH is decreased in fibroblasts with a Y715C mutation in CLCN7 and 
treatment with chloroquine rescues the hyperacidity 
If mutant ClCN7 facilitates increased Cl- movement into lysosomes, then the anion 
may act as a counterion and allow a greater number of H+ to enter the lysosome, resulting 
in a more acidic luminal pH. We tested this prediction qualitatively with Lysotracker, a 
membrane permeable dye that accumulates in acidic compartments. While not quantitative, 
the more acidic the compartment, the greater the accumulation of dye and the more 
fluorescent the sample. We found that the fibroblasts of Proband 1 accumulated ~7-fold 
more lysotracker compared to wild-type controls, and ~3-fold more than our positive 
control, NPC25 cultured fibroblasts (Fig. 5A-B), highly indicative that lysosomal pH is 
more acidic in the Y715C patient cells. 
We sought to confirm the change in a quantitative manner by measuring lysosomal 
pH in cultured fibroblasts from both patients and neonatal controls using the ratiometric 
dye Oregon Green 488-dextran (OGD). After incubating fibroblasts with the dextran 
overnight, the dye is endocytosed and trafficks to lysosomes (Fig 5D). In patient cells, the 
dextran accumulated only in small punctate compartments in the spaces between the large 
vacuoles and, like the Lamp1 staining pattern (Fig 3C), the large vacuoles failed to 
accumulate a substantial amount of dye (Fig 5C-D). This pattern is very different from the 
control, where dye is accumulated in a fewer number of distinct compartments. The 
fluorescent signal from the Proband 1 cells was ~4 times that of control fluorescence, 
indicating an increased amount of internalized dye (Fig 5C), as assessed after 4 and 16hrs 
of incubation with dye. Ratiometric imaging revealed that the lysosomes in cultured 
fibroblasts of both patients exhibited significantly lower luminal pH than those in control 
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cells (Fig 5E-F). These results show that a mutation in ClCN7 affects lysosomal pH, a role 
that has previously been highly debated (26, 93), possibly caused by the increased transport 
capabilities of the mutant transporter.  
Hyperacidic lysosomal pH may influence the enzymatic function of the lysosome 
and/or could be contributing to the accumulation of vacuoles. Thus, returning lysosomal 
pH back to normal levels is a potential therapeutic treatment. To achieve this, we tested the 
effects of the antimalaria drug chloroquine, a weak base that accumulates in acidic 
compartments and increases lysosomal pH (161), on the lysosomal pH of the fibroblasts. 
Patient cells incubated with chloroquine displayed reduced lysosomal pH in a dose-
dependent fashion when evaluated with OGD or lysotracker over 24 or 72 hrs, respectively 
(Fig. 6). However, as far as we can tell, the size of the vesicles remained unchanged. In the 
future, we will explore if longer periods of treatment may assist in reducing vacuole 










Figure 5: Y715C patient fibroblasts have hyperacidic lysosomes 
Raluca-Elena Nicoli (A and B) and Mary Weston (C-F) contributed to this figure. 
(A) Fluorescent images of control and patient fibroblasts incubated with LysoTracker Red 
for one hour. (B) Quantitative data of the fluorescence from (A), expressed as intensity of 
lysotracker.(C) Representative brightfield images of identical exposure levels of control and 
Proband 1 fibroblasts incubated with FITC-dextran for 4 or 16hrs and fixed with PFA. (D) 
Representative confocal images of control and Proband 1 fibroblasts incubated with Oregon 
Green 488 overnight. (E) Representative data from one experiment measuring lysosomal 
pH of neonatal control, Proband 1, and Proband 2. Each dot represents the average 
lysosomal pH of a single cell. The black points are the average and SEM for each cell type. 
(F) The average and SEM of the lysosomal pH from multiple experiments for Proband 1, 
Proband 2, and control neonatal fibroblasts loaded with Oregon Green 488-dextran. A 















Figure 6: Lysosomal pH of Y715C fibroblasts and treatment with chloroquine 
Raluca-Elena Nicoli (A and B) and Mary Weston (C) contributed to this figure. 
(A) Fluorescent images of Proband 1 fibroblasts treated with 0-40 nM chloroquine for 72 
hrs and incubated with LysoTracker Red for the final hour prior to imaging. 
(B) Quantitative data of the fluorescence from (A), expressed as intensity of lysotracker. 
(C) Proband 1 fibroblasts loaded with Oregon Green 488-dextran and incubated with the 
designated concentration of chloroquine for 18hrs and a non-drug control. Each dot 
represents the average lysosomal pH of one cell and the black points represent the average 




Loss-of-function and dominant negative mutations in CLCN7 lead to osteopetrosis 
and lysosomal storage disease (LSD) in mice and humans, caused by a plethora of 
cellular defects that include delayed degradation of endocytosed proteins and reduced 
acidification of the resorption lacuna (99, 100, 103). In this paper, we presented two 
patients with an identical pathogenic de novo variant in CLCN7, who display 
hypopigmentation, a delay in gross and fine motor skills, abnormal liver/spleen/kidneys, 
and failure to thrive. However, unlike every previously reported CLCN7 mutation, neither 
patient displays osteopetrosis. Lysosomal pH in cultured patient fibroblasts are more 
acidic than neonatal controls and electrophysiological measurements of the mutant 
transporter show altered gating and increased current, reflecting an increase in the 
turnover rate of transport. The simplest model to explain these results posits that 
increased turnover of lysosomal ClC-7 provides an increased counterion conductance 
which facilitates increased proton transport via the lysosomal V-ATPase and results in 
increased lysosomal acidity. These results clearly show that ClC-7 is involved in 
lysosomal pH, a role that is strongly debated (26, 93). We speculate that the numerous 
cellular and physiological defects observed in both patients result from the downstream 
sequalae of the hyperacidified lysosome, given the exquisitely tuned pH sensitivity of 
many lysosomal processes.   
We presented two patients with an identical heterozygous point mutation of Y715C in 
CLCN7. This de novo mutation results in a striking cellular phenotype – the cytoplasm is 
filled with vacuole-like compartments that greatly vary in size (Fig 3). These vacuoles 
did not stain for various endosomal and lysosomal markers and their composition remains 
144 
 
unknown. Further, the origins of the vacuoles remain unknown as well – are they derived 
from lysosomes, a different organelle, or an accumulation of an inappropriately processed 
material? 
Lysosomes, the most acidic compartment in the cell, creates and maintains its luminal 
pH via the proton pumping action of the V-ATPase. This is an electrogenic process and a 
neutralizing counterion, either a cation or anion, must also move across the membrane to 
dissipate any buildup in membrane potential. ClC-7 is the primary pathway for Cl- into 
the lysosomes (44). Isolated lysosomes from ClC-7 KO animals display reduced 
acidification in comparison to WT, suggesting a role for Cl- as a neutralizing counterion 
in lysosomal acidification (20, 23, 92). Furthermore, siRNA knockdown of ClC-7 has 
been shown to cause a decrease in lysosomal pH in HeLa cells and specialized glial 
macrophages (44, 115). However, the steady-state lysosomal pH in neurons, 
macrophages, and fibroblasts isolated from ClC-7 null mice is unaltered (94, 100, 102).  
Thus, the role of ClC-7 in lysosomal physiology is not clear. These contrasting results 
suggest that a regulatory or compensating mechanism is employed in vivo to regulate 
lysosomal pH, but it may not be sufficient to compensate in all conditions/cell types. 
Interestingly, while knocking out ClC-7 does not appear to affect lysosomal pH, 
suggesting that transporter is not involved in lysosomal pH, our results clearly show that 
ClC-7 is important in lysosomal pH because the Y715C mutation results in hyperacidic 
lysosomes (Fig. 5).  
Mice expressing a mutant form of ClC-7 that uncouples Cl- and H+ transport (“Unc”), 
essentially turning the transporter into a channel, are reported to have less severe 
osteopetrosis symptoms and regain coat color (102). Because a Cl- shunt was unable to 
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compensate for the loss of ClC-7, but the steady state lysosomal pH was similar to WT, 
this suggests that the transporter plays a specific role in regulating the luminal [Cl-], 
possibly controlling the activity of enzymes. In agreement with this argument, molecular 
simulations comparing a lysosomal Cl- channel to an antiporter indicate the transporter 
accumulates a higher concentration of Cl- than the channel (106).  Interestingly, a recent 
paper suggests the importance of high lysosomal Cl-, arguing that luminal [Cl-] in several 
lysosomal disease models is reduced and that lowering luminal [Cl-] reduces the activity 
of two lysosomal enzymes (107). However, [Cl-]-dependent enzymatic activity has not 
been noted in other lysosomal proteins. As opposed to [Cl-]-reducing effects other LSDs 
may exhibit, the Y715C mutant protein may be increasing the lysosomal [Cl-] based on 
the electrophysiology characteristics the mutant has compared to WT (Fig 4). The mutant 
protein appears to conduct about three times the current as WT, in addition to having 
altered gating, possibly affecting the enzymatic activity of the lysosome. Additionally, 
increasing the rate of Cl- transport may be influencing pH, resulting in the observed 
hyperacidification of patient lysosomes (Fig 5).  
A change in the lysosomal pH and/or an increase in luminal [Cl-] may change the size 
and ionic homeostasis of the lysosome (27). Using a mathematical model of lysosomal 
acidification, Ishida et al. predicted that a mixture of cations and Cl- acting as counterions 
would result in the observed lysosomal size (106). However, only using Cl- would likely 
increase the overall number of luminal ions, in turn increasing lysosomal size, possibly 
creating some of the small vacuoles we observed. This may be happening in the patient 
lysosomes. Changes in lysosomal size, ionic composition, or membrane potential may 
have a variety of effects on lysosomal function and trafficking. For example, if luminal 
146 
 
[Ca2+] was reduced, lysosomal Ca2+ channels may not be able to function properly and 
could affect, among other things, organelle fusion (27). Some vacuole formation has been 
observed in cells with non-functional TRPML-1, a Ca2+ channel in lysosomes that signals 
and regulates lysosomal fusion, but the quantity of vacuoles is not as T715C de novo 
patients (CITE). Additionally, the effects on lysosomal pH in TRPML-1 mutants is 
undetermined: different groups have reported hypoacidification, hyperacidification, and 
no change to lysosomal pH (162). However, even with an effect on trafficking, the 
patient cells have many acidic lysosome-like compartments containing Oregon Green 
dextran, implying some level of endosome to lysosome trafficking is likely to have 
occurred. Interestingly, the patient cells appear to endocytose dye at a faster rate than the 
control (Fig 5C), possibly indicating increased endocytosis at the plasma membrane.  
We do not know the physical and structural effects of the Y715C mutation on the 
ClC-7 protein. Changing a tyrosine to a cysteine may have removed a physphorylation 
site, caused a structural change in ClC-7, and/or introduced a sulfur group capable of 
making unwelcome disulfide bonds with another part of the protein structure. These 
changes may affect way ClC-7 interacts with other proteins or lipids. Mice expressing a 
non-conducting ClC-7 mutant (“Td”) still have severe osteopetrosis like a KO animal, but 
regain their coat color, suggesting that the presence of the protein is sufficient to recover 
activity (116). Interestingly, the patients’ de novo mutation affects human pigmentation, 
suggesting that this Y715C may be involved in some sort of signaling pathway or 
complex. A new finding by Gayle et al. hints at a new form of ClC-7 regulation or a 
protein-protein interaction (117). PIKfyve is a phosphoinositol kinase that interacts with a 
scaffolding complex to phosphorylate PI3P to generate PI(3,5)P2, a lipid that assists in 
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endolysomal trafficking and regulation (118). Treatment with the PIKfyve inhibitor 
apilimod has selective cytotoxic activity in B-cell non-Hodgkin lymphoma (B-NHL) 
compared to normal cells, but knocking out ClC-7 or Ostm1 (its β-subunit) abolished the 
killing effect. The reason for this is unknown, but suggests that ClC-7 could be regulated 
by PI(3,5)P2, is a downstream target PIKfyve, or interacts with the PIKfyve complex. 
Interestingly, treating cells with apilimod also induces vacuole formation and, although 
the cells look different than the Y715C patient cells, it is possible that the de novo 
mutation may somehow be related to this pathway. 
 We explored a possible therapy treatment for the patient by treating with 
chloroquine, a malaria drug that increases lysosomal pH. We induced a small shift in the 
lysosomal pH of the patient to a less acidic pH (Fig 6), moving it closer to the range of 
the WT pH. We did not see an effect on the vacuoles in the cytoplasm, but we only 
treated up to 72hrs and longer treatment courses may be necessary to at least partially 
reverse the vacuole phenotype. Thus, chloroquine presents a possible FDA-approved 
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Chapter 5: Concluding remarks  
 
Organelles within the endocytic pathway must strictly maintain their internal pH 
to function properly. While luminal pH is generated and maintained by the V-type 
ATPase (V-ATPase) (4), the voltage-shunting counterions also required to facilitate 
organelle acidification are not clear. Further, the mechanism used to regulate organelle 
pH is not known and, if counterion movement is a rate-limiting step in acidification, 
could be a means of regulation. In most endosomal organelles, Cl- has emerged as the 
primary counterion candidate. 
Counterion movement in endosomes is still not fully understood and part of the 
work in this thesis sought to use clathrin-coated vesicles (CCVs), a subset of early 
endosomes, as a model system of endosomal acidification. We successfully isolated a 
sample of highly enriched bovine brain CCVs that exhibited V-ATPase facilitated 
acidification and required the presence of Cl-, but was independent of the monovalent 
cations present. Our findings were very similar to the acidification properties previously 
reported in both brain and liver CCVs (21, 22, 24), except while other studies found that 
acidification was partially influenced by the cation present (22), our vesicles displayed no 
reliance on cations. Thus, we have the cleanest preparation of CCVs, which further 
highlights the importance of Cl- in acidification. While we were unable to identify the Cl- 
transporting protein responsible for acidification, we did explore solubilization conditions 
that may be useful in future CCV studies.  
In addition to looking at the counterion requirements of CCVs, we functionally 
confirmed that CCVs are primarily composed of synaptic vesicles (SVs). This result 
suggests that the protein facilitating brain CCV acidification is likely to be vGLUT1, a 
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glutamate transporter with a Cl- permeability that, like the CCVs, requires a small [Cl-] to 
facilitate glutamate uptake (67, 141). However, CCVs are present throughout the body, 
while vGLUT1 is primarily expressed in neurons. Since both brain and liver CCVs need 
Cl- to acidify, vesicles from non-neuronal sources may have organ specific Cl- 
transporting proteins and/or counterion requirements. In fact, liver CCVs have a slightly 
different counterion requirement profile in that they do not require Cl- for acidification, 
but its presence greatly enhances the extent of acidification (21), arguing that liver CCVs 
utilize a different method to acidify the lumen. The Cl- acidification in liver may result 
from trafficking Cl- transporting proteins, like intracellular ClCs, around the cell. 
Previous work has indicated the ClC-3, -4, and -5 interact with clathrin (83), and our 
mass spectroscopy results also show that ClC-4 is present in the sample in low quantities. 
Examining CCVs from other organs could provide further insight into the role of Cl- and 
counterions in these early endosomes.  
 Similar to endosomes, Cl- is also a major candidate counterion in lysosomes. 
Much of this thesis was spent on determining if ClC-7, a 2Cl-/H+ transporter, plays a role 
in lysosomal acidification. Early studies have shown that isolated lysosomes appear to be 
permeable to Cl- and K+, and that both ions assist with acidification, although Cl- seems 
to function as the primary counterion (18-20, 23, 92, 95). The primary Cl- permeation 
pathway through the lysosomal membrane is provided by ClC-7 and siRNA knockdown 
of the transporter in HeLa cells, U2OS cells (S.B. Lioi and J.A. Mindell; unpublished 
work), and cultured glial macrophages all result in hypoacidic lysosomes (44, 115). 
Together, these data argue that ClC-7 mediates counterion movement in lysosomes and 
assists in acidification. However, several different studies evaluating the lysosomal pH of 
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murine primary cells that lack either ClC-7 or its β-subunit Ostm1 reveal no significant 
pH change compared to WT, even though the mice themselves have severe osteopetrosis 
and lysosomal storage defects (94, 99, 100, 102, 116). Thus, the role that ClC-7 plays in 
lysosomal physiology is currently under debate.  
We created a ClC-7 liver specific KO mouse to address these conflicting results, 
for the first time directly comparing the acidification properties of isolated lysosomes to 
the lysosomal pH of cultured cells derived from the same tissue. The isolated WT 
lysosomes exhibited Cl--dependent acidification that was absent in KO lysosomes. 
Additionally, we found that H+-driven 36Cl--uptake is abolished in isolated KO lysosomes 
in our experiments, making it unlikely that another protein is providing an alternative Cl- 
permeability pathway in the lysosomal membrane of this system. However, the lysosomal 
pH in cultured KO hepatocytes was similar to WT. We explored the ability of hepatocytic 
lysosomes to respond to stressful conditions by measuring pH after autophagy induction 
and after organelle alkalization by a weak base. Again, the lysosomal pH of KO primary 
hepatocytes matched that of the WT in both situations. The unaltered pH in KO 
hepatocytes is perplexing, but agrees with the existing body of published data obtained 
from several different ClC-7 KO cell types (47, 94, 100, 102).  
While we did not find an obvious role for ClC-7 in hepatocytic lysosomal pH, we 
observed indications that ClC-7 affects metabolism. The KO mouse typically had 
noticeable fat lining the gut that was absent in WT. Additionally, the body weight and the 
liver weight of the KO mouse were 25-30% heavier than WT. These results are consistent 
with those published by Weinert et al., who showed an increase in an autophagy marker 
when a non-conducting mutant ClC-7 was expressed in place of the WT (163). ClC-7 
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may be involved in the vast signaling pathway of mTORC1, the major regulator of 
autophagy and metabolism in the cell, which resides at the lysosomal membrane and 
senses and responds to changes in amino acid levels. Expanding our studies to look at 
various autophagy markers/characteristics in the ClC-7 KO mouse liver, and other KO 
tissues, may increase our understanding of the role of the transporter.  
We characterized the pH lysosomes in cells from two patients with a de novo 
Y715C mutation in a single allele of ClC-7. All other reported detrimental mutations in 
ClC-7 and its β-subunit Ostm1 have resulted in osteopetrosis and lysosomal storage 
disease, but these two patients do not have osteopetrosis and, instead, display 
hypopigmentation, a delay in gross and fine motor skills, abnormal liver/spleen/kidneys, 
and failure to thrive. Unexpectedly, we found that the de novo patient fibroblasts had 
hyperacidic lysosomes compared to a neonatal control. Electrophysiological 
measurements of the mutant transporter showed altered gating and larger current, 
indicative of an increase in the turnover rate of transport, and suggesting that an increase 
in Cl- transport provides additional counterions for acidification. Thus, we present strong 
evidence showing that ClC-7 is important in lysosomal pH. 
How could a single, heterozygous mutation in one allele cause such a significant 
impact? The Y715C mutation, located in the cytoplasmic CBS domain of ClC-7, could 
change the structure of the transporter, result in loss of a phosphorylation site, and/or 
introduce an unwanted disulfide bond. A recent paper suggests that ClC-7 functions 
downstream of PIKfyve, a phosphoinositol kinase that phosphorylates PI3P to generate 
PI(3,5)P2 (117). ClC-7 could itself be a target of the PIKfyve kinase, may be interacting 
with the PIKfyve scaffolding complex, or could be regulated by PI(3,5)P2, an important 
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lysosomal signaling lipid known to regulate other membrane proteins. Interestingly, 
treatment with apilimod also induces vacuole formation in various cell types, although 
the vacuoles look different than the Y715C patient cells, and our unpublished results 
show that apilimod treatment results in hyperacidic lysosomes as well (M.R. Weston and 
J.A. Mindell, unpublished results). Future experiments exploring the effects of apilimod 
on WT, ClC-7 KO, and the Y715C mutant may lend insight as to the interaction of 
PIKfyve and PI(3,5)P2 with ClC-7, and its influence on lysosomal pH.  
We still do not know how to reconcile the conflicting results of how KO ClC-7 
lysosomes cultured from multiple tissues have a normal steady state pH, but hypoacidic 
lysosomes are observed after the KD of ClC-7 with siRNA also occur. Possibly a 
mechanism to compensate for the loss of ClC-7 develops in the KO cells, but the KD 
cells lack enough time to acquire this ability. Measuring lysosomal pH in an inducible 
ClC-7 KO cell line over time could clarify this question and, if lysosomal pH does 
recover, comparing RNA expression at different time points may reveal if a change in 
protein expression is responsible, potentially indicating a compensatory mechanism.  
An alternative compensation mechanism for ClC-7 may be a factor that 
transiently associates with the lysosome on the cytoplasmic side of the membrane, but is 
lost upon lysosome isolation. Our lab added cytoplasm back to isolated lysosomes, but 
saw no change in acidification, making the cytoplasmic factor hypothesis less likely 
(unpublished results, A. Amin and J.A. Mindell). Therefore, because the ClC-7 KO 
hepatocyte lysosomes appear to have little to no Cl- conductance across their membranes, 
the KO lysosomes likely use cations as counterions. Yet, how the lysosome is supplied 
with cations to allow acidification is unclear. While no cation channel has been shown to 
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regulate lysosomal pH under quiescent conditions, the loss of either TMEM175 or 
TPC1/2 (K+ and Na+ channels, respectively) has been shown to result in hypoacidic 
lysosomes upon starvation (110, 113). Comparing the expression levels of these cation 
channels in WT and ClC-7 KO lysosomes may indicate if these proteins are over 
expressed in the organelle.   
ClC-7 asymmetrically affects different processes in the body and the way various 
tissues and cell types compensate for the loss of ClC-7 is unknown. In osteoclasts, the 
resorption lacuna, an external compartment similar to lysosomes, appears less acidic (99). 
Perhaps tissues most affected by a loss of ClC-7, such as brain and bone, either 
compensate differently or place a higher demand on their lysosomes then macrophages 
and fibroblasts, where KO lysosomal pH has primarily been evaluated. Although our 
starvation experiments in KO hepatocytes were not able to reveal a role for ClC-7, 
exploring other means of exerting stress on lysosomes may yet hint as to its function and 
should be pursued. 
The lysosomal luminal [Cl-] may be important for both acidification and general 
lysosomal physiology. Mice expressing a ClC-7 containing a mutation that uncouples Cl- 
and H+ movement, effectively changing the transporter to a Cl- channel, is only able to 
partially compensate for the loss of the transporter, suggesting that ClC-7 is needed to 
provide sufficient luminal [Cl-] (102). A mathematical model of lysosomal acidification 
supports this idea with simulations that predict the 2Cl-/H+ antiporter can generate a 
larger luminal [Cl-] than a Cl- channel (106). The need for luminal [Cl-] is unknown, but 
only a few lysosomal enzymes have reported Cl--dependent activity. However, a change 
in the lysosomal pH and/or an increase in luminal [Cl-] may alter the size, ionic 
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homeostasis, or membrane potential of the lysosome (27). If the Y715C mutant transports 
a greater number of Cl- ions, this may boost the total internal ion composition, causing an 
increase in lysosomal size and potentially creating some of the small vacuoles observed 
in the patient cells. Developing methods to measure ionic concentrations in lysosomes 
will help move the field forward and assist in modeling, calculating membrane potential 
and clarifying if any cation(s) are present at sufficient concentrations to act as a 
counterion during lysosomal acidification. 
Many aspects in lysosomal physiology and pH regulation are open to debate. How 
lysosomal pH is regulated is still unknown, and finding a transporter whose absence 
affects lysosomal pH under quiescent conditions will be enlightening. Perhaps the reason 
the absence of one protein does not affect general lysosomal pH is that regulation is 
performed by many proteins working together. Interestingly, the Y715C mutation may be 
an exception in that it lowers lysosomal pH, a situation for which the cell might not have 
any prevention mechanisms.  
The experiments described in this thesis, using pH-sensitive dyes to measure 
lysosomal pH in various systems, have provided us clues as to the mechanism lysosomes 
use to acidify and have shown a role for ClC-7 in this process. Additionally, these 
experiments have suggested a potential treatment for the CLCN7 Y715C patients, and I 
hope that our research will help alleviate their symptoms. Ultimately, I hope this body of 
work will lead to a better understanding of organelle acidification, the counterions 
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